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Thesis Summary 
 
Human dental pulp stem cells (hDPSCs) are increasingly being recognised as a viable 
cell source in regenerative medicine.  However, significant heterogeneity in their ex 
vivo expansion capabilities are well-established, which influences their multipotent 
differentiation and therapeutic potential. This is partly attributed to contrasting 
telomere lengths between individual DPSC sub-populations influencing their relative 
susceptibilities to replicative (telomere-dependent) senescence, which impairs cellular 
regenerative properties.  This has significant implication for regenerative medicine, in 
terms of obtaining sufficient cell numbers for therapeutic use, whilst maintaining stem 
cell and multipotency characteristics.  As DPSCs have no reverse transcriptase, human 
telomerase catalytic subunit (hTERT) expression, this suggests that other mechanisms 
are responsible for variations in telomere lengths and replicative senescence 
susceptibilities between high and low proliferative DPSCs.  As oxidative stress is a 
well-established mediator of cellular senescence, this study investigated whether 
DPSCs also differed in their susceptibilities to oxidative stress (0-200µM H2O2)-
induced (telomere-independent) senescence and bimolecular damage; and whether 
differences in enzymic antioxidant profiles contribute to contrasting oxidative stress 
responses in high and low proliferative DPSC sub-populations. 
 Significant variations were shown in the susceptibilities of DPSC sub-populations 
to H2O2-induced senescence.  Low proliferative DPSCs underwent accelerated 
senescence (<40PDs) with 0-200µM H2O2 treatments, accompanied by increased SA-
β-galactosidase and senescence marker (p53, p21waf1, p16INK4a) detection.  High 
proliferative DPSCs exhibited increased resistance to H2O2-induced senescence, 
reaching 80PDs (0-50µM H2O2) or 50-76PDs (100-200µΜ H2O2), prior to senescence 
marker detection.  However, telomere lengths and stem cell marker expression were 
largely unaffected by increasing H2O2 treatment or culture expansion.  Enhanced low 
proliferative DPSC susceptibility to H2O2-induced senescence was accompanied by 
increased oxidative stress-induced bimolecular damage at early PDs (2-10PDs), with 
elevated DNA (8-hydroxy-deoxy-guanosine), protein (carbonyl content) and lipid 
(peroxidation) detection, irrespective of H2O2 treatments.  In contrast, high 
proliferative DPSCs exhibited limited oxidative biomolecular damage at early PDs (2-
10PDs), only equivalent to low proliferative DPSCs at much later PDs (45-60PDs). 
 In line with their resistance to H2O2-induced senescence and biomolecular 
damage, significant increases in superoxide dismutase (SOD2) and glutathione S-
transferase ζ (GSTZ1) expression, in addition to significantly increased total SOD 
activities, were identified in high proliferative DPSCs at early PDs (10-25PDs).  
However, SOD1/GSTZ1 expression and total SOD activities significantly declined 
during culture expansion (45-60PDs).  In contrast, low proliferative DPSCs at early 
PDs (2-10PDs) mostly exhibited low/negligible SOD1, SOD2, SOD3, catalase, 
GSTZ1 and other glutathione-related antioxidant expression/activities overall, 
implying that antioxidant mechanisms are impaired in these sub-populations. 
 This study demonstrates that significant variations exist in the susceptibilities of 
high and low proliferative DPSC sub-populations to oxidative stress-induced 
senescence and biomolecular damage, contributed to by inherent differences in SOD2 
and GSTZ1 antioxidant profiles, which help maintain the proliferative, stemness and 
multipotency capabilities of high proliferative DPSCs during ex vivo expansion.  Thus, 
the identification of such contrasting enzymic antioxidant profiles between high and 
low proliferative DPSCs enhances our understanding of DPSC biology and its inter-
relationship with oxidative stress and cellular ageing overall. 
 iv 
Publications and Presentations 
 
Publications 
Alraies A, Alaidaroos NYA, Waddington RJ, Moseley R, Sloan AJ.  Variations in 
Human Dental Pulp Stem Cell Ageing Profiles Reflect Contrasting Proliferative and 
Regenerative Capabilities.  BMC Molecular and Cell Biology (2017), 18:12-25. 
 
Presentations 
Alaidaroos N, Alraies A, Sloan AJ, Waddington RJ and Moseley R.  Dental Pulp Stem 
Cells:  Finding a Needle in a Dental Pulp Haystack.  Speaking of Science Conference, 
Cardiff, UK, May 2015. 
Alaidaroos N, Alraies A, Sloan AJ, Waddington RJ and Moseley R.  Role of Oxidative 
Stress Responses in Clonal Variations in Dental Pulp Progenitor Cell Ageing and 
Regenerative Potential.  30th Annual School of Medicine and Dentistry Postgraduate 
Research Day, Cardiff, UK, November 2015. 
Alaidaroos N, Alraies A, Sloan AJ, Waddington RJ and Moseley R.  Role of Oxidative 
Stress Responses in Clonal Variations in Dental Pulp Progenitor Cell Ageing and 
Regenerative Potential.  31st Annual School of Medicine and Dentistry Postgraduate 
Research Day, Cardiff, UK, January 2017. 
Alaidaroos N, Alraies A, Sloan AJ, Waddington RJ and Moseley R.  Oxidative Stress 
Variations in Dental Pulp Progenitor Cell Ageing/Regenerative Potential.  British 
Society for Oral and Dental Research (BSODR) Annual Meeting, Plymouth, UK, 
September 2017. 
Alaidaroos N, Alraies A, Sloan AJ, Waddington RJ and Moseley R.  Oxidative Stress 
Variations in Dental Pulp Progenitor Cell Ageing/Regenerative Potential.  Cardiff 
Institute for Tissue Engineering and Repair (CITER) Annual Scientific Meeting, 
Cardiff, UK, September 2017. 
Alaidaroos N, Waddington RJ, Sloan AJ and Moseley R.  Role of Oxidative Stress 
Responses in Clonal Variations in Dental Pulp Progenitor Cell Ageing and 
Regenerative Potential.  32nd Annual School of Medicine and Dentistry Postgraduate 
Research Day, Cardiff, UK, January 2018 (poster-prize awarded). 
Alaidaroos N, Waddington RJ, Sloan AJ and Moseley R.  Role of Oxidative Stress 
Responses in Clonal Variations in Dental Pulp Progenitor Cell Ageing and 
Regenerative Potential.  Annual School of Dentistry Research Day, Cardiff, UK, May 
2018. 
Alaidaroos N, Alraies A, Waddington RJ, Sloan AJ and Moseley R.  Antioxidant 
Profiles Reflect Variations in Dental Pulp Progenitor Cell Proliferation/Regeneration.  
International Association for Dental Research (IADR/PER) Annual Meeting, London, 
UK, July 2018. 
Alaidaroos N, Alraies A, Waddington RJ, Sloan AJ and Moseley R.  Antioxidant 
Profiles Reflect Variations in Dental Pulp Progenitor Cell Proliferation/Regeneration.  
Cardiff Institute for Tissue Engineering and Repair (CITER) Annual Scientific 
Meeting, Hensol, UK, September 2018. 
 v 
Glossary of Abbreviations and Nomenclature 
 
3D 3 Dimensional 
4-HNE 4-Hydroxynonenal 
8-OHdG 8-Hydroxy-deoxy-guanosine 
α-MEM α-Modification minimal essential medium 
AB-MSCs Alveolar bone-derived, mesenchymal stem cells 
AD-MSCs Adipose-derived, mesenchymal stem cells 
ALP Alkaline phosphatase 
ANOVA Analysis of variance 
ARE Antioxidant responsive element 
ATP Adenosine triphosphate 
BCA Bicinchoninic acid 
BDNF 
BM-MSCs 
Brain derived neurotrophic factor 
Bone marrow-derived, stem cells 
BMP4 Bone morphogenic protein-4 
BODIPY® Boron dipyrromethene 
BSA 
CAT 
Bovine serum albumin 
Catalase 
CD Cluster of differentiation 
cDNA Complimentary deoxyribonucleic acid 
CO2 Carbon dioxide 
CT Cycle threshold 
Ctrl Control DNA sample 
dCT Delta cycle threshold/difference in cycle threshold 
DDR DNA damage response  
DFPCs Dental follicle progenitor stem cells  
DIG Digoxigenin 
DMSO Dimethyl sulphoxide 
DNA Deoxyribonucleic acid 
DNase Deoxyribonuclease 
DNPH 2,4-Dinitrophenylhydrazine 
dNTPs Deoxyribonucleotide triphosphates 
DPSCs Dental pulp stem cells 
DTT Dithiothreitol 
E Early PDs 
ECL Enhanced chemiluminescence 
EDTA Ethylenediaminetetraacetic acid 
ESC Embryonic stem cell 
EVs Extracellular vesicles 
 vi 
FCS Foetal calf serum 
FGF Fibroblast growth factor 
FITC Fluorescein isothiocyanate 
GDNF Glial derived neurotrophic factor 
GFAP Glial fibrillary acidic protein 
GMSCs Gingival mesenchymal stem cells 
GPX Glutathione peroxidase 
GSH Reduced glutathione 
GSR Glutathione reductase 
GSS Glutathione synthetase 
GSSG Oxidized glutathione 
GST Glutathione S-transferase 
GSTZ1 Glutathione S-transferase ζ 
H2O Water 
H2O2 Hydrogen peroxide 
HCl Hydrochloric acid 
HRP Horseradish peroxidase 
HSC Hematopoietic stem cell 
hTERT Reverse transcriptase, human telomerase catalytic subunit 
Klf4 Kruppel-like factor 4 
ICC Immunocytochemistry 
IL Interleukin 
iPSCs Induced pluripotent stem cells 
L Late PDs 
LANGFR Low affinity nerve growth factor receptor  
LIF Leukaemia inhibitory factor 
LOOHs Lipid hydroperoxides 
MDA Malondialdehyde 
M-MLV Moloney-murine leukaemia virus 
MMP Matrix metalloproteinase 
mRNA Messenger ribonucleic acid 
MSC Mesenchymal stem cell 
MVs Microvesicles 
MW Molecular weight 
NaCl Sodium chloride 
NRES National Research Ethics Service 
NADPH Nicotinamide adenine dinucleotide phosphate 
NGF Nerve growth factor 
Nrf2 Nf-E2 related factor 2 
 vii 
O2 Oxygen 
·O2-
                                    Superoxide radical 
Oct4 Octamer-binding transcription factor 4 
OD Optical density 
ODFR Oxygen-derived free radical 
·OH Hydroxyl radical 
PBS Phosphate buffered saline 
PDLSCs Periodontal ligament stem cells 
PDs Population doublings 
PMSF Phenylmethylsulfonyl fluoride 
PPARγ Peroxisome proliferator-activated receptor-γ 
pRb Retinoblastoma protein 
PRXs Peroxiredoxins 
PVDF Polyvinylidene difluoride 
RIPA Radio-Immunoprecipitation Assay 
RNA Ribonucleic acid 
RNase Ribonuclease 
ROS Reactive oxygen species 
RQ Relative quantification of gene expression 
rRNA Ribosomal RNA 
RT Reverse Transcription 
RT-PCR Reverse transcription-polymerase chain reaction 
RT-QPCR Real time quantitative polymerase chain reaction 
SA-β-Gal Senescence associated β-galactosidase 
SASP Senescence-associated secretory phenotype 
SCAPs Stem cells from dental papilla 
SDS Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
SEM Standard error of the mean 
SHEDs Stem cells from human exfoliated deciduous teeth 
SIPS Stress-induced premature senescence 
SOD Superoxide dismutase 
Sox2 Sex determining region Y-box 2 
SSEA Stage-specific embryonic antigen 
TA Transit amplifying 
TAE Tris acetate 
TBE Tris/borate/EDTA 
TBS Tris-buffered saline 
TGF-β Transforming growth factor-β 
 viii 
TGPCs Tooth germ progenitor cells 
TRF Terminal restriction fragment 
TRITC Tetramethylrhodamine 
TRX Thioredoxin 
UK United Kingdom 
USA United States of America 
UV Ultraviolet  
VEGF Vascular endothelial growth factor  
 
 
Units of Measurement 
 
% Percentage 
°C Degrees Celsius 
×g Gravitational acceleration 
AU Arbitrary units 
bp Base pair 
cm Centimetre 
μm Micrometre 
Nm Nanometre 
g Gram 
kb Kilo base pair 
M Molar 
mM Millimolar 
μM Micromolar 
mg Milligram 
μg Microgram 
ng Nanogram 
l Litre 
ml Millilitre 
μl Microlitre 
h Hours 
min Minutes 
S Seconds 
Rpm Revolutions per minute  
V Volts 
mW Milliwatt  
  
 
 ix 
Table of Contents 
Page 
Chapter 1 – General Introduction .......................................................................... 1 
1.1  Overview ................................................................................................................. 2 
1.2  Stem Cells ............................................................................................................... 3 
     1.2.1  Embryonic Stem Cells ................................................................................ 3 
     1.2.2  Induced pluripotent stem cells .................................................................... 4 
     1.2.3  Adult Stem Cells ......................................................................................... 5 
               1.2.3.1  Mesenchymal Stem Cells ............................................................... 6 
               1.2.3.2  Therapeutic Effects of Mesenchymal Stem Cells .......................... 6 
               1.2.3.3  Challenges with Mesenchymal Stem Cells .................................... 8 
               1.2.3.4  Hierarchical Model of Mesenchymal Stem Cells .......................... 9 
               1.2.3.5  Asymmetric Stem Cell Division .................................................. 10 
               1.2.3.6  Other Types of Adult Stem Cells ................................................. 11 
 1.3  Dental Pulp .......................................................................................................... 13 
          1.3.1  Tooth Development .................................................................................. 13 
     1.3.2  Dental Pulp Stem Cells ............................................................................. 14 
               1.3.2.1  Origin and Sources of Dental Pulp Stem Cells ............................ 15 
               1.3.2.2  Advantages of Dental Pulp Stem Cells ........................................ 17 
               1.3.2.3  Dental Pulp Stem Cells and Dental Tissue Repair ...................... 18 
               1.3.2.4  Dental Pulp Stem Cells and Tissue Engineering ......................... 19 
               1.3.2.5  Heterogeneity and Surface Markers in Dental Pulp Stem Cells .. 22 
1.4  Mesenchymal Stem Cell Expansion and Cellular Senescence ......................... 24 
      1.4.1  Telomere-Dependent Senescence ............................................................ 26 
      1.4.2  Telomere-Independent Senescence .......................................................... 30 
1.5  Oxidative Stress ................................................................................................... 31 
      1.5.1  Reactive Oxygen Species (ROS) ............................................................. 31 
            1.5.1.1  Physiological Role of ROS ............................................................. 31 
      1.5.2  Consequences of Oxidative Damage to DNA, Proteins and Lipids ........ 33 
            1.5.2.1  Effects of Oxidative Stress on DNA ............................................... 33 
            1.5.2.2  Effects of Oxidative Stress on Proteins .......................................... 34 
 x 
            1.5.2.3  Effects of Oxidative Stress on Lipids ............................................. 35 
      1.5.3  Antioxidants Defences Against Oxidative Stress .................................... 36 
      1.5.4  Role of Oxidative Stress and Antioxidants in Mesenchymal Stem Cells...39 
1.6  Aims of Thesis ...................................................................................................... 40 
     Chapter 2 – Assessment of Dental Pulp Stem Cell Susceptibility to Oxidative 
Stress-Induced Cellular Senescence ..................................................................... 42 
2.1  Introduction ......................................................................................................... 43 
2.2  Chapter Aims ....................................................................................................... 46 
2.3  Materials and Methods ....................................................................................... 46 
     2.3.1  Isolation of Dental Pulp Stem Cells .......................................................... 46 
               2.3.1.1  Fibronectin Adhesion Assay for Dental Pulp Stem Cells Isolation 
               ................................................................................................................... 47 
     2.3.2  General Cell Culture  ................................................................................ 48 
               2.3.2.1  Cryopreservation and Cell Retrieval ............................................ 49 
               2.3.2.2  Screening of Mycoplasma Contamination ................................... 49 
     2.3.3  Dental Pulp Stem Cell Expansion Under Oxidative Stress Conditions .... 50 
     2.3.4  Population Doubling Analysis .................................................................. 51 
     2.3.5  Senescence-Associated β-Galactosidase Staining .................................... 51 
     2.3.6  Gene Expression Analysis ........................................................................ 52 
               2.3.6.1  mRNA Extraction ........................................................................ 52 
               2.3.6.2  Reverse Transcription (RT)-PCR ................................................ 53 
               2.3.6.3  Agarose Gel Electrophoresis ....................................................... 55 
     2.3.7  Telomere Length Analysis ........................................................................ 55 
               2.3.7.1  DNA Extraction ........................................................................... 55 
               2.3.7.2  Terminal Restriction Fragment Assay and Southern Blot Analysis 
        .......................................................................................................................... 56 
2.4. Statistical Analysis ............................................................................................... 57 
2.5. Results ................................................................................................................... 58 
     2.5.1  Dental Pulp Stem Cell Population Doublings Under Oxidative Stress .... 58 
     2.5.2  Senescence-Associated β-Galactosidase Staining .................................... 64 
     2.5.3  Senescence Marker Gene Expression ....................................................... 69 
     2.5.4  Telomere Length Analysis ........................................................................ 69 
     2.5.5  Stem Cell Marker Gene Expression .......................................................... 75 
 xi 
2.6. Discussion ............................................................................................................. 78 
     Chapter 3 – Assessment of Dental Pulp Stem Cells Susceptibility to Oxidative 
Stress Induced Biomarker Formation ................................................................. 87 
3.1  Introduction ......................................................................................................... 88 
3.2  Chapter Aims ....................................................................................................... 91 
3.3  Materials and Methods  ...................................................................................... 91 
     3.3.1  Isolation, Culture and Expansion of Dental Pulp Stem Cells Under 
               Oxidative Stress Conditions ...................................................................... 91 
     3.3.2  Oxidative DNA Damage Detection .......................................................... 91 
     3.3.3  Oxidative Protein Damage Detection ....................................................... 92 
     3.3.4  Oxidative Lipid Damage Detection .......................................................... 93 
3.4. Results ................................................................................................................... 94 
     3.4.1  Oxidative DNA Damage in Dental Pulp Stem Cells Under Oxidative 
               Stress ......................................................................................................... 94 
     3.4.2  Oxidative Protein Damage in Dental Pulp Stem Cells Under Oxidative 
               Stress ....................................................................................................... 101 
     3.4.3  Oxidative Lipid Damage in Dental Pulp Stem Cells Under Oxidative 
               Stress ....................................................................................................... 107 
3.5. Discussion ........................................................................................................... 113 
     Chapter 4 – Assessment of Enzymic Antioxidant Expression Profiles Between 
Dental Pulp Stem Cell Sub-Populations ............................................................ 117 
4.1  Introduction ....................................................................................................... 118 
4.2  Chapter Aims ..................................................................................................... 120 
4.3  Materials and Methods ..................................................................................... 121 
     4.3.1  Isolation, Culture and Expansion of Dental Pulp Stem Cells Under 
               Oxidative Stress Conditions .................................................................... 121 
     4.3.2  Enzymic Antioxidant Gene Expression Analysis ................................... 121 
                 4.3.2.1  Real Time Quantitative Polymerase Chain Reaction (RT-QPCR) 
                  .............................................................................................................. 121 
                 4.3.2.2  TaqMan QPCR  Polymerase Chain Reaction (RT-QPCR) ..... 121 
                 4.3.2.3  Quantification of Gene Expression .......................................... 122 
     4.3.3  Enzymic Antioxidant Protein Level Analysis ........................................ 124 
                 4.3.3.1  Protein Extraction .................................................................... 124 
 xii 
                 4.3.3.2  Western Blotting ...................................................................... 125 
     4.3.4  Enzymic Antioxidant Activity Analysis ................................................. 129 
                4.3.4.1  Superoxide Dismutase Activity ................................................ 129 
                4.3.4.2  Catalase Activity ....................................................................... 130 
                4.3.4.3  Glutathione Peroxidase Activity ............................................... 131 
4.4. Statistical Analysis ............................................................................................. 132 
4.5. Results ................................................................................................................. 132 
     4.5.1  Enzymic Antioxidant Gene Expression .................................................. 132 
     4.5.2  Enzymic Antioxidant Protein Levels ...................................................... 142 
     4.5.3  Enzymic Antioxidant Activity Levels .................................................... 148 
4.6. Discussion ........................................................................................................... 149 
     Chapter 5 – General Discussion ......................................................................... 159 
5.1  Overview ............................................................................................................. 160 
5.2  Future Work ...................................................................................................... 168 
     References ............................................................................................................. 171 
 
 1 
 
 
 
 
 
 
 
 
Chapter 1 
 
General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 2 
 
Chapter 1 
 
General Introduction 
 
1.1 Overview 
With the increase of aging populations worldwide, the development of new and 
successful treatment strategies to repair and regenerate traumatised tissue becomes 
a necessity to restore the form, vitality and function of the diseased organ.  Many 
diseases may ultimately reach an advanced stage, causing total organ failure due to 
the limited available reparative treatment modalities.  Tissue engineering utilising 
stem cell therapy is currently amongst the most promising therapeutic strategies that 
presents an area of particular interest to researchers and scientists across the world.  
With the remarkable progress being made in cellular therapy throughout the past 
decade, challenges still remain.  Undoubtedly, the successful resolution of said issues 
will reflect positively on the quality of life, especially in the ever-increasing aged 
populations worldwide, through the regeneration of affected organs so providing 
cures for their late-stage disease. 
Mesenchymal stem cells (MSCs) are considered an excellent resource for 
stem cell therapy and tissue repair, due to the special biological properties they 
possess.  MSCs are privileged with self-renewal and multi-lineage differentiation 
potentials, in addition to immunomodulatory effects, which make them ideal for 
regenerative medicine applications.  Dental pulp presents a unique source for MSCs 
due to their ease of obtainability, availability and the relative lack of ethical issues 
associated with their collection.  However, the necessity for long-term culture 
expansion in vitro can lead to the onset of cellular senescence, which influences the 
biological properties of MSC populations, including dental pulp stem cells (DPSCs).  
Furthermore, as dental pulp is acknowledged to be composed of heterogeneous 
stem/progenitor cell populations with contrasting properties and behaviours, this 
presents another challenge due to the different biological characteristics each DPSC 
sub-population may possess. 
This Thesis investigates one potential area behind the contrasting biological 
properties between DPSCs, by assessing the inter-relationships between DPSC 
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expansion capabilities, susceptibilities to cellular senescence, oxidative stress and 
the inherent enzymic antioxidant potentials of DPSC sub-populations.  By 
identifying potential differences between DPSCs, this Thesis aims to enhance our 
understanding of the differences between DPSC sub-populations at a cellular and 
molecular level, whilst also being able to utilise the findings obtained for the 
selective screening, identification and isolation of more desirable DPSC sub-
populations with superior proliferative and multipotency capabilities, for more 
efficient DPSC-based therapy development and regenerative medicine applications 
in future. 
 
1.2 Stem Cells 
Stem cells have the ability of indefinite self-replication through life. When certain 
signals are provided, these cells have the potential to self-regenerate and differentiate 
into various cell types, thereby forming the tissue required.  Stem cells reside in 
quiescent state within various specialised niches located throughout the body 
(Gronthos et al., 2000).  A niche is a highly organised micro-environment that 
provide a habitat for stem cells containing the elements necessary (such as growth 
factors and mediators of cell-cell/cell-extracellular matrix interaction), to enable 
stem cells self-renewal and the regulation of cell proliferation, differentiation and 
migration in response to injury (Gronthos et al., 2000; Discher, et al., 2009).  Due to 
the essential roles that stem cells possess in the repair and regeneration of various 
tissues, there is a strongly held belief amongst scientists that stem cells offer highly 
promising potential as therapies for tissue engineering and regenerative medicine 
applications.  Stem cells are essentially divided into two main types, embryonic stem 
cells and adult stem cells. 
 
1.2.1 Embryonic Stem Cells 
Embryonic stem cells (ESCs) are pluripotent stem cells that possess an ability to 
generate all cell types, due to their unlimited differentiation potential into the three 
germ tissue lineages: ectoderm, endoderm and mesoderm (Asatrian et al., 2015).  
These extraordinary abilities make ESCs amongst the most valuable stem cells 
source for the exploitation in regenerative medicine research.  However, many 
ethical issues remain around their use, due to the unavoidable necessity to destruct 
their source, i.e. the embryo, to derive them.  In addition, major obstacles exist due 
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the possibility of allogeneic rejection and teratoma formation that has been witnessed 
by several investigators (Grinnemo et al., 2006; Aldahmash et al., 2013).  Thus, 
although ESC transplantation holds promising therapeutic potentials, safety issues 
remain a major limitation for their use in clinical tissue engineering (Asatrian et al., 
2015). 
Human ESCs are characterised by the expression of many cell surface 
markers and transcription factors, such as stage-specific embryonic antigen-3 
(SSEA-3), stage-specific embryonic antigen-4 (SSEA-4), octamer-binding 
transcription factor-4 (Oct4), sex determining region Y-box 2 (Sox2) and Nanog 
(Rodda et al., 2005).  Noteworthy, together with some specific growth factors, such 
as fibroblast growth factor (FGF, Pan and Thomson, 2007), Oct4 and Nanog are 
among the key transcription factors involved in maintaining the pluripotency and 
self-renewal ability of embryonic stem cells (Wang et al., 2006; Huang et al., 2014a).  
Oct4 is a transcription factor observed in cells of early embryos and in the 
undifferentiated embryonic stem cells, expressed in the embryonic neural crest (Guo 
et al., 2002).  Bone morphogenic protein-4 (BMP4) and the leukaemia inhibitory 
factor (LIF) are also expressed in human embryonic cells to maintain pluripotency 
(Pan and Thomson, 2007). 
 
1.2.2 Induced Pluripotent Stem Cells 
The discovery of induced pluripotent stem cells (iPSCs) by Takahashi and 
Yamanaka (2006), is considered a major breakthrough in regenerative medicine.  
iPSCs are produced from somatic cells (such as human dermal fibroblasts), by their 
genetic reprogramming to a pluripotent, ESC-like state through the overexpression 
of key pluripotency genes, Oct4, Sox2, c-Myc and Kruppel-like factor 4 (Klf4) 
(Takahashi et al., 2007; Hackett and Fortier, 2011; Pennarossa et al., 2013).  
Transfections into reprogrammable cells are facilitated by methods, such as viral, 
plasmid, excisable constructs (Cre/LoxP system) or synthetic mRNA gene transfer 
(Yu et al., 2009; Yoshioka et al., 2013; Hu, 2014a, 2014b). 
As iPSCs eliminate many of the ethical issues associated with human ESCs, 
these represent a viable alternative cellular source to ESCs for regenerative 
medicine-based therapies.  Indeed, iPSCs are now being evaluated for a wide range 
of therapeutic applications in numerous biomedical fields, such as Neurology, 
Ophthalmology and Cardiology (Lee-Kubli and Lu, 2015; Hayashi et al., 2016; 
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Mazzola and Di Pasquale, 2020).  However, despite such promise, many issues still 
remain as although iPSCs and ESCs exhibit similar cellular morphologies, gene 
expression profiles and teratoma forming capacities, studies have shown an 
increased risk of tumour formation with iPSCs (Gutierrez‐Aranda et al., 2010).  
Therefore, ongoing research is aiming to overcome these issues, although iPSCs are 
also currently used as a multi-purpose tool in biomedical research, particularly in 
terms of the development and optimisation of iPSC-based models for drug 
development and disease modelling applications (Robinton and Daley, 2012; Chang 
et al., 2020; Nakao et al., 2020). 
 
1.2.3 Adult Stem Cells 
Adult stem cells have gained an ever-increasing growing popularity, due to their 
histocompatibility with patient tissue.  In addition, these cells share certain 
characteristics to ESCs (Liao, 2005; Lin et al., 2008) and the expression of certain 
cell surface makers (Hoffman and Carpenter, 2005).  Adult stem cells are defined as 
undifferentiated cells that reside within a specialised tissue.  They are cells that have 
the potential for self-renewal, proliferation and differentiation towards multiple cell 
lineages (Polak and Bishop, 2006).  Hence, adult stem cells give rise into all of the 
specialised cell types of their tissue of origin.  This differentiation process eventually 
leads to changes in cell morphology, while expressing tissue specific proteins 
simultaneously (Weissman, 2002).  The main function of adult stem cells is to 
maintain haemostasis, which is essential for tissue renewal and regeneration 
(Leblond, 1964; Gussoni et al., 1999).  Adult stem cells have also been identified in 
the vast majority of body tissues and organs, such as brain, heart, dental pulp, blood 
vessels, bone marrow, the cornea and retina of the eye, pancreas, skin, liver, skeletal 
muscle, ovarian epithelium and testis (Bissels et al., 2013).  Adult stem cells are 
classified according their location in the body.  Bone marrow have at least two 
distinct types of stem cells populations:  hematopoietic stem cells (HSCs) that form 
blood cell types within the bone marrow, and the stromal stem cells (also referred to 
as MSCs), which are capable of differentiating into different types of tissue, such as 
bone and cartilage (Otto and Wright, 2011). 
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1.2.3.1 Mesenchymal Stem Cells 
MSCs have gained considerable interest in the regenerative medicine field, making 
them an excellent resource for stem cell therapy and tissue repair, due to the 
specialised characteristics they possess.  MSCs can potentially present valuable 
therapeutic strategies for many diseases, as they are privileged with unique biologic 
properties (Sharma et al., 2014), including self-renewal and multipotent 
differentiation abilities (Figure 1.1), in addition to their paracrine effects on other 
cell types within the local stem cell niche or wound environments.  Consequently, 
MSCs are considered ideal for regenerative medicine applications (Manuguerra‐
Gagné et al., 2013). 
MSCs were first discovered in bone marrow by Friedenstein et al. (1968), 
who then discovered their ability to form fibroblastoid cells colonies (Friedenstein 
et al., 1970).  Subsequent studies found that MSCs can be isolated from various 
tissues, such as adipose tissue (Eirin et al., 2012), umbilical cord blood (Martin‐
Rendon et al., 2008), placenta (Fukuchi et al., 2004), dental pulp (Huang et al., 
2009), synovial membrane (Hermida-Gómez et al., 2011), peripheral blood 
(Tondreau et al., 2005), periodontal ligament (Park et al., 2011), and endometrium 
(Schwab et al., 2008).  There is an evidence that MSCs are present in all vascularised 
tissues throughout the body (Crisan et al., 2008).  However, the identity and the niche 
sources of MSCs in vivo are not entirely clear and under intense debate.  Indeed, 
some scientists have proposed that MSCs are derived from the cells lining the 
capillaries i.e. the pericytes (Caplan, 2008), while others report that additional cell 
types can also give rise to MSCs (Corselli et al., 2011; Zhao et al., 2014). 
 
1.2.3.2 Therapeutic Effects of Mesenchymal Stem Cells 
MSCs can apply their therapeutic effects via several mechanisms.  They can migrate 
to sites of inflammation, differentiate into various cell types and exert anti-
inflammatory and immunomodulatory effects.  In addition, MSCs can stimulate 
repair processes via the secretion of bioactive molecules (Otto and Wright, 2011; 
Wang et al., 2012).  Many researchers have reported that MSC migration is 
influenced by a range of inflammatory cytokines and growth factors (Aggarwal and 
Pittenger, 2005; Yagi et al., 2010).  Once MSCs reach sites of inflammation, they 
can release mediators that prevent immune cell proliferation and activate systemic 
anti-inflammatory responses.  Furthermore, their secretion of specific cytokines and   
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Figure 1.1.  Multi-lineage differentiation of MSCs (Caplan and Bruder, 2001). 
 
growth factors, such as transforming growth factor-ß (TGF-ß), interleukin-6 (IL-6) 
and IL-10, together with other trophic molecules that promote cell-cell interactions, 
positively influence repair mechanisms (Plotnikov et al., 2008; Ankrum and Karp, 
2010).  Moreover, MSCs have the potential to recruit autologous stem cells to sites 
of inflammation to promote tissue repair (Phinney and Prockop, 2007).  Therefore, 
MSCs have unique immunomodulatory effects (Liechty et al., 2000; Popp et al., 
2008).  Although cell-cell contact and the release of immunosuppressive factors play 
major role in immunomodulatory effect of MSCs, the mechanism behind these 
effects is still not fully understood. 
Although MSCs rely on various mechanisms to exert to their therapeutic 
effect, many clinical experiments have concluded that the therapeutic potential of 
MSCs is mainly attributable to the paracrine factors, the secretome, contained within 
released microvesicles (MVs), particularly the exosome fraction of extracellular 
vesicles (EVs).  Indeed, ever-increasing evidence indicates a prominent role for such 
exosomes in mediating intracellular communications in various cell types, including 
MSCs (Spees et al., 2016).  Thus, due to their ever-emerging immuno-modulatory 
and stimulatory properties on reparative processes, MSC-derived exosomes are 
increasingly be advocated and exploited as novel therapeutic candidates for 
regenerative medicine applications in a wide range of diseases and medical 
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conditions (Zhang et al., 2014; Colao et al., 2018; Nooshabadi et al., 2018; Zhao et 
al., 2019). 
 
1.2.3.3 Challenges with Mesenchymal Stem Cells 
With all the advantages of MSCs, some obstacles still remain.  Although MSCs 
present low risk of cancer development compared to embryonic stem cells, tumour 
formation has been reported with MSCs (Fang et al., 2005).  Obtaining MSCs can 
also be difficult, due to the inevitable invasive procedures needed to derive them 
from the donor.  Another major obstacle hindering the successful use of MSCs in 
cell therapy and tissue engineering is the limited numbers of MSCs available to 
isolate.  For instance, it is estimated that MSCs comprise only 0.01%-0.001% of the 
total number of cells within bone marrow tissues (Friedenstein et al., 1982). 
Therefore, extensive in vitro expansion is necessary to obtain sufficient cell numbers 
for successful tissue engineering therapy development and use.  Indeed, it has been 
estimated that at least 108 total cells are ideally needed for a successful MSC 
transplant therapy (Ringdén et al., 2006). 
Another obstacle is the limited differentiation potential with increasing donor 
age, which can present significant problems (Kern et al., 2006; Martens et al., 2012). 
In addition, as MSCs exhibit different lineage commitment relating to their in vivo 
niche environments and their tissue sources, this often results in heterogeneous 
population of MSCs being isolated (Russell et al., 2010; Lv et al., 2012).  For 
example, the ectopic transplantation of bone marrow-derived MSCs (BM-MSCs) 
forms heterotopic bone tissue, while DPSC transplantation forms reparative dentine-
like tissue (Batouli et al., 2003).  By and large, MSCs are considered promising 
cellular sources for tissue engineering, due to their favourable biological properties, 
accessibility and diverse differentiation capabilities.  However, a more 
comprehensive understanding of their behaviour could potentially minimise some of 
the issues currently surrounding their clinical development and applications as cell 
therapies, as described above. 
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1.2.3.4 Hierarchical Model of Mesenchymal Stem Cells 
Although stem cells vary in their types and niche sources, they share common 
characteristics that make them distinctive from other mammalian cells, namely their 
self-renewal and multipotency properties.  Stem cells possess a unique 
undifferentiated nature, in which they maintain their stemness through their self-
renewal capabilities of generating identical daughter cells, as well as being 
multipotent through the generation of differentiated daughter cells capable of 
forming all cell types necessary for tissue formation or repair (Weissman, 2002; 
Riquelme et al., 2007).  However, stem cells remain in a quiescent state, unless 
stimulated to enter the cell cycle and undergo cell division (Li and Clevers, 2010; 
Cheung and Rando, 2013).  This process occurs in a very well executed hierarchy to 
minimise the risk of DNA replication mutation (Reya et al., 2001). 
In order for MSCs to successfully accomplish their functions of self-renewal 
and differentiation, they go through a slow cell division process in which they first 
divide symmetrically producing identical daughter cells that both have equivalent 
low proliferative and multi-potential differentiation properties (Ho, 2005).  Some of 
these adult stem cells continue this division process asymmetrically to produce cells 
with different cellular fates, giving rise to two distinct daughter cells, where one is 
an identical daughter cell copy of the original stem cell and the second cell is a 
progenitor cell known as transit amplifying (TA) cell, which has high proliferative 
and low differentiation capabilities.  TA cells further divide to form large colonies 
to provide enough cell numbers, before achieving a more mature progeny in which 
they produce a smaller colony of progenitor cells that are more committed, yet with 
reduced proliferation abilities (Ho, 2005; Morrison and Kimble, 2006; Riquelme et 
al., 2007; Figure 1.2).  In this context, although MSCs are capable of multi-lineage 
differentiation into adipogenic, osteogenic and chondrogenic lineages (Pittenger et 
al., 1999), this differentiation capacity is considered to be lineage restricted (Russell 
et al., 2010).  It is also suggested that successful MSC differentiation potential in 
vitro depends on the protocol used and the cell donor source.  However, studies have 
shown that 50% of MSC clones possess tri-potential, 30% have bi-potential and 10% 
exhibit uni-potential capabilities (Russell et al., 2010).  In fact, while such variation 
in lineage potential renders MSC populations functionally heterogeneous that may 
influence their use for tissue regenerative purposes, it offers an opportunity to repair 
a wider range of tissues following cell screening and the identification of suitable 
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cell sub-populations for therapeutic use.  For example, MSC populations screened 
for above-average chondrogenic potential demonstrated more robust cartilage repair 
properties, compared to unscreened populations (Jiang et al., 2014).  Furthermore, 
another study showed that only approximately half of a subcutaneously-implanted 
MSC population demonstrated osteogenic potential in mice (Kuznetsov et al., 1997). 
 
Figure 1.2.  Hierarchy model of stem cells division (Chan et al., 2004). 
 
1.2.3.5 Asymmetric Stem Cell Division 
While the main goal of symmetric cell division goal is the proliferation and 
expansion of cell populations, usually in response to pathology or tissue injury 
(Morrison and Kimble, 2006), asymmetric cell division aims to generate cells of 
different properties while maintaining a constant stem cell population, thereby 
providing the cellular diversity found in all multicellular organisms (Berika et al., 
2014; Figure 1.2).  Although the exact mechanisms are unclear, asymmetric cell 
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division is controlled by a combination of complex biological pathways that include 
intrinsic and extrinsic cellular mechanisms within the stem cell niche (Yamashita, 
2009).  The main goal of cell division is to support self-renewal and maintain the 
balance between self-renewal and stem cell differentiation.  This well-controlled 
balance is important for organ development and maintenance, but also critical for 
the repair and regeneration of tissues post-injury (Berika et al., 2014).  For instance, 
during tissue repair, a temporary increase in the number of symmetric divisions may 
be required.  On the other hand, chronic tissue injury may compromise stem cell 
abilities to adequately respond to repair the affected tissues.  Indeed, it has been 
observed that over long periods in culture, one daughter cell can be less proficient as 
a stem cell than another, even when both daughter stem cells maintain their stem cell 
markers expression following a limited number of cell divisions (Inaba and 
Yamashita, 2012).  This is an important finding and must be considered during the 
selection of stem cells for the use in stem cell therapy.  Therefore, understanding the 
biological behavior of adult stem cells and the factors behind their properties is 
essential for in vitro cell expansion, maintenance of stem cell characteristics and 
their differentiation potential in culture, in order for stem cell populations to be of 
optimal quality for therapeutic purposes (Berika et al., 2014). 
 
1.2.3.6 Other Types of Adult Stem Cells 
Many other types of adult stem cells are present in different tissues for repair and 
regeneration, such as HSCs, epithelial stem cells, neural stem cells and endothelial 
stem cells.  HSCs are adult stem cells that reside in the hematopoietic system 
(Stocum, 2001).  Within this system, HSCs are the only cells that possess the 
potential for self-renewal and multipotency to generate all specialised blood cells, 
while maintaining sufficient pools of hematopoietic stem cells throughout the entire 
mammalian lifespan (Chotinantakul and Leeanansaksiri, 2012).  Although the 
primary site for the maintenance of HSCs and haematopoiesis is the bone marrow, 
they can also be isolated from peripheral blood and umbilical cord blood, 
characterised based on their expression of cell surface markers, such as CD34, c-
KIT and CD90 (Morrison and Scadden, 2014). 
The remarkable potential that HSCs possess appears in their ability to 
differentiate into all mature blood cells involved in various biological activities, 
including the inflammatory response, haemostatic control and immune function 
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(Seita and Weissman, 2010).  HSCs can also differentiate into other cells beyond the 
tissue where they reside, such as endothelial cells (Elkhafif et al., 2011), adipocytes 
(Sera et al., 2009), osteochondrocytes (Mehrotra et al., 2010), cardiomyocytes 
(Pozzobon et al., 2010), fibroblasts/myofibroblasts  (Ebihara et al., 2006), liver cells 
(Sellamuthu et al., 2011) and pancreatic cells (Minamiguchi et al., 2008).  For more 
than three decades, HSC transplantation has been widely used as the standard of care 
during the treatment of many diseases, such as leukemia and lymphoma 
(Hołowiecki, 2008).  Nevertheless, HSC transplantation remains challenging and 
can still cause many serious complications to patients (Gratwohl et al., 2010). 
Epithelial stem cells reside in the epidermis of skin and in the epithelial lining 
of all organs, such as the digestive tract (Barker et al., 2009; Van der Flier and 
Clevers, 2009; Kong et al., 2018), lungs (Rawlins and Hogan, 2006) and cornea 
(Ramos et al., 2015).  Although epithelial stem cells have not been reported in human 
teeth, these have been located within the cervical loop regions of mouse root apices, 
where these generate ameloblasts that form enamel (Chavez et al., 2012).  This could 
be related to the continuous need for enamel regeneration within the continually 
erupting mouse incisor, in contrast to human incisors. 
Neural crest cells are initially formed during embryogenesis in the dorsal 
margins of neural folds, ultimately delaminating during epithelial-mesenchymal 
transition and migrate to several locations within the embryo, where they contribute 
to the formation of a wide variety of tissue types (Sauka-Spengler and Bronner-
Fraser, 2008).  Cranial neural crest gives rise to the neural cells that contribute 
mainly to the bone and cartilage of the orofacial region, in addition to the nerve 
ganglia, smooth muscles and connective tissues.  As such, dental tissue-derived, 
MSCs are proposed to possess similar properties to those of neural crest cell 
progenitors, considering that they originate from the dental mesenchyme derived 
from neural crest tissue (Achilleos and Trainor, 2012). 
Endothelial stem cells are located in the lining of blood vessels and are 
involved in the repair of endothelial tissues (Sen et al., 2011).  Several studies have 
demonstrated that DPSCs exhibit endothelial-like phenotypes (d'Aquino et al., 
2007).  In vivo studies have demonstrated the ability of DPSCs to form capillary-like 
structures (Iohara et al., 2008; Marchionni et al., 2009) and increase blood vessel 
density (Aksel and Huang, 2017), suggesting differentiation properties similar to 
endothelial-derived, stem cells. 
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1.3 Dental Pulp 
Dental pulp is a loose connective tissue located within the pulp chamber of the root 
canal.  Through apical foramen, the dental pulp connects to the surrounding 
periodontium, allowing blood vessels, lymphatics and nerves to enter the pulp canal 
and provide nourishment, sensation and inflammatory reactions.  The dental pulp 
originates from ectomesenchymal and mesenchymal origins that develop from the 
dental papilla.  It is rich in vasculature and innervation, in addition to lymphatics, 
immune cells, fibroblasts, odontoblasts and water (Trowbridge, 2003).  Dental pulp 
contains a distinct heterogeneous cell population existing in several niches within 
different zones of the pulp (Mitsiadis et al., 2003).  Thus, it is established that DPSCs 
have contrasting proliferative capacities, which are attributed to these contrasting 
neural crest or mesodermal developmental origins that can be difficult to distinguish 
(Komada et al., 2012).  Normally, odontoblasts are responsible for formation of 
primary dentine that surrounds the pulp (Smith et al., 1995), in addition to the 
secondary dentine formed throughout the life and in response to mild injury by 
reactionary dentinogenesis.  However, during severe dental trauma or insult leading 
to odontoblast cell death, DPSCs induce dentine repair through their differentiation 
into odontoblast-like cells and secretion of tertiary reparative dentine (Smith et al., 
1995; Duque et al., 2006). 
 
1.3.1 Tooth Development 
Human dental development is initiated prenatally and continues until the age of 18-
25 years (Aiello and Dean, 1990).  Embryonically, the oral cavity is lined by the 
ectoderm, which together with the endoderm and mesoderm, is one of the three germ 
layers that give rise to the organism.  Tooth germs are characterised by their dual 
composition, ectoderm and mesoderm.  While enamel is of ectodermal origin, all 
other dental tissues, including the dentine and dental pulp, originate from the 
associated mesenchyme.  Specifically, dental pulp is formed by combination of 
ectodermal and mesodermal layers during the sixth week of embryogenesis (Thesleff 
and Sharpe, 1997; Sinanan et al., 2004). 
Some studies suggested that odontoblasts, the dentine matrix and the 
majority of the pulpal tissue are all of cranial neural crest origin (Chai et al., 2000).  
The primary odontoblasts differentiate from dental papilla cells and ultimately 
secrete dentine.  The very last division of dental papilla cells gives rise to two 
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daughter cells, one is fully differentiated into odontoblast while the other remains 
undifferentiated forming the sub-odontoblast population (Ruch et al., 1995; Smith 
and Lesot, 2001).  As development continues, the dental pulp population grows 
further containing additional cells that are of non-neural crest origin.  These cells are 
suggested to be derivatives of the first branchial arch mesenchyme (Chai et al., 
2000).  Thus, such events result in the existence of heterogeneous cellular 
populations that will be ultimately occupying the mature dental pulp. 
 
1.3.2 Dental Pulp Stem Cells 
Several dental tissue-derived, stem cell populations have been recognized within oral 
tissues.  Not only have these been found to be appropriate for applications in oral 
and maxillofacial tissue engineering, but beyond.  Indeed, these were described as 
MSCs according to the minimal criteria of the International Society for Cellular 
Therapy (Huang et al, 2009a).  These include DPSCs (Gronthos et al., 2000), “stem 
cells from human exfoliated deciduous teeth” (SHEDs, Miura et al., 2003), 
“periodontal ligament stem cells” (PDLSCs, Seo et al., 2004), “dental follicle 
progenitor stem cells” (DFPCs, Morsczeck et al., 2005), “stem cells from dental 
papilla” (SCAPs, Sonoyama et al., 2006), “tooth germ progenitor cells” (TGPCs, 
(Ikeda et al., 2008), “gingival mesenchymal stem cells” (GMSCs, Zhang et al., 2009) 
and “alveolar bone-derived mesenchymal stem cells” (AB-MSCs, Matsubara et al., 
2005; Figure 1.3). 
Figure 1.3.  Main sources of human dental-derived stem cells (Egusa et al., 2012). 
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1.3.2.1 Origin and Sources of Dental Pulp Stem Cells 
The dental pulp is considered a unique source of mesenchymal stem cells.  DPSCs 
were first discovered by Gronthos et al. (2000), who isolated these cells from the 
dental pulp of impacted wisdom teeth of adult donors.  Upon investigation, these 
cells were shown to exhibit some characteristics of both neural and epithelial stem 
cells.  Various studies have since suggested that DPSCs are adult multipotent stem 
cells that arise from several stem cell niches.  These niches are proposed to be located 
within three histologically distinguishable different zones in the dental pulp; namely 
the cell-rich zone, which is the innermost layer densely populated with cells 
including undifferentiated MSCs, fibroblasts, macrophages and capillaries, the pulp 
matrix zone in the central region of the pulp, which contain pulp capillaries, nerves 
and dental pulp cells and the outermost odontoblasts-containing layer which contain 
the odontoblasts responsible for dentine formation.  Additionally, a fourth zone 
called zone of Weil is observed beneath the odontoblastic layer in the coronal region 
of the pulp.  However, it is a cell-free zone suggested to be an area for odontoblasts 
replacement (Lizier et al., 2012; Figure 1.4).  Morphologically, DPSCs are described 
as large spindle-shaped cells, containing a large centrally located nucleus and 
cytoplasmic extensions in culture, being morphologically identical to BM-MSCs 
(Gronthos et al., 2000). 
Figure 1.4.  Architecture and zones within dental pulp (Orban and Bhaskar, 1972). 
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The origin of DPSCs is a subject of intense debate.  Seo et al (2004) related 
DPSCs expression of early markers for both mesenchymal and neuro-ectodermal 
stem cells to their cranial neural crest origin.  However, it was recently reported that 
a significant subpopulation of DPSCs are of glial origin.  Based on this observation, 
it was suggested that each DPSC population can be defined based on its ability to 
regenerate diseased tissue and this will depend on their tissue of origin (Kaukua et 
al., 2014).  DPSCs can be found in dental pulp tissue of primary and permanent 
human teeth and most commonly in wisdom teeth (d'Aquino et al., 2007).  
Interestingly, scientists have observed that third molar dental germ pulp distinctly 
contains some undifferentiated cells, located within the cell-rich zone of the dental 
pulp (Yalvaç et al., 2010).  This may be due to the fact that the roots of wisdom teeth 
continue the growing process even by the age of eighteen years.  Theoretically, 
wisdom teeth contain the most undifferentiated cells as they have the youngest pulp 
being the last teeth to erupt (Ponnaiyan and Jegadeesan, 2014). 
Another source for DPSCs is the supernumerary teeth.  Huang et al. isolated 
DPSCs from supernumerary tooth and noticed that DPSCs derived at the 
development stage of the crown are more proliferative than those derived at later 
stages (Huang et al., 2008a).  The SHEDs from exfoliated human deciduous teeth 
are another source of DPSCs.  These cells are immature and were observed to express 
a wide variety of neural stem cell markers, including nestin, β-III tubulin and glial 
fibrillary acidic protein (GFAP, Kerkis et al., 2006).  In addition, they have 
demonstrated superior growth rates, compared to those derived from other regions.  
This can be related to their lower level of maturity, compared to other stem cells 
within the body and can provide a reasonable justification for their rapid growth rate 
(Kabir et al., 2014).  Moreover, DPSCs can be isolated from inflamed pulps, such as 
pulp polyp tissue.  This tissue have been reported to contain suitable amounts of 
dental pulp stem cells with multi-lineage differentiation potential analogous to those 
of normal pulp tissues (Attar et al., 2014).  Likewise, Alongi et al. (2010) isolated 
DPSCs from inflamed pulps and although these lost some of their stem cell 
properties in vitro, they still demonstrated tissue regeneration capability in vivo.  
Nevertheless, inflamed pulps are still considered as an attractive source of DPSCs, 
particularly as inflamed pulps are always disposed of following pulpectomies. 
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1.3.2.2 Advantages of Dental Pulp Stem Cells 
Dental pulp provides a remarkable source of MSCs, due to the many advantages they 
possess (Huang et al., 2006, Figure 1.5).  Indeed, the MSC-like traits that DPSCs 
present render them potentially superior to other stem cell types described in the 
literature.  Indeed, one of the most favourable characteristics of DPSCs is their multi-
lineage differentiation potential (Huang et al., 2009a).  DPSCs have an in vitro ability 
to differentiate into all classical mesodermal cell lineages, demonstrating osteogenic, 
chondrogenic and adipogenic capabilities, although their ability towards adipogenic 
differentiation appears to be less achievable (Struys et al., 2011; Hilkens et al., 2013).  
Moreover, many studies have reported that DPSCs have similar regenerative 
properties to BM-MSCs (Kawashima, 2012; Tatullo et al., 2015).  Interestingly, it 
has been reported that human DPSCs have a higher proliferation potential, self-
renewal capacity and a higher immunomodulatory ability in vitro, in comparison to 
human BM-MSCs (Gronthos et al., 2002).  Another advantage of DPSCs is their 
relative ease of obtainability with minimal tissue interference.  The reason behind 
this is that DPSCs are obtained from pulps of teeth that are to be disposed of, either 
because they are clinically un-restorable or due to orthodontic purposes (Woods et 
al., 2009), yet with a relatively lack of ethical and legal issues in their removal 
(Huang et al., 2009a).  In addition, DPSCs are readily available due to the possibility 
of stem cell banking.  Most studies have reported that DPSCs can be cryopreserved 
long-term, whilst maintaining their biological characteristics, including their 
viability, proliferative and differentiation capabilities, secretory profiles and 
functions upon thawing (Woods et al., 2009; Galipeau and Krampera, 2015; Wuchter 
et al., 2015).  For example, osteoblasts derived from DPSC osteogenic differentiation 
were shown to form a woven bone-like tissue that successfully produced a 3-
dimensional (3D) lamella bone tissue upon transplantation in immunocompromised 
rats, following long-term cryopreservation (Papaccio et al., 2006).  Furthermore, 
DPSCs have been shown to preserve their stem cell properties after cell and whole 
dental tissue cryopreservation (Temmerman et al., 2010; Lee et al., 2012). 
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Figure 1.5.  Multi-lineage differentiation capabilities of DPSCs and their potential 
uses in tissue regeneration (Lee et al., 2014). 
 
Another important point to consider, prior to the clinical use of DPSCs is 
their genetic stability.  Studies have demonstrated the presence of high percentages 
of aneuploid human MSCs during normal in vitro culture expansion, progressively 
increasing until senescence.  Moreover, the more senescence prone sub-populations 
showed lower proliferation ability and higher incidence of aneuploidy, compared to 
the non-senescent sub-populations.  Accordingly, aneuploidy must be taken in 
consideration as a significant factor in MSC senescence induction (Estrada et al., 
2013).  Therefore, although DPSCs can present an outstanding source for MSCs due 
to the favourable characteristics they possess, many factors should be taken into 
consideration to maintain those properties for safer and more effective clinical use 
in regenerative medicine. 
 
1.3.2.3 Dental Pulp Stem Cells and Dental Tissue Repair 
DPSCs are promising candidates in regenerative dental therapy.  Many researchers 
have investigated the ability of DPSCs to form dentine-pulp tissue and proved that 
DPSCs hold the golden key for regenerative endodontics, that will help maintain the 
integrity of both hard and soft dental tissues (Na et al., 2013).  Studies have 
demonstrated the ability of DPSCs to migrate and differentiate into odontoblasts, 
capable of mineralised nodules formation, promoting dentinogenesis and repairing 
damaged sites within teeth (Goldberg et al., 2006; About, 2011; Wang et al., 2014).  
 
Dental pulp stem cells 
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Consequently, several tissue engineering-based techniques have since been 
implemented to successfully regenerate dentine using DPSCs (Chiang et al., 2016; 
Zhang et al., 2016; Song et al., 2017; Loison-Robert et al., 2018).  When comparing 
the in vitro mineralisation and dentinogenic capacities of DPSCs, BM-MSCs and 
adipose-derived MSCs (AD-MSCs), DPSCs showed the greatest capacity to form 
high volume of mineralised tissue (Davies et al., 2015).  In addition, they showed a 
greater ability to regenerate the dentine-pulp complex, with good vascularity in a 
simulated perforation repair model (Alsanea et al., 2011) and in empty root canals 
using ectopic tooth transplantation models in immunocompromised mice (Huang et 
al., 2010).  Furthermore, DPSCs transplanted subcutaneously using scaffolds into 
immunocompromised mice, resulted in soft connective tissue formation identical to 
dental pulp tissue (Nakashima and Iohara, 2011). 
 Many in vivo studies have been reported using scaffolds seeded with DPSCs 
to test their ability to develop tooth-like structures in an attempt to regenerate teeth 
of normal size and structure (Huang et al., 2009b).  When bell-stage tooth bud stem 
cells were expanded in vitro, cultured in scaffold and re-implanted into the original 
alveolar socket of a swine model, dentine, root and periodontium formation were 
observed (Kuo et al., 2008).  In a recent study, human tooth root canals filled with 
DPSC constructs and subcutaneously implanted into immuno-deficient mice, 
showed active self-organising ability forming odontoblast-like mineralising cells at 
sites in proximity to dentine and endothelial cells at the centre demonstrating a 
promising potential of DPSCs to form a blood vessel-rich pulp-like tissues and 
regenerate dental pulp tissue (Itoh et al., 2018). 
 
1.3.2.4 Dental Pulp Stem Cells and Tissue Engineering 
It is undoubted that DPSCs have a natural ability of responding well to tissue injury.  
Similarly, their distinctive differentiation potential towards different cell phenotypes 
is very promising (Lee et al., 2013).  Indeed, their proliferative and regenerative 
potentials, availability and neurogenic and angiogenic capacities, have been shown 
to be greater than those for BM-MSCs (Alge et al., 2010; Khanna-Jain et al., 2012).  
These favourable characteristics make DPSCs a useful alternative stem cell source 
for cellular therapy and tissue engineering, even in non-dental tissues (Kim et al., 
2012).  However, although DPSCs have a stronger ability towards osteogenic lineage 
differentiation, they appear less able to undergo adipogenic differentiation than BM-
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MSCs (Shi et al., 2001; Yamada et al., 2006).  In vivo administration of human 
DPSCs to diseased animal models with myocardial infarction, cerebral stroke and 
neural disease, have demonstrated the remarkable therapeutic potential of DPSCs 
(Gandia et al., 2008; Leong et al., 2012), with no immune rejection or teratoma 
formation (Huang et al., 2008b).  Additionally, their immunomodulatory properties 
in inducing T-cell apoptosis, while inhibiting the proliferation of both T-cell and 
peripheral blood mononuclear cells, were of great interest to researchers, especially 
as DPSCs exhibited superior immunosuppressive activities, compared to BM-MSCs 
(Tomic et al., 2010; Zhao et al., 2012). 
DPSCs are also considered a potential cell source for cartilage repair 
(Poltavtseva et al., 2014) and bone defect regeneration (Bressan et al., 2012).  
Although some investigators reported a limited potential for in vivo bone 
regeneration using DPSCs (Annibali et al., 2013), several other studies have 
confirmed the osteogenic differentiation potential of DPSCs and ultimately, 
considered them as a potent cell source for 3D bone tissue structure fabrication, 
including around dental implant osseointegration (Ito et al., 2011; Kim et al., 2012).  
In a follow up clinical study, DPSCs were seeded into collagen scaffolds and loaded 
into the socket of an extracted wisdom tooth and compared to the opposite control 
socket, which received a cell-free scaffold.  Although radiographical and histological 
analysis revealed significant less bone regenerated than controls 3 months post-
surgery, follow up after three years showed that the regenerated bone was evenly 
vascularised, compact and of higher matrix density than control tissues (Giuliani et 
al., 2013).  Other studies demonstrated that DPSCs differentiated into osteoblasts 
and added to scaffolds, resulted in enhanced bone mineral density in a rat calvarial 
critical bone defect model (Annibali et al., 2013; Maraldi et al., 2013).  Interestingly, 
a pilot study showed that DPSCs isolated from inflamed dental pulps also exhibited 
similar positive results repairing periodontal bone defect (Li et al., 2016).  Therefore, 
DPSC applications show strong promise as therapeutic approaches for the repair of 
craniofacial and alveolar bone (d'Aquino et al., 2009; Machado et al., 2012). 
Various studies have documented the ability of DPSCs to differentiate into 
cardiac cells (Armiñán et al., 2009).  Following injection of DPSCs into mice with 
myocardial infarctions, significant recovery was noticed compared to controls, albeit 
with no apparent cell differentiation; suggesting that DPSCs may promote cardiac 
repair by alternative mechanisms (Gandia et al., 2008).  Many authors have 
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suggested that DPSCs present a great candidate for dentine-pulp regenerative 
purposes, due to their angiogenesis potential (Aksel and Huang, 2017).  While 
DPSCs demonstrated a potent ability to enhance blood flow and improve 
vasculogenesis in animal models (Iohara et al., 2008; Aksel and Huang, 2017), they 
also showed an ability to form capillary-like structures when cultured with vascular 
endothelial growth factor (VEGF, Marchionni et al., 2009).  In addition, DPSCs 
displayed a capacity to stimulate blood vessels formation and peripheral nerve tissue 
myelination of adult rats (Sasaki et al., 2008).  Moreover, they also hold promising 
therapeutic potential for the treatment of muscular dystrophy, as DPSCs displayed 
significant engraftment upon treatment of muscular dystrophy in dogs (Yang et al., 
2010).  DPSCs have further been shown to differentiate into pancreatic insulin-
producing cells (Annibali et al., 2013; Carnevale et al., 2013), with a higher 
differentiation potential towards insulin-producing cells than human PDLSCs 
(Sawangmake et al., 2014); suggesting that DPSCs may be used as a stem cell-based 
therapy for diabetes. 
DPSCs manifested remarkable competency in promoting regeneration of 
nerve tissue (Young et al, 2013), due to their ability to differentiate into neuronal 
and oligodendrocyte-like cells, express neuronal cell markers and induce recovery 
post-neurological dysfunction (de Almeida et al., 2011; Sakai et al., 2012; Young et 
al., 2016).  Indeed, human DPSCs demonstrate an ability to express neutrophic 
factors, such as nerve growth factor (NGF), brain-derived neurotrophic factor 
(BDNF) and glial cell-derived neurotrophic factor (GDNF), in addition to low-
affinity nerve growth factor receptor (LANGFR), VEGF and other proangiogenic 
growth factors (Nosrat et al., 2004; Mikami et al., 2010; Bronckaers et al., 2013).  
Expression of these factors aids the provision of the necessary trophic support to 
neuronal cells, thereby maintaining the reparative response and neurogenesis.  
Consequently, there is growing evidence that there is an active population of neural 
crest cells residing within dental pulp tissues responsible for regenerating 
odontoblasts and Schwann cells of the pulp (Kaukua et al., 2014; Aurrekoetxea et 
al., 2015).  Following in vivo DPSCs transplantation into diseased rats with cerebral 
artery occlusion (Leong et al., 2012) and spinal injury (Sakai et al., 2012), marked 
neurogenesis associated with improved functional recovery were observed (Martens 
et al., 2014).  Recently, human DPSCs successfully contributed to the generation of 
neovasculature in mouse brain tissue in vivo, after differentiation into endothelial 
 22 
cells (Luzuriaga et al., 2019).  Therefore, such properties make DPSCs promising 
candidates for neuronal tissue engineering. 
DPSCs also exhibit an ability to differentiate into hepatocyte-like cells 
(Ishkitiev et al., 2012).  Indeed, transplanted DPSCs into rat models prevented the 
progression of liver fibrosis and contributed to liver function repair (Ikeda et al., 
2008; Cho et al., 2015).  In addition, when unfractionated human DPSCs 
transplanted into surgically inactivated hair follicles, they have displayed potential 
to regenerate new end bulbs and to create multiple differentiated hair fibres 
(Reynolds and Jahoda, 2004).  Therapeutic use of DPSCs extend to corneal 
reconstruction as well.  In rabbits with corneal defects, transparency of cornea was 
enhanced after corneal epithelium reconstruction by transplantation of a human 
dental pulp stem cell sheet (Gomes et al., 2010). 
 
1.3.2.5 Heterogeneity and Surface Markers in Dental Pulp Stem Cells 
Human DPSCs are considered a promising source of multipotent MSCs analogous 
to MSCs from other sources.  DPSCs exhibit a fibroblast-like morphology, plastic 
adherence and express MSC markers, CD73, CD90 and CD105, thus satisfy the 
minimal criteria for MSCs (Huang et al., 2009a; Kawashima, 2012).  Indeed, DPSCs 
present a novel population of MSCs that uniquely express differentiation and lineage 
specific genes. 
Researchers describe DPSCs as a heterogeneous population (Pisciotta et al., 
2015).  This presents a major challenge during the course of in vitro cell expansion, 
as the different sub-populations comprising the heterogeneous population as a whole 
manifest different biological behaviours, varied proliferation rates and specific MSC 
marker expression profiles (Wagner, et al., 2010; Kawashima, 2012).  While DPSC 
heterogeneous populations exhibit multi-lineage differentiation potential into 
osteoblasts, chondrocytes, adipocytes, neurocytes and myocytes, it has been reported 
that there are occasions where adipogenic, chondrogenic and myogenic 
differentiation are impaired, potentially as a consequence of their stem cell niche of 
origin within dental pulp tissues (Huang et al., 2009a). 
Studies on the properties of stem cell niches within human dental pulp tissues 
have shown that each niche possess cells expressing nestin, a neuro-epithelial marker 
known to be mostly expressed by neuronal stem cells (Park et al., 2010; Lizier et al., 
2012).  In addition, several embryonic stem cell markers have been reported to be 
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expressed in human DPSCs, such as SSEA-4, Oct4 and Nanog (Kawanabe et al., 
2012).  Notably, the multipotency properties of DPSCs have been reported to be 
related to Oct4 and Nanog expression, as these are transcriptional factors responsible 
for the maintenance of pluri-/multi-potency (Kerkis et al., 2006).  Furthermore, Oct4 
and Nanog overexpression was observed to be critical in promoting the induction of 
osteogenic, chondrogenic and adipogenic differentiation in DPSCs, whilst Oct4 and 
Nanog down-regulation reduced the MSCs properties of DPSCs (Huang et al., 
2014b). 
CD34 is a hematopoietic stem cell marker expressed by several cell types 
including MSCs (Lin et al., 2012), playing a role in cell adhesion, proliferation and 
differentiation (Scherberich et al., 2013).  However, CD34 has also been found to be 
expressed by some subsets of human DPSCs (Hilkens et al., 2013).  Other DPSC 
sub-populations are reported to express STRO-1 (Huang, et al., 2009a; Yang et al., 
2009), which may have a role in clonogenicity, homing and angiogenesis in MSCs.  
In addition, CD146 and 3G5 are both considered as pericyte markers (Shi and 
Gronthos, 2003).  Notably, CD146 expression has been observed in MSCs with 
multi-lineage, osteogenic, chondrogenic and adipogenic differentiation capabilities 
(Xu et al., 2008). 
c-Kit (CD117) is a tyrosine-protein kinase receptor that is expressed by 
various types of stem cells, such as neural crest-derived cells (Laino et al., 2005), 
hematopoietic stem cells (Ashman, 1999), AD-MSCs (Blazquez-Martinez et al., 
2014), BM-MSCs (Hatzistergos et al., 2010) and DPSCs (Pisciotta et al., 2015).  
Another marker that has a role in the differentiation of DPSCs is CD271, which is 
considered to be a marker for neural derived cells (Pisciotta et al., 2015).  CD271 is 
a p75 neurotrophin receptor and nerve growth factor receptor that inhibits the 
differentiation of DPSCs into osteogenic, myogenic, chondrogenic or adipogenic 
lineages while promoting survival and differentiation to neuronal cells (Park et al., 
2010).  Consequently, CD271 can be considered an important marker to determine 
differentiation ability of cells (Mikami et al., 2010).  Indeed, highly proliferative, 
multipotent DPSC sub-populations capable of >80 population doublings (PDs) 
during in vitro culture expansion, have been shown to exhibit no CD271 expression 
in contrast to low proliferative/unipotent DPSCs only capable of <40PDs in culture 
(Alraies et al., 2017).  A study by Pisciotta et al. suggested the existence of more 
than one stem cell population within human dental pulp, those that are positive for 
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STRO-1, c-Kit and CD34, which showed nestin and CD271 marker expression and 
have stronger tendency towards neurogenic differentiation compared to the other 
DPSCs that are positive to STRO-1, c-Kit, but negative for CD34, nestin and CD271 
(Pisciotta et al., 2015).  However, both cell populations demonstrated no significant 
differences in differentiation potential towards osteogenic, adipogenic or myogenic 
lineages.  This could be explained by their origin, which could be either the 
mesodermal or the neuro-ectodermal (Chai et al., 2000). 
CD105 (endoglin, SH2) is a component of the TGF-β complex (Aslan et al., 
2006).  It is associated with cell migration and haematopoiesis (Conley et al., 2004) 
and identified to be expressed in DPSCs, although some studies reported relatively 
low levels (compared to BM-MSCs), that decreases towards osteogenic 
differentiation process (Ponnaiyan and Jegadeesan, 2014).  However, other studies 
have observed high expression in MSCs capable of multi-lineage differentiation 
particularly osteogenesis (Maleki et al., 2014).  Of note, upon comparison of DPSCs 
properties isolated from normal and inflamed dental pulp, STRO-1, CD90, CD105 
and CD146 cell markers were expressed in higher levels in DPSCs derived from 
inflamed dental pulp tissues (Alongi et al., 2010; Pereira et al., 2012). 
 Therefore, DPSC and MSC heterogeneity in general, can have major 
implications for regenerative medicine, in terms of determining whether particular 
sub-populations provide viable therapeutic options or not.  Generally, homogenous 
populations are more favourable for clinical use, due to their predetermined 
biological activity, unlike heterogeneous populations that may produce unwanted 
biological activities, such as teratoma formation or inefficient differentiation (Müller 
et al., 2010; Downes et al., 2011).  Therefore, it is highly recommended that 
homogenous populations are selectively purified that impact positively on DPSCs 
biological behavior and subsequently through their regenerative potential and tissue 
engineering applications.  However, the proposed limited numbers of MSCs within 
tissues (Friedenstein et al., 1982), necessitates extensive in vitro expansion in order 
to provide sufficient number to enable efficient clinical use (Wagner et al., 2010). 
 
1.4 Mesenchymal Stem Cell Expansion and Cellular Senescence 
The term “senescence” is derived from the Latin “senex”, meaning “growing old”.  
Cellular senescence is the limited ability of diploid cells to replicate when cultured 
in vitro, whilst limited cell proliferative lifespan have further been proposed as a 
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possible mechanism for human ageing in vivo (Hayflick and Moorhead, 1961).  
Consequently, while many advantages exist that DPSCs possess over MSCs from 
other sources, one barrier which can potentially have a negative impact on their 
development as therapies for clinical applications in regenerative medicine, is their 
finite culture expansion capabilities in vitro (Roobrouck et al., 2008).  Indeed, MSCs 
gradually show less division and reduced proliferation rates during extended culture, 
until they enter a senescence state and stop proliferating, upon reaching their 
Hayflick limit (Hayflick, 1965; Bonab et al., 2006; Markert et al., 2009).  Therefore, 
although the necessity to obtain adequate number of MSCs mandates extensive in 
vitro expansion, this eventually leads to proliferative decline and cellular senescence.  
Although senescent cells remain viable and metabolically active, the onset of 
senescence induces changes in cellular genotypes and phenotypes, coupled with an 
altered secretome associated with development of the senescence-associated 
secretory phenotype (SASP), loss of stem cell marker expression and impaired 
multipotent differentiation, immunomodulatory and regenerative potentials 
(D'Ippolito et al., 1999; Coppé et al., 2008; Wagner et al., 2010; de Jesus and Blasco, 
2012; Malaquin et al., 2016; Alraies et al., 2017; McHugh and Gil, 2018).  For 
example, it has been particularly shown that MSCs approaching the end of their 
proliferative life-spans tend to lose osteogenic potential in favour of adipogenic 
potential, a phenomenon known as the “osteogenic to adipogenic shift’’ (Banfi et al., 
2000; Stenderup et al., 2003). 
 Due to their altered or impaired genotypic and phenotypic characteristics, 
senescent MSC populations are not recommended for transplantation purposes, not 
only because this will decrease the chances for good results, but may even be 
harmful.  Consequently, it is crucial to monitor the state of cellular senescence within 
MSC populations, throughout their proliferative lifespans.  Although passage 
number can be an indicator of cellular senescence, as it indicates the number of times 
the cells have been sub-cultured and allowed to grow, this is not a precise method.  
Thus, a more accurate measure of cell growth/proliferation and the onset of 
senescence is to determine PDs (Larson et al., 2008), with senescence indicated once 
cells proliferate at <0.5PDs/week (Cristofalo et al., 1998).  Therefore, it has been 
recommended to use MSCs at early PDs (no more than 4-7PDs) in preparations for 
therapeutic use due to their ability to maintain more primitive cell phenotype that is 
still have the ability to perform more cell divisions (Banfi et al., 2000; Walenda et 
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al., 2010). 
 PDs for different MSC populations vary significantly, depending on various 
factors, including the MSC tissue source and patient donor age (Bonab et al., 2006).  
For example, BM-MSCs have been reported to have a life-span that ranges from 20-
40PDs (Banfi et al., 2000), with differences attributed to increasing patient donor 
age increasing cell susceptibility to premature cellular senescence (Stenderup et al., 
2003; Mareschi et al., 2006; Hwang, 2014).  Significant heterogeneity in DPSCs 
have also been reported, with heterogeneous DPSC populations being capable of 
>120PDs in vitro, although only 20% of purified DPSC sub-populations are capable 
of proliferating >20PDs (Gronthos et al., 2000, 2002; Huang et al., 2009a).  Of these, 
only two-thirds were able to generate abundant ectopic dentine in vivo, this can 
indicate that DPSC populations have contrasting regenerative potential (Gronthos et 
al., 2002; Huang et al., 2009a).  Furthermore, similar animal and human studies have 
established the effects of increasing donor age on the impairment of DPSC 
proliferative and regenerative capabilities (Ma et al., 2009; Bressan et al., 2012; Feng 
et al., 2013, 2014; Horibe et al., 2014). 
 Despite significant differences in the ex vivo expansion capabilities of 
individual DPSCs being recognized, only recently has work begun to address the 
impact of such variations in proliferative capabilities prior to senescence, on the 
multipotency of different DPSC sub-populations (Alraies et al., 2017).  Although 
high proliferative DPSCs achieved >80PDs, low proliferating DPSCs only 
completed <40PDs before senescence, correlating with DPSCs with high 
proliferative capacities possessing longer telomeres (>18kb) than less proliferative 
populations (5-13kb).  Low proliferative DPSC senescence was also associated with 
early loss of stem cell marker characteristics and impaired osteogenic and 
chondrogenic differentiation, in favour of adipogenesis.  In contrast, high 
proliferative DPSCs retained multipotent differentiation capabilities, only 
demonstrating impaired differentiation following prolonged in vitro expansion 
(>60PDs, Alraies et al., 2017). 
 
1.4.1 Telomere-Dependent Senescence 
Cells appear to be able to undergo senescence via different pathways.  As diploid 
cells only exhibit a finite ability to replicate, cells lose their ability to divide and are 
irreversibly arrested following a certain number of PDs (Hayflick and Moorhead 
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1961).  In such circumstances, proliferative decline and subsequent cellular 
senescence is a consequence of replicative (telomere-dependent) senescence, 
characterised by progressive telomere shortening and the loss of telomeric TTAGGG 
repeats, due to repeated cell divisions (Campisi and d'Adda di Fagagna, 2007; 
Morsczeck et al., 2016).  Indeed, due to this inherent limitation in the mechanics of 
DNA replication, telomeric shortening (erosion) occurs with each cell division (50-
200bp per PD) (Harley et al., 1990).  However, replicative senesce can also be a 
result of chronic activation of DNA damage response triggered by deformed 
telomeres (Pole et al., 2016). 
 Telomeres are specialised DNA-protein complexes at the end of eukaryotic 
chromosomes, which protect chromosomes against genomic instability-promoting 
events (Griffith et al., 1999; De Lange, 2005; Harbo et al., 2012; Figure 1.6).  
Telomerase is a specialised ribonucleoprotein reverse transcriptase, with a role in 
maintaining telomere lengths through the complete replication of telomere ends, 
thereby protecting telomeres from progressive erosion, modification and degradation 
(Allsopp et al., 2003; Flores et al., 2005; Bernardo et al., 2007; Serakinci et al, 2008).  
In the absence of telomerase, when telomere shortening reaches a “critical length”, 
cells are susceptible to chromosomal aberrations, such as end-to-end fusion and 
aneuploidy.  In this state, the cells cease to divide, and replicative senescence ensues.  
Thus, by imposing a limit on the proliferative lifespan of MSCs and somatic cells, 
telomeric erosion represents an innate mechanism for tumour suppression (Faragher 
and Kipling 1998). 
 Replicative senescence has been described in numerous cell types, including 
MSCs (Wagner et al., 2010; Li et al., 2017).  Upon reaching replicative senescence, 
cells become post-mitotic and under permanent growth arrest in the G1 phase of the 
cell cycle, unable to undergo G1-S phase transition.  Increased expression of the 
tumour suppressor genes, p53 and retinoblastoma protein (pRb), mediate the 
induction of replicative senescence via the cyclin-dependant kinase inhibitors, 
p21waf1 and p16INK4a (Campisi and d'Adda di Fagagna, 2007, Morsczeck et al., 2016; 
Figure 1.7).  Other established markers of senescence include changes in cell 
morphology from bipolar spindle-shaped into enlarged, flattened, non-polar 
multinucleated cells with identifiable cytoskeletal stress fibres (Matsumura et al., 
1980; Sethe et al., 2006; de Jesus and Blasco, 2012); and an increased detection of 
positive SA-β-galactosidase (SA-β-Gal) activity (Dimri et al., 1995). 
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Fig 1.6.  The structure of telomeres.  Caps at the end of chromosome containing 
unique repeats of DNA sequence (“TTAGGG” in humans) that preserve genome 
integrity and prevents erosion (Harman, 2009). 
 
Figure 1.7.  Summary of conditions causing cellular senescence.  p53, pRb and 
p21waf1 are common factors in both telomere-dependent (replicative) senescence and 
telomere-independent (stress-induced, premature) senescence (de Jesus and Blasco, 
2012). 
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 Replicative senescence has been proposed by many authors as the 
mechanism behind human ageing.  Indeed, several studies provide evidence for the 
role of telomere dysfunction in cellular aging, demonstrating that telomere 
dysfunction results in decreased proliferation, acceleration of cellular ageing and 
impaired organ function (Saeed and Iqtedar, 2013; Birch et al., 2015).  With the loss 
of proliferation, the ability of tissue to repair itself becomes limited and may account 
for many of the changes associated with senescent MSC and/or MSCs derived from 
more aged patient donors (D'Ippolito et al., 1999; Banfi et al., 2000; Stenderup et al., 
2003; Mareschi et al., 2006; Coppé et al., 2008; Ma et al., 2009; Wagner et al., 2010; 
Bressan et al., 2012; de Jesus and Blasco, 2012; Feng et al., 2013, 2014; Horibe et 
al., 2014; Hwang, 2014; Malaquin et al., 2016; Alraies et al., 2017; McHugh and 
Gil, 2018).  On the contrary, MSCs with longer telomeres demonstrate better repair 
capabilities, post-injury (Montgomery et al., 2011; Alraies et al., 2017). 
 Contrasting telomere lengths between MSC populations may reflect 
variations in telomerase activity among stem cell population from different 
developmental, tissue or niche origins.  For example, the high level of telomerase 
present in ESCs renders these virtually immortal (Marion et al., 2009).  Although 
this may be true, telomerase expression in adult stem cells is still under debate, as 
telomerase expression and activity have also been widely described in adult stem 
cells, albeit at much lower levels than ESCs (Bernardo et al., 2007).  Expression of 
the reverse transcriptase, human telomerase catalytic subunit (hTERT) has also been 
reported in foetal cells, germ lines, stem cells and many tumour cells (Serakinci et 
al., 2008).  However, although certain studies have reported positive hTERT 
expression in DPSCs (Flores and Blasco, 2010; Jeon et al., 2011; Hakki et al., 2015), 
most report no or negligible hTERT expression in DPSCs (Egbuniwe et al., 2011; 
Mehrazarin et al., 2011a; Murakami et al., 2013; Alraies et al., 2017).  In addition, 
several studies have suggested that active telomerase activity is insufficient for the 
complete prevention of telomere loss (Mokry et al., 2010). Thus, it is unlikely that 
hTERT is responsible for maintaining telomere integrity and the superior 
proliferative/multipotency capabilities of high proliferative DPSC sub-populations 
(Alraies et al., 2017).  In fact, many MSC populations, including DPSCs, are capable 
of maintaining proliferative lifespans during extended in vitro culture expansion, 
whilst maintaining their stemness, differentiation and regenerative properties, even 
in the absence of strong telomerase/hTERT expression capabilities (Mokry et al., 
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2010; Saeed and Iqtedar, 2013; Fukada et al., 2014).  Therefore, other intrinsic 
telomere protective mechanisms may account for the contrasting differences in 
telomere lengths, proliferation rates and differentiation capabilities between high 
and low proliferative DPSCs (Saretzki, 2009; Liu et al., 2011; Shyh-Chang et al., 
2013; Li et al., 2017). 
 
1.4.2 Telomere-Independent Senescence 
In addition to telomere-dependent senescence, somatic cells can also undergo 
replicative arrest, independent of their telomere lengths (Campisi and d'Adda di 
Fagagna, 2007; Morsczeck et al., 2016).  The main mechanisms purported to induce 
such telomere-independent senescence, include DNA damage mediated by p53, 
genotoxic agents, ionizing radiation, oxidative stress loss of heterochromatin and the 
expression of certain oncogenes, such as Ras or Raf (Shay and Wright, 2007; Alves 
et al., 2013; El Alami et al., 2014; Fukada, et al., 2014; Mas-Bargues et al., 2017). 
 Of these mechanisms, oxidative stress is a prominent and well-established 
mediator of telomere-independent senescence (also known as premature senescence 
or stress-induced premature senescence, SIPS).  Telomere-independent senescence 
has been identified in various cell types, including somatic cells and MSCs (Liu et 
al., 2011; Shyh-Chang et al., 2013; Li et al., 2017).  It is proposed that telomere-
independent senescence induced by oxidative stress is promoted through the 
induction of DNA damage, resulting in single-strand breaks in telomeres without 
significant telomere shortening, unless exposed to high levels of oxidative stress over 
prolonged periods (Ben-Porath and Weinberg, 2004; Rübe et al., 2011).  Indeed, 
recent evidence suggests that oxidative stress induces telomeric double stranded-
breaks that are unrepairable, causing persistent DNA damage response signalling 
(DDR).  Subsequently, cells undergo telomere-independent senescence, where cells 
cease replication irrespective of telomere lengths (Victorelli and Passos, 2017). 
As with telomere-dependent (replicative) senescence, telomere-independent 
senescence is associated with increased cellular morphologies, positive SA-β-Gal 
activity and the activation of various signalling pathways, including those involving 
the tumour suppressor genes, p53 and pRb, via DNA damage-induced cyclin-
dependant kinase inhibitor, p21waf1, that commence growth arrest followed by 
increased p16INK4a expression that disrupts G1-S phase transition and normal cell 
cycle progression (Itahana et al., 2001; Campisi and d'Adda di Fagagna, 2007; 
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Huang et al., 2011; Morsczeck et al., 2016; Figure 1.7).  However, it appears that the 
main difference between replicative senescence and stress-induced senescence lies 
in the presence of telomere shortening and the time elapsed before proliferation 
ceases (Bielak-Zmijewska et al., 2018).  Nonetheless, senescence mediated via both 
replicative and stress-induced mechanisms induce significant alterations in cellular 
genotype and phenotype, ultimately influencing their overall biological functions 
and mediating impaired repair, disease and organismal ageing (Sikora et al., 2011). 
 
1.5 Oxidative Stress 
Oxidative stress refers to the disturbance in the balance between the production of 
intracellular reactive oxygen species (ROS) and cellular antioxidant defence 
mechanisms.  Although ROS are generated via a wide range of cellular mechanisms, 
mitochondria are considered the principle ROS source under normal physiological 
conditions (Balaban et al., 2005).  Low ROS levels play important roles in the 
regulation of cellular functions, including metabolism, signal transduction, gene 
expression, cell proliferation and differentiation (Guzik and Harrison, 2006; 
Genestra, 2007; Storz, 2011; Coso et al., 2012).  In particular, oxidative stress is 
capable of promoting indiscriminate biomolecular damage to cellular 
macromolecules, including DNA, proteins and lipids (Levine and Stadtman, 2001; 
Spiteller, 2001; Cooke et al., 2003; Evans et al., 2004; Chaudhari et al., 2014); in 
addition to accelerating telomere-independent senescence (Itahana et al., 2001; Ben-
Porath and Weinberg, 2004; Campisi and d'Adda di Fagagna, 2007; Huang et al., 
2011; Morsczeck et al., 2016).  Consequently, oxidative stress induces significant 
alterations in cellular genotype and phenotype ultimately influencing their overall 
biological functions, resulting in age-related disease pathologies associated with 
impaired tissue function and repair processes (Dayem et al., 2010; Sikora et al., 
2011; Atashi et al., 2015). 
 
1.5.1 Reactive Oxygen Species 
1.5.1.1 Physiological Role of ROS 
ROS include oxygen-derived free radical (ODFR) species, such as superoxide (O2.-) 
and hydroxyl (.OH) radicals, in addition to non-radical derivatives of oxygen, such 
as hydrogen peroxide (H2O2, Halliwell et al., 1992; Dröge, 2002; Bigarella et al., 
2014; Figure 1.8).  The radical species in particular, such as O2.- and .OH, are 
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extremely reactive due to the presence of one or more unpaired electrons in their 
outer orbitals. 
 
Figure 1.8.  Electron structures of common ROS.  The • in red indicates unpaired 
electrons (Halliwell et al., 1992). 
 
 ODFRs, especially O2.-, are produced by a number of mechanisms in 
biological systems.  Mitochondria are considered as the main source of ROS within 
the cell due to the presence of the electron transport chain within the inner 
mitochondrial membrane, ultimately resulting in production of adenosine 
triphosphate (ATP) during oxidative phosphorylation (Balaban et al., 2005).  
However, during high flux, electron leakage at complexes I and III causes the 
(Bigarella et al., 2014), causing reduction of O2 and the generation of O2- (Valko et 
al., 2007).  In fact, it is suggested that @0.1-0.2% of O2 consumed by mitochondria 
form ROS (Tahara et al., 2009), although the quantities of ROS produced by 
mitochondria varies depending on factors such as cell type and mitochondrial 
activity (Murphy, 2009).  Other mechanisms responsible for cellular O2.- production 
include autoxidation reactions and numerous enzymic reactions, especially the 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase present in the 
plasma membrane of cells, particularly phagocytes (Waddington et al., 2000).  O2.- 
is also a precursor for the formation of other ROS.  For instance, can undergo a 
dismutation reaction, which may be either spontaneous or catalysed by superoxide 
dismutases (SODs), to form H2O2 (Waddington et al., 2000; Atashi et al., 2015). 
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 H2O2 is a physiological constituent of all living cells presumed to occur at 
intracellular levels of 1-700nM, depending on cell type (Gülden et al., 2010).  It is 
normally involved in the cellular signalling process and is able to undergo transition 
metal ion-catalysed, Fenton or Haber-Weiss reactions to produce highly reactive 
.OH, which cause significant oxidative damage (Waddington et al., 2000).  
Consequently, any H2O2 concentration above 1μM is considered pathological and 
result in oxidative stress, eventually leading to cell senescence and/or cell death 
(Duan et al., 2005; Stone and Yang, 2006). 
 
1.5.2 Consequences of Oxidative Damage to DNA, Proteins and Lipids 
Although the physiologic upregulation of ROS production is essential for normal 
cellular functions, it is well-established that a chronically unbalanced redox status, 
as a consequence of excessive ROS production, affect cellular activities particularly 
at a biomolecular level.  Cellular targets for oxidative modification by ROS include 
DNA, proteins and lipids, with the order of preference for modification depending 
on a number of factors, such as the location of ROS production, the relative ability 
for the molecule to be oxidized and the availability of metal ions (Evans et al., 2004; 
Lyublinskaya et al., 2015).  Nonetheless, oxidative modification and/or degradation 
of such biomolecules can significantly alter cell fates and promote cellular 
senescence or even apoptosis (Kim et al., 2011; Mandal et al., 2011; Cummins et al., 
2013).  Indeed, several studies reported a direct link between oxidative stress and 
many pathological conditions, such as cancer (Dizdaroglu, 2015), diabetes (Muoio 
and Newgard, 2008), cardiovascular and other chronic inflammatory diseases 
(Waddington et al., 2000; Ho et al., 2013), neurodegenerative diseases (Halliwell 
and Whiteman, 2004; Agarwal et al., 2005; Kehrer and Klotz, 2015), and several 
age-related conditions (Jacob et al., 2013). 
 
1.5.2.1 Effects of Oxidative Stress on DNA 
Several pathological conditions can occur as a consequence of oxidative damage to 
DNA.  For this reason, oxidative DNA damage has been widely studied in various 
cell lines.  For instance, fibroblasts exhibit higher levels of 8-hydroxy-deoxy-
guanosine (8-OHdG) in senescent cells than in young cells, indicating increased 
oxidative DNA damage (Chen et al., 1995).  Notably, oxidative DNA damage results 
in different types of DNA lesions depending on the ROS involved, the duration of 
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exposure and the cellular reparative ability (Halliwell and Chirico, 1993).  ROS 
interactions with DNA are mainly attributed to .OH species causing DNA base 
modification, deoxyribose sugar damage, formation of DNA protein cross-links, 
single and double strand breaks, and the formation of apurinic lesions, many of 
which are mutagenic (Shibutani et al., 1991; Finkel and Holbrook, 2000).  DNA 
bases are particularly vulnerable to oxidation by ROS, with guanine base having the 
lowest reduction/oxidation potential of the four bases (Neeley and Essigmann, 
2006).  Consequently, .OH species induce DNA damage at the C-8 position of 
guanine base yielding 8-OHdG as an oxidation product, which has led to 8-OHdG 
becoming a well-established marker of in vitro and in vivo oxidative DNA damage 
(Toussaint et al., 2000; Tahara et al., 2001; David et al., 2007).  Nonetheless, ROS 
can also attack other positions in the structures of guanine or other purine/pyrimidine 
DNA bases, yielding a wide range of oxidative DNA base damage products (Cooke 
et al., 2003; Evans et al., 2004).  In contrast to .OH species, less reactive species, 
such as O2.- and H2O2, cause indirect DNA damage by acting as a source for other 
ROS, such as OH species (Halliwell, 1999; Poulsen et al., 2000; Ames, 2001; 
Kasprzak, 2002).  Indeed, DNA oxidation is a complex process and many studies 
have reported that ROS can promote site-specific damage (Enright et al., 1996).  
Accordingly, the cellular repair responses towards ROS-induced DNA lesions are 
also complex, as different DNA repair mechanisms may exist depending on the 
source and extent of oxidative damage induced (Giorgio et al., 2007; Hazane-Puch 
et al., 2010).  Reports have also shown that increased mitochondrial ROS production 
can disrupt mitochondrial integrity causing mitochondrial DNA mutations, 
eventually resulting in a loop of further ROS generation and more DNA damage 
(Linnane et al., 1989), thereby accelerating cellular senescence (Madamanchi and 
Runge, 2007; Lee and Wei, 2007). 
 
1.5.2.2 Effects of Oxidative Stress on Proteins 
Previous research has recognized a strong association between protein oxidation and 
oxidative stress, senescence and aging, with numerous studies utilising oxidative 
protein damage as a marker of oxidative stress in research on many different 
pathological conditions (Flint Beal, 2002), such as diabetes (Almogbel and Rasheed, 
2017), Alzheimer’s disease (Greilberger et al., 2010) and arthritis (Pullaiah et al., 
2018).  Protein oxidation results from ROS accumulation (Berlett and Stadtman, 
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1997).  Upon oxidation, protein damage is presented as modifications to amino acid 
structure leading to fragmentation to lower molecular weight products.  ROS 
modification of amino acids results in the formation of numerous oxidized by-
products, including oxo acids, aldehydes, hydroperoxides and hydroxylated 
derivatives, due to a range of chemical reactions, including the hydroxylation of 
amino acid side chains, decarboxylation and deamination reactions.  Studies have 
highlighted a number of amino acids that are more susceptible to modification by 
ROS, including proline, histidine, lysine, arginine and tyrosine, resulting in 
formation of chemically stable moieties (Dean et al, 1997; Dalle-Donne et al., 2003).  
Additionally, carbonyl derivatives can be produced indirectly on the nucleophilic 
side chains of cysteine, histidine and lysine by secondary reaction with aldehydes 
produced during lipid peroxidation, or with reactive carbonyl derivatives generated 
during glycation and glycoxidation reactions (Berlett and Stadtman, 1997; Halliwell, 
1999; Uchida, 2000).  Indeed, the increased presence of protein carbonyl groups as 
a consequence of oxidative stress exposure and amino acid side chain modifications, 
is the most widely used biomarker to implicate oxidative protein damage in the 
aetiology and/or progression of various diseases and conditions (Dalle-Donne et al., 
2003).  Normally, oxidized proteins are degraded by proteasomes.  However, 
proteasomal activity may not be sufficient to overcome chronic oxidative stress, 
resulting in oxidized protein accumulation during cellular senescence and ageing 
(Pole et al., 2016).  Consequently, many studies have documented age-associated 
accumulation of oxidized proteins (Sitte et al., 2000; Grune et al, 2005; Torres and 
Perez, 2008; Baraibar et al., 2012; Rodríguez-Sureda et al., 2015).  In addition to 
DNA damage, elevated mitochondrial ROS level can result in irreversible protein 
damage (Madamanchi and Runge, 2007). 
 
1.5.2.3 Effects of Oxidative Stress on Lipids 
Lipids constitute a major component of cell membrane rendering integrity.  
However, lipids are also liable to oxidative damage due to their high unsaturated 
fatty acid contents, resulting in lipid peroxidation (Halliwell, 1999; Spiteller, 2001; 
Kohen and Nyska, 2002).  Although lipid peroxidation is a normal physiological 
process necessary for renovation of biological membranes, excessive activation is 
linked to many pathologies.  Lipid peroxidation of membranes affects several aspects 
of cellular machinery, such as the loss of membrane fluidity and integrity leading to 
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impaired cellular function (Halliwell, 1999).  ODFR particularly target carbon-
carbon bonds of polyunsaturated fatty acids, forming lipid hydroperoxides (LOOHs) 
as primary products of lipid peroxidation, (Yin et al., 2011), in addition to secondary 
products, such as malondialdehyde (MDA) which has a high capability to react with 
multiple molecules including proteins and DNA resulting in adducts formation 
(Łuczaj and Skrzydlewska, 2003; Zarkovic et al., 2013) and 4-hydroxynonenal (4-
HNE) (Halliwell, 1999; Spiteller, 2001; Kohen and Nyska, 2002).  Therefore, end 
products formed, such as MDA, 4-HNE and the prostaglandin-like products, 
isoprostanes, are now commonly used as markers of oxidative lipid peroxidation 
(Halliwell and Chirico, 1993; Spiteller, 2001; Kohen and Nyska, 2002). 
 
1.5.3 Antioxidants Defences Against Reactive Oxygen Species 
The potential occurrence of excessive ROS-induced cell/tissue damage may be 
partly counteracted through ROS detoxification by a series of antioxidant defence 
mechanisms, thereby restoring cellular redox homeostasis.  An antioxidant is defined 
as any substance that can inhibit or significantly delay the oxidation of an oxidisable 
substrate when present at lower concentrations than that substrate (Halliwell et al., 
1992).  These antioxidants act by several mechanisms in order to protect biological 
systems from oxidative damage, including via direct scavenging of ROS and by 
sequestration of free catalytic metal ions.  In essence, antioxidants neutralise ROS 
by accepting their electrons, ultimately counteracting their effect by reducing ROS 
levels and by repairing the consequences of oxidative damage.  Antioxidants vary 
from simple, low molecular weight compounds, such as ascorbate and a-tocopherol, 
to ROS detoxifying enzymes, such as SODs, catalase and glutathione-metabolising 
enzymes, including glutathione peroxidases (GPXs), transferases, reductases and 
synthetases (Waddington et al., 2000).  Due to their paramount importance within 
cells, antioxidants are found in different locations within the cell corresponding to 
different functions.  Their presence in the cytosol scavenge hydrophilic peroxide 
species, such as H2O2, whilst their presence in mitochondria allows the protection 
from O2.- and .OH species. 
Enzymic antioxidant defence mechanisms are mainly orchestrated by Nf-E2 
related factor 2 (Nrf2), which activates the various antioxidant responsive element 
(ARE)-dependent genes that encode enzymic antioxidants, ultimately mitigating 
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oxidative stress (Kensler et al., 2007; Nguyen et al., 2009; Ma, 2013).  SODs 
catalyse O2.-dismutation into H2O2.  Three SOD isoenzymes which have been 
identified in cells.  SOD1 (known as copper zinc SOD or Cu/ZnSOD) occurs in the 
cytoplasm, the intermembrane space of mitochondria and in the nucleus.  SOD2 
(known as manganese SOD or MnSOD) is located to the mitochondria matrix and 
SOD3 (known as extracellular SOD or EC-SOD) is secreted into the extracellular 
matrix (Zelko et al., 2002; Fattman et al., 2003; Nozik-Grayck et al., 2005; Fukai 
and Ushio-Fukai, 2011).  SODs catalyse the dismutation of O2 into H2O2, a less 
reactive species, within their respective intracellular or extracellular locations 
(Waddington et al., 2000; Figure 1.9). 
 Most aerobic cells contain catalase, which catalyses the dismutation of H2O2 
into H2O and is mostly localised intracellularly in peroxisomes within the cytosol 
(Kirkman and Gaetani, 2007; Figure 1.9).  However, considering that mitochondria 
is the primary source of ROS, many authors suggested that the catalase system may 
not be the most efficient due to absence of catalase expression in the mitochondria 
(Pervaiz et al., 2009).  However, when catalase was upregulated and targeted 
specifically to the mitochondria in transgenic mice, less oxidative DNA damage was 
observed with 20% increases in organismal lifespan, suggesting an enhanced 
mitochondrial antioxidant defence mechanism.  This indicate that mitochondrial 
ROS are considered important limiting factor of cell longevity and further emphasize 
the importance of mitochondria as ROS sources (Schriner et al., 2005). 
GPXs provide another mechanism to remove excessive intracellular H2O2 
levels, by catalysing the reduction of H2O2 to H2O and LOOHs into their 
corresponding alcohols, using reduced glutathione (GSH) as a coenzyme which is 
then oxidized to glutathione disulphide (GSSG, Figure 1.9).  GPXs are tetrameric 
proteins localised within the cytoplasm, mitochondria and nuclei, with each subunit 
containing an atom of selenium present at the active site as selenocysteine (Deponte, 
2013, Lu, 2013).  Reduced GSH is produced by the formation of γ-glutamylcysteine 
from glutamate and cysteine, followed by the formation of GSH from γ-
glutamylcysteine, catalysed by γ-glutamylcysteine synthetase and glutathione 
synthetase (GSS), respectively (Lu, 2013).  GSH is a non-enzymatic tripeptide thiol, 
synthesised by cells upon the need to initiate the defensive mechanism and detoxify 
ROS (Bigarella,et al., 2014).  Although it exists abundantly in the cytosol in which 
it is exclusively synthesised, it is also distributed intracellularly in other cellular  
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Figure 1.9.  The main enzymatic antioxidant defence systems and their reactions.  
A) SOD catalyses the reduction of O2.- to H2O2 and O2.  B) Catalase catalyses the 
reduction of H2O2 to H2O.  C-D) GPXs catalyse the reduction of H2O2 to H2O and 
LOOHs into their corresponding alcohols, using reduced GSH as a cofactor.  GSR 
reduces the oxidized GSSG reacts with protein sulfhydryl group forming mixed 
disulfide.  Therefore, the intracellular redox potential is largely determined by the 
GSH GSSG ratio. 
 
compartments, including the nuclei, mitochondria and endoplasmic reticulum (Mari 
et al., 2009, 2010).  Glutathione acts as a ·OH scavenger.  Additionally, it acts as a 
cofactor for antioxidant enzymes, such as GPXs and certain Glutathione S-
transferases (GSTs), to detoxify H2O2.  In normal physiological state, glutathione 
exists in a thiol-reduced (GSH) state (90%), and disulphide-oxidized (GSSG) state 
(10%) within the cell (Pompella et al., 2003).  During oxidation, disulphides are 
formed between thiol-groups of cysteine in glutathione GSH, resulting in a reaction 
between two reactive GSH forming glutathione disulfide (GSSG). 
 The GPX family consists of several distinct isozymes localised within 
specific tissues and cells, playing important defensive roles against oxidative stress 
(de Haan et al., 2003; Lubos et al., 2011).  GPX1 was the first to be identified and it 
is present in mitochondria, nuclei and the cytosol.  GPX2 is mainly gastrointestinal 
and found in the cytosol and nuclei.  GPX3 is found mostly in extracellular fluids 
(Brigelius-Flohé, 1999) and cytosol (Lu, 2013).  GPX4 has a key dual function as an 
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antioxidant and anti-apoptotic protein (Savaskan et al., 2007), found in the 
mitochondria, cytosol and nuclei (Schneider et al., 2009).  GPx5 is expressed mainly 
into the epidydimal lumen (Lu, 2013).  Although the GPXs family are potent ROS 
scavengers, very limited knowledge is available on their kinetics and activities. 
 GSTs are located within the cytoplasm, mitochondria and microsomal 
compartments of cells, where these catalyse the conjugation of GSH via sulfhydryl 
groups, to electrophilic centres on a wide variety of substrates, in order to detoxify 
compounds and make them more water-soluble (Wu and Dong, 2012; Board and 
Menon, 2013, Lu, 2013).  Reduced GSH is regenerated by the activity of glutathione 
reductase (GSR), using NADPH as a reducing cofactor (Deponte, 2013).  However, 
during persistent oxidative stress, it exceeds the cellular ability to regenerate GSH 
from GSSG.  The GST superfamily also contains glutathione transferase ζ (GSTZ1, 
also known as maleylacetoacetate isomerase) amongst other isoforms, which 
catalyses the reaction of GSH with xenobiotics and endobiotics (Board and Anders, 
2011).  GSTZ1 is expressed in many tissues.  However, although GSTZ1 is located 
in the cytosol, it is also localised within cellular mitochondria (Mannervik et al., 
2005; Li et al., 2011).  Some properties of cytosolic and mitochondrial GSTZ1 differ, 
these are not related to differences in amino acid sequence or post-translationally 
modified residues (Zhong et al., 2018). Furthermore, although GSTZ1 role in the 
oxidative defence mechanism is confirmed, and their deficiency results in generation 
of a constant level of oxidative stress (Blackburn et al., 2006), reports suggest that 
GSTZ1 function indirectly by modulating antioxidant response element (ARE)-
regulated enzymes unlike other GSTs enzymes (Hayes et al., 2005). 
 
1.5.4 Role of Oxidative Stress and Antioxidants in Mesenchymal Stem Cells 
Despite possessing such an array of tightly-regulated, cellular antioxidant defence 
mechanisms, imbalance between ROS overproduction and cellular antioxidant 
capacity are strongly correlated with increased oxidative stress-induced 
biomolecular damage and the induction of telomere-independent senescence in a 
variety of cell types, particularly fibroblasts (Serra et al., 2000, 2003; Lorenz et al., 
2001; Blander et al., 2003; Brown and Stuart, 2007; Richter and von Zglinicki 2007; 
Hammad et al., 2018).  However, more recent studies into the effects of oxidative 
stress on embryonic stem cell (ESC) behaviour have confirmed that stem cells have 
contrasting responses to oxidative stress than somatic cells, due to the activation of 
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different antioxidant defence mechanisms (Barandalla et al., 2016).  Furthermore, 
correlations between the susceptibilities of MSCs from various sources to cellular 
senescence, with their relative enzymic antioxidant expression and activity 
capabilities, have also been established (Valle-Prieto and Conget, 2010; Ko et al., 
2012; Jeong and Cho, 2015; Yu et al., 2018; Chen et al., 2019).  This is also the case, 
in terms of MSC susceptibilities to oxidative stress-induced biomolecular damage, 
with cellular resistance to oxidative damage being attributed to their relatively high 
enzymic antioxidant capacities (He et al., 2004; Ko et al., 2012; Yu et al., 2018; Chen 
et al., 2019).  Thus, although the reasons behind such contrasting oxidative stress 
responses between different stem cell populations is still under debate, the majority 
of theories are increasingly focussed on the roles of antioxidants as being major 
influences in providing stem cell resistance to oxidative stress, via their possession 
of superior enzymic antioxidant induction capabilities (Liu et al., 2011; Shyh-Chang 
et al., 2013; Urao and Ushio-Fukai, 2013; Benameur et al., 2015; Sheshadri and 
Kumar, 2016). 
 
1.6 Aims of Thesis 
Based on previous findings that hTERT plays a minimal role in facilitating variations 
in proliferative life-span and the onset of replicative (telomere-dependent) 
senescence between high and low proliferative DPSC sub-populations (Alraies et al., 
2017), this implies that other intrinsic telomere protective mechanisms may account 
for the contrasting differences in telomere lengths, proliferation rates and 
differentiation capabilities between high and low proliferative DPSCs.  Therefore, 
as oxidative stress and its counteraction by enzymic antioxidants are well-
established concepts in the relative susceptibilities of somatic and MSCs to cellular 
senescence, this Thesis evaluated whether similar variation existed in the relative 
susceptibilities high proliferative/multipotent and low proliferative/unipotent 
DPSCs to oxidative stress-induced biomolecular damage and telomere-independent 
senescence and whether such differences were related to contrasting enzymic 
antioxidant profiles between these DPSC sub-populations.  In summary, the specific 
objectives of this Thesis are: 
 
1.  To investigate the effect of oxidative stress (H2O2)-induced (telomere-
independent), cellular senescence in DPSC sub-populations via the analysis of 
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various parameters associated with the establishment of the senescence phenotype, 
such as PDs, morphological changes, telomere lengths, SA-β-gal staining and stem 
cell marker (p53, p21waf1 and p16INK4a) expression. 
2.  To investigate whether in DPSC sub-populations also differed in their respective 
susceptibilities to oxidative stress-induced, biomarker formation via the analysis of 
established oxidative stress marker levels of DNA (8-OHdG), protein (carbonyl 
content) and lipid (peroxidation) damage. 
3.  To investigate whether differences in specific enzymic antioxidant capabilities 
further contributed to the contrasting susceptibilities of high and low proliferative 
DPSC sub-populations to oxidative stress-induced telomere-independent senescence 
and biomolecular damage. 
 
 By confirming such differences in the relative susceptibilities of high and 
low proliferative DPSC sub-populations to oxidative stress-induced, senescence and 
biomolecular damage, as a consequence of superior enzymic antioxidant capabilities 
of high proliferative DPSCs, would significantly enhance our understanding of 
DPSC biology and its inter-relationship with oxidative stress and cellular 
senescence. 
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Chapter 2 
 
Assessment of Dental Pulp Stem Cell Susceptibility to 
Oxidative Stress-Induced Cellular Senescence 
 
2.1 Introduction 
Dental pulp stem cells (DPSCs) are increasingly being characterised and evaluated 
as alternative stem cell sources, for the development of more effective stem cell-
based regenerative therapies for clinical use (Huang et al., 2009; Sloan and 
Waddington, 2009; Ledesma-Martínez et al., 2016; Nuti et al., 2016; Chalisserry et 
al., 2017; Anitua et al., 2018).  Such developments are based on DPSCs being 
recognized as a viable stem cell source, due to their accessibility, multi-lineage (e.g. 
osteogenic, chondrogenic, adipogenic, myogenic, neurogenic) differentiation 
capabilities and similarities to bone marrow-derived stem cells (Gronthos et al., 
2002; Shoi et al., 2014).  Indeed, DPSCs have already been shown to be beneficial 
to repair following transplantation into various animal model defects in vivo, related 
to diseases and traumas within clinical fields such as Dentistry, Orthopaedics, 
Neurology, Ophthalmology and Cardiology (Ledesma-Martínez et al., 2016; Nuti et 
al., 2016; Chalisserry et al., 2017; Anitua et al., 2018). 
 Distinct DPSC subsets/niches are proposed to exist within dental pulp (i.e. 
the sub-odontoblast layer near existing post-mitotic odontoblasts, associated with the 
pulpal vasculature and within the central pulpal stroma itself), with contrasting 
proliferative and regenerative capabilities (Sloan and Waddington, 2009).  This is an 
important consideration for the exploitation of DPSCs, as a significant limitation of 
stem cell therapy is the extensive in vitro expansion necessary to produce sufficient 
cell numbers for clinical use, which leads to proliferative decline and cellular 
senescence, accompanied by altered cellular differentiation and regenerative 
capabilities (Campisi and d'Adda di Fagagna, 2007; Wagner et al., 2010; Li et al., 
2017).  Thus, DPSCs have a distinctive highly heterogeneous nature with multiple 
progenitor cell populations residing within different niches of the pulp (Gronthos et 
al., 2000, 2002; Shi and Gronthos, 2003; Løvschall et al., 2005; Lizier et al., 2012; 
Kaukua et al., 2014).  This is supported by studies demonstrating that despite 
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heterogeneous DPSC populations being capable of >120 population doublings (PDs) 
in vitro before reaching senescence, only 20% of purified DPSCs undergo >20PDs, 
suggesting that DPSC have sub-populations that differ in their proliferative 
capacities and developmental potential (Huang et al., 2009). 
 It has been recognized for some time that there are significant differences in 
the relative ex vivo expansion capabilities of individual DPSCs isolated from dental 
pulp tissues, with their heterogeneous nature potentially posing challenges during in 
vitro expansion due to the diverse proliferative and regenerative potential of the 
different subsets ultimately affecting their stemness (Huang et al., 2009).  However, 
only recently has work begun to address the reasons behind these differences and the 
subsequent impact of such variations in proliferative capabilities on differentiation 
and regenerative potential.  Previous findings have confirmed major variations in 
proliferative capacity and senescence within different DPSC sub-populations 
(Alraies et al., 2017).  Whilst highly proliferative DPSCs reached >80PDs before 
senescence, other low proliferative DPSCs only achieved <40PDs, correlating with 
DPSCs with high proliferative capacities possessing longer telomeres (18.9kb) than 
less proliferative populations (5-13kb).  High proliferative capacity DPSCs exhibited 
prolonged stem cell marker expression, but lack CD271.  Early-onset senescence, 
stem cell marker loss and positive CD271 expression in DPSCs with low 
proliferative capacities were associated with impaired osteogenic and chondrogenic 
differentiation, favouring adipogenesis.  DPSCs with high proliferative capacities 
only demonstrated impaired differentiation following prolonged expansion 
(>60PDs).  Therefore, we have previously shown that DPSC proliferative and 
regenerative heterogeneity is related to contrasting telomere lengths and CD271 
expression between DPSC populations. 
 Although certain studies have reported positive human DPSC expression for 
the reverse transcriptase, human telomerase catalytic subunit (hTERT), capable of 
the complete replication of telomere ends and counteracting telomeric erosion 
(Flores and Blasco, 2010; Jeon et al., 2011; Hakki et al., 2015), most report no or 
negligible hTERT expression in DPSCs (Egbuniwe et al., 2011; Mehrazarin et al., 
2011a; Murakami et al., 2013; Alraies et al., 2017).  Therefore, hTERT expression 
and activity appears not to be responsible for the maintenance of telomere lengths in 
high proliferative DPSCs or the variations in proliferative capabilities.  Therefore, 
other intrinsic telomere protective mechanisms may be responsible for these 
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contrasting differences in telomere length, proliferation rates and regenerative 
potential between high and low proliferative DPSCs, such as differential oxidative 
stress responses and antioxidant profiles between DPSC populations.  For most cell 
types, in vitro expansion and subsequent cellular senescence is a consequence of 
replicative (telomere-dependent) senescence, characterised by progressive telomere 
shortening and the loss of telomeric TTAGGG repeats, due to repeated cell divisions 
(Campisi and d'Adda di Fagagna, 2007). 
Oxidative stress is another mechanism well-established to be capable of 
promoting cellular senescence (also known as telomere-independent senescence, 
premature senescence or stress-induced premature senescence, SIPS), in various cell 
types, including somatic cells and mesenchymal stem cells (Liu et al., 2011; Shyh-
Chang et al., 2013; Li et al., 2017).  Oxidative stress refers to the disturbance in the 
balance between the production of intracellular reactive oxygen species (ROS), such 
as superoxide and hydroxyl radical species (O2.- and .OH, respectively) and non-
radical species, such as hydrogen peroxide (H2O2) and cellular antioxidant defence 
mechanisms.  ROS are generated via a wide range of cellular mechanisms; however, 
under normal  physiological conditions, mitochondria is the primary source for ROS 
production (Balaban et al., 2005).  Although low ROS levels play important roles in 
the regulation of cell signalling and functions (Genestra, 2007), elevated ROS levels 
at the expense of antioxidant levels and subsequent oxidative stress, is capable of 
accelerating cellular senescence in vitro and in vivo, through the induction of DNA 
damage without significant telomere shortening, unless exposed to high levels of 
oxidative stress over prolonged periods (Ben-Porath and Weinberg, 2004).  Indeed, 
recent evidence suggests that oxidative stress induces telomeric double stranded-
breaks that are unrepairable, causing persistent DNA damage response signalling 
(DDR).  Subsequently, cells undergo telomere-independent senescence, where cells 
cease replication irrespective of telomere lengths (Victorelli and Passos, 2017). 
Both replicative and stress-induced senescence are associated with increased 
cellular morphologies, positive senescence associated β-galactosidase (SA-β-Gal) 
staining and the activation of various signalling pathways, including those involving 
the tumour suppressor genes, p53 and retinoblastoma protein (pRb), via the cyclin-
dependant kinase inhibitors, p21waf1 and p16INK4a, respectively (Campisi and d'Adda 
di Fagagna, 2007; Morsczeck et al., 2016).  This eventually blocks cell transfer from 
G1 to S phase causing cell cycle arrest.  However, it appears that the main difference 
 46 
between replicative senescence and the other forms of cell senescence lie in the 
presence of telomere shortening and the time elapsed before proliferation ceases 
(Bielak-Zmijewska et al., 2018).  Although senescent cells are under a permanent 
state of cellular growth arrest, in which cells cease dividing without undergoing 
apoptosis, they remain metabolically active and secrete various pro-inflammatory 
factors, such as proteases, chemokines and cytokines (commonly known as the 
senescence-associated secretory phenotype, SASP), which influences cellular 
behaviour within the surrounding tissue microenvironments (Malaquin et al., 2016; 
McHugh and Gil, 2018).  Consequently, senescence mediated via both replicative 
and stress-induced mechanisms induce significant alterations in cellular genotype 
and phenotype, ultimately influencing their overall biological functions and 
mediating impaired repair, disease and organismal ageing (Sikora et al., 2011). 
 
2.2 Chapter Aims 
In light of the minimal role that hTERT plays in facilitating variations in proliferative 
life-span and the onset of replicative (telomere-dependent) senescence between high 
and low proliferative DPSCs (Alraies et al., 2017), this Chapter aimed to identify 
whether DPSCs also differed in their respective susceptibilities to oxidative stress-
induced (telomere-independent), cellular senescence via the analysis of various 
parameters associated with the establishment of the senescence phenotype, such as 
PDs, morphological changes, telomere lengths,  SA-β-gal staining and stem cell 
marker (p53, p21waf1 and p16INK4a) expression.  By confirming such differences 
between high and low proliferative DPSCs, this would potentially provide additional 
evidence to support high proliferative DPSCs being more resistant to SIPS, 
compared to low proliferative DPSCs, thereby enhancing our understanding of 
DPSC biology and its inter-relationship with cellular ageing. 
 
2.3 Materials and Methods 
2.3.1 Isolation of Dental Pulp Stem Cells 
Human DPSCs were isolated from third molar teeth collected from adult patients 
(Patients A, C and D, all female, age range 18-30 years), undergoing orthodontic 
extractions at the School of Dentistry, Cardiff University, UK; as previously 
described (Alraies et al., 2017).  Teeth were collected with informed patient consent 
and ethical approval from the South East Wales Research Ethics Committee of the 
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National Research Ethics Service (NRES), UK.  To disinfect the teeth, the tooth 
outer surfaces were sterilised with 70% ethanol and soft tissue removed using a paper 
towel.  Teeth were then grooved in the mesial, distal and occlusal regions with a 
slow speed rotary bone saw and halved on a dissection board using a chisel and 
hammer.  Pulps were removed using a forceps and immediately placed in culture 
medium to maintain hydration, consisting of α-modified Minimum Essential 
Medium (αMEM) containing ribonucleosides, deoxyribonucleosides, 4mM L-
glutamine, 100U/ml penicillin G sodium, 0.1µg/ml streptomycin sulphate, 
0.25µg/ml amphotericin; and 20% foetal calf serum (FCS; all ThermoFisher 
Scientific, Paisley, UK), in addition to 100µM L-ascorbate 2-phosphate (Sigma, 
Poole, UK).  Pulp tissues were subsequently minced on a glass slide and placed in 
5ml bijoux tubes containing 4μg/μl collagenase/dispase (1ml, Roche, Welwyn 
Garden City, UK), for 1h at 37ºC, with gentle agitation every 20min.  Pulpal tissues 
from individual patients were prepared separately.  Pulpal digests were filtered 
through 70μm nylon cell strainers, eluted using αMEM medium (10ml).  The eluents 
were collected in 50ml Falcon tube (BD Biosciences, Wokingham, UK), to obtain 
single cell suspensions.  Cells were centrifuged (1,800rpm, 5min, Labofuge 400, 
ThermoFisher Scientific) and further re-suspended in αMEM medium (1ml).  Cell 
counts were calculated using 0.4% Trypan Blue vitality stain (Sigma).  As viable 
cells with an intact cell membrane do not allow the Trypan Blue stain to pass 
through, viable cell counts were determined through counting the non-stained cells.  
Aliquots (10μl) of each DPSC suspension were mixed well with Trypan Blue (10μl) 
and cells counted using a Neubauer Improved Haemocytometer (ThermoFisher 
Scientific) by light microscopy at x100 magnification (Nikon Eclipse TS100 
Microscope, Kingston upon Thames, UK). 
 
2.3.1.1 Fibronectin Adhesion Assay for Dental Pulp Stem Cell Isolation 
DPSCs were preferentially selected and isolated via a fibronectin adhesion assay as 
previously described, based on their expression of high β1-integrin levels on stem 
cell surfaces (Jones and Watt, 1993; Waddington et al., 2009; Harrington et al., 2014; 
Alraies et al., 2017).  Following the calculation of viable cell counts, cells were 
seeded onto 6-well plates (Sarstedt, Leicester, UK), previously coated overnight with 
fibronectin (10μg/ml, 1ml/well, derived from human plasma, Sigma), reconstituted 
in 0.1M phosphate buffered saline (PBS), pH 7.4.  Cell were seeded onto fibronectin-
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coated wells at 4,000 cells/cm2.  Plates were maintained at 37ºC/5% CO2 for 20min, 
to allow cell adherence (Adherent 1).  Following adhesion, culture medium and non-
adherent cells were removed and stored in new sterile Universal tubes.  The 6-well 
plates containing adherent cells were replenished with fresh αMEM medium (2ml).  
The collected non-adherent cells were then seeded onto fresh fibronectin-coated 6 
well-plates and allowed to adhere at 37ºC/5% CO2 for 40min (Adherent 2).  
Following adhesion, the culture medium containing non-adherent cells was removed 
and stored and the 6-well plates containing adherent cells replenished, as described 
above.  The collected non-adherent cells were subsequently seeded onto fresh 
fibronectin-coated 6 well-plates and again allowed to adhere at 37ºC/5% CO2 for 
40min (Adherent 3).  All adherence cells isolated from procedures Adherent 1, 2 and 
3 above, were maintained at 37ºC/5% CO2 in αMEM medium (2ml), with culture 
medium changed every 2 days. 
 Isolated DPSCs were monitored daily throughout culture, using an inverted 
light microscopy (Nikon Eclipse TS100) at x10 magnification and the number of 
cells per colony was recorded.  DPSC colonies were allowed to form up to 12 days 
in culture, with a minimum of 32 cells considered as a colony (Jones and Watt, 
1993), although rapidly forming colonies were isolated sooner to prevent colony 
merger.  Identified colonies of ³32 cells were harvested within cloning rings, using 
pre-warmed, StemPro® Accutase® (100µl, ThermoFisher Scientific) and re-seeded 
into 1 well of a 96-well plate (Sarstedt), with fresh αMEM medium (100µl).  Isolated 
colonies were subsequently expanded at 37ºC/5% CO2, until the numbers were 
sufficient for seeding into T-75 flasks (VWR International, Lutterworth, UK).  
Culture medium was changed every 2-3 days. 
 All DPSCs utilised in this study were isolated according to the protocols 
described above.  However, certain DPSC sub-populations were isolated previously 
by Dr Amr Alraies, School of Dentistry, Cardiff University (Alraies et al., 2017), 
whereas other DPSCs were isolated by myself, as above. 
 
2.3.2 General Cell Culture 
To ensure sterility of the working environment, safety cabinets and equipment were 
sprayed with 70% ethanol prior to carrying out any cell culture.  In addition, the 
incubators, safety cabinets and water baths were cleaned on a weekly basis.  All 
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consumables, glassware, some plastics, PBS and double-distilled water, were 
sterilised through autoclaving (123°C, 15lb/m2, 15 min) and any equipment required 
remained in the tissue culture laboratory. 
 All procedures involving cell culture were performed under sterile conditions 
in aseptic Class II Tissue Culture Hoods (Astec Microflow, Andover, UK).  70% 
ethanol was used to disinfect work areas and any item to be placed in the hoods.  
Cells were maintained in sterile cell culture plates and flasks within a 5% CO2 
humidified, 37°C incubators (Sarstedt). 
 T-75 flasks containing DPSCs were maintained at 37ºC/5% CO2 in αMEM 
medium.  Upon reaching 80-90% confluence, DPSCs were washed with 0.1M PBS, 
before treating with pre-warmed, StemPro® Accutase® (2ml).  Flasks were incubated 
at 37ºC/5% CO2 for 5-10min, to ensure cell detachment.  The StemPro® Accutase® 
was subsequently inactivated by the addition of αMEM medium (10ml) and 
centrifuged (1800rpm, 5min).  The resulting pellets were re-suspended in αMEM 
medium, before cell counting (as above) and reseeding. 
 
2.3.2.1 Cryopreservation and Cell Retrieval 
To cryopreserve cells, DPSCs were centrifuged (1,800rpm, 5min), counted using 
Trypan Blue and re-suspended in freezing mix (1ml), containing 10% dimethyl 
sulfoxide (DMSO, Sigma) and 90% FCS.  Freezing mix was added to cryovials and 
placed in Mr Frosty freezing pots at -80ºC.  After 24h, cryovials were transferred to 
liquid nitrogen for long term storage.  When cells were required, DPSCs were rapidly 
thawed by transferring to a 37ºC water bath.  Cells were immediately re-suspended 
in 5ml αMEM medium and centrifuged, as above.  Cells were then rewashed with 
αMEM medium and expanded in culture. 
 
2.3.2.2 Screening of Mycoplasma Contamination 
Routine screening was performed on DPSCs on a monthly basis through their 
proliferative life-spans in culture, to determine whether mycoplasma contamination 
was present.  Samples of culture media (100µl) were obtained when DPSCs reached 
90-100% confluence.  Samples were stored at -20°C until required for assessment, 
then thawed on ice before incubated at 95°C for 5min, then centrifuged to pellet cell 
debris.  Mycoplasma detection was confirmed using a VenorGeM Mycoplasma 
Detection Kit for Conventional PCR (Cambio, Cambridge, UK), according to 
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manufacturer’s protocol.  Media supernatant aliquots (2µl) were used to establish 
polymerase chain reaction (PCR) Master Mix reactions (total volume, 25µl), 
containing nuclease-free water, GoTaq Green buffer, magnesium chloride, 
primer/nucleotide mix, internal control, GoTaq polymerase (all from Promega Ltd., 
Southampton, UK). A negative control of nuclease-free water only and a positive 
control DNA, were used to determine whether mycoplasma contamination was 
present.  RNA-free water was used for negative control, while DNA template as 
positive control.  PCR cycles was performed as follows: single cycle at 94°C for 
2min, followed by 39 cycles at 94°C for 30s, 55°C for 30s and 72°C for 30s then 
held at 4°C.  The samples were run on 2% agarose gels (ThermoFisher Scientific), 
at 100V for 20min, using a Mini-Horizontal Electrophoresis Unit (Jencons, Leighton 
Buzzard, UK).  Each gel was viewed on a GelDoc™ Scanner using Doc™ EZ 
Imaging System with Image Lab™ Version 5 for taking images (Bio-Rad 
Laboratories Ltd., Hemel Hempstead, UK).  A positive mycoplasma contamination 
was shown by the presence of a strong band present at 267bp.  An internal control 
always produces a band at 191bp, to show the reaction had worked, although the 
internal control band at 191bp was not visible if strong mycoplasma contamination 
was present. 
 If DPSCs were found to be mycoplasma positive, they were subsequently 
treated with BM Cyclin (Roche, Burgess Hill, UK) for 3 weeks, consisting of 3 
cycles of treatment.  Contaminated culture medium was removed, with fresh αMEM 
medium containing BM Cyclin 1 (4μl of stock solution/ml, final concentration 
10μg/ml) added.  DPSCs were cultured as previously described for three days and 
passaged when necessary.  Culture medium containing BM Cyclin 1 was 
subsequently removed and replaced with fresh αMEM medium containing BM 
Cyclin 2 (4μl of stock solution/ml, final concentration 5μg/ml).  Cells were cultured 
as previously described for 4 days and passaged when necessary.  This 7-day 
treatment cycle was performed 3 times, before fresh αMEM medium was reassessed 
to confirm eradication of mycoplasma contamination. 
 
2.3.3 Dental Pulp Stem Cell Expansion Under Oxidative Stress Conditions 
DPSCs were seeded at 5,000 cells/cm2 in T-75 flasks in and maintained at 37ºC/5% 
CO2 in αMEM medium, in the absence and presence of sub-lethal doses of 
exogenous H2O2 (0, 50µM, 100µM or 200μM, ThermoFisher Scientific).  Culture 
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medium was changed every two days.  Cells were grown to 80-90% confluence and 
sub-cultured, as described above.  DPSCs were subsequently expanded in culture 
throughout their proliferative life-spans to senescence. 
 
2.3.4 Population Doubling Analysis 
PD analysis is an established and widely used method to detect and quantify cellular 
senescence.  It is defined as the number of times cell number is doubled and based 
on the observation that proliferative potential decreases during cellular aging (Ben-
Porath and Weinberg, 2005).  PDs for all DPSCs cultured in the absence and 
presence of H2O2 (0, 50µM, 100µM or 200μM), were monitored throughout their 
proliferative life-spans to senescence.  Upon reaching 80-90% confluence, DPSCs 
were sub-cultured as described above, from which the total numbers of viable cell 
counts at each sub-culture were obtained using a haemocytometer and the number 
of cells reseeded was recorded.  PDs were calculated based on the original number 
of DPSCs seeded and the final cell number, using the formula: 
 
log10 (total cell counts obtained) - log10 (total cell counts re-seeded) 
log10 (2) 
 
Cumulative PDs were subsequently plotted against time in culture, with the onset of 
cellular senescence confirmed when DPSCs underwent <0.5PDs/week (Cristofalo et 
al., 1998; Alraies et al., 2017). 
 
2.3.5 Senescence-Associated β-Galactosidase Staining 
The detection of positive SA-β-Gal activity is one of the most widely used markers 
to identify senescent cells.  It is a lysosomal hydrolase that is only active in senescent 
cells at pH 6, unlike non-senescent cells, where it is active at pH 4 (Dimri et al., 
1995; Krishnamurthy et al., 2004).  SA-β-Gal activity as a marker of senescence was 
assessed in DPSC populations once they exhibited <0.5PDs/week, using Senescence 
Cell Histochemical Kits (Sigma), according to manufacturer’s instructions.  DPSCs 
at selected PDs were seeded in 6 well-plates at 5,000 cells/cm2 and maintained at 
37ºC/5% CO2 in αMEM medium for 24h, in the absence and presence of H2O2 (0, 
50µM, 100µM or 200μM).  The culture medium was subsequently aspirated and the 
DPSCs washed (x2) with PBS (in Kit) diluted 1:10 in ultrapure water.  Fixation 
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Buffer (1:10 diluted in ultrapure water, 1.5ml/well) was added for 7min at room 
temperature.  Meanwhile, 10ml of Staining Mixture was prepared by mixing pre-
warmed Staining Solution (1ml/well, in Kit), Reagent B (0.125ml, in Kit), Reagent 
C (0.125ml, in Kit) and X-gal solution (0.25ml, in Kit), with ultrapure water (8.5ml).  
Following incubation with Fixation Buffer, cells were rinsed (x3) with PBS 
(1ml/well).  Staining Mixture (1ml) was added to each well and incubated at 
37ºC/5% CO2 overnight, with the plate sealed with Parafilm to prevent drying.  
DPSCs were subsequently observed by light microscopy (Nikon Eclipse TS100 
Microscope) and the mean % positively blue-stained cells calculated in triplicate, 
from 20 random regions within the fields of view (30μm2).  Finally, the percentage 
of cells expressing β-galactosidase activity were calculated.   
 
2.3.6 Gene Expression Analysis 
2.3.6.1 mRNA Extraction 
DPSCs at selected PDs were seeded in 6 well-plates at 5,000 cells/cm2 and 
maintained at 37ºC/5% CO2 in αMEM medium, in the absence and presence of H2O2 
(0, 50µM, 100µM or 200μM), until they reached 80-90% confluence.  The culture 
medium was subsequently aspirated and mRNA extraction performed using RNeasy 
Mini Kit (Qiagen, Manchester, UK), following manufacturer’s protocols.  DPSCs in 
each well were lysed with RLT Lysis Buffer (300μl, Qiagen), supplemented with 
10μl/ml β-mercaptoethanol (Sigma).  Lysates (in 600μl aliquots) were transferred to 
QiaShredder columns (Qiagen) and centrifuged (13,500g, 2min, Spectrafuge 24D, 
Jencons), to shear cellular components and separate cellular debris.  Lysates were 
subsequently treated with 1:1 volumes of 70% molecular-grade ethanol (Sigma), 
followed by centrifugation (10,000g, 15s), using RNeasy Mini Kit columns 
(Qiagen).  After discarding the flow-through, columns were washed with 350μL of 
Buffer RW1 (350µl, Qiagen) and centrifuged (10,000g, 15s).  Resultant flow-though 
was discarded and a mixture of 10μL of DNase I stock (10µl) and Buffer RDD (70µl, 
both Qiagen) added.  To remove any contaminant DNA, columns were incubated for 
15min at room temperature.  Subsequently, Buffer RW1 (350µl) was added and 
columns centrifuged (10,000g, 15s), followed by addition of Buffer RPE (500μl) and 
further centrifugation (10,000g, 1min) and the flow-through discarded.  New 1.5ml 
Eppendorf tubes (ThermoFisher Scientific) were used for the column inserts, DNase-
free water (40µl, Promega) was added and the columns centrifuged (10,000g, 1min).  
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To maximise RNA yields, elutes were transferred back into the columns and re-
centrifuged.  Finally, RNA collected in each Eppendorf tube was stored at -80ºC, 
until required.  For RNA quantification, NanoVue (GE Healthcare, Little Chalfont, 
UK) was used.  Initially, the Nanovue was standardised with DNase-free water (2µl) 
and RNA samples (2µl) were subsequently quantified.  RNA purity was determined 
using the ratio between absorbance values at 260 and 280nm (260/280 ratio), with 
purities over 1.7 considered sufficient for downstream applications. 
 
2.3.6.2 Reserve Transcription (RT)-PCR 
cDNA was synthesised by adding 0.5μg random primers (Promega) to total RNA 
(1µg), followed by the addition of followed by DNase-free water to a final volume 
of 15μl.  Mixtures were incubated in a G-Storm™ GS1 Thermal Cycler (Genetic 
Research Instrumentation, Braintree, UK), at 70°C for 5 min.  Master mixes 
consisting of 5X Moloney murine leukaemia virus (M-MLV) buffer (5μl), Random 
Primers (0.5μg), RNasin (0.6μl), deoxynucleotide triphosphates (dNTPs; 10mM, 
1.25μl) and M-MLV reverse transcriptase (1μl), were then added immediately to the 
cooled product followed by addition of DNase-free water, to a final volume of 25μl.  
Reaction reaction mixtures minus mRNA were also prepared as negative controls.  
All reactions were performed on a G-Storm™ GS1 Thermal Cycler (Genetic 
Research Instrumentation, Braintree, UK), at 37ºC for 1h, followed by 95ºC for 
5min.  Resultant cDNA samples were stored at -20°C, until required. 
 All PCR reactions were established by the addition of cDNA (1μl), 5x Green 
GoTaq™ Flexi Buffer (5μl), 25mM Magnesium Chloride Solution (1μl), 10mM 
PCR Nucleotide Mix (0.5μl), 5U/μl GoTaq™ DNA Polymerase (0.25μl, all 
Promega), 10μM forward and reverse primers (both 1.25μl).  PCR were performed 
using the primer sequences described in Table 2.1, with β-actin serving as the 
housekeeping gene.  All reactions were established to 25µl with nuclease-free water.  
Reactions were run on a G-Storm™ GS1 Thermal Cycler, with an initial denaturing 
step of 95°C (5min), followed by 35 cycles at a denaturing step temperature of 95ºC 
(1min), 1 cycle at primer-specific annealing temperatures of 52-62ºC (1min), 1 cycle 
at 72°C (1min) and 1 cycle at extension step temperature of 72°C (5min).  Total 
human RNA (ThermoFisher Scientific) was used as a positive control for all genes 
analysed.  Primer replacement with nuclease-free water served as negative controls. 
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Table 2.1: Details of the forward and reverse primers used for PCR amplification. 
 
Gene 
Marker Primer Sequence 
Annealing 
Temp. (°C) Cycles 
NCBI Reference 
Sequence 
CD73 F:5'-GTCGCGAACTTGCGCCTGGCCGCCAAG-3' R:5'-TGCAGCGGCTGGCGTTGACGCACTTGC-3' 65 35 NM_001204813.1 
CD90 F:5'- ATGAACCTGGCCATCAGCATCG-3' R:5'- CACGAGGTGTTCTGAGCCAGCA-3' 55 35 NM_006288.3 
CD105 F:5'-GAAACAGTCCATTGTGACCTTCAG-3' R: 5'-GATGGCAGCTCTGTGGTGTTGACC-3' 65 35 NM_001114753.2 
CD271 F:5'- CTGCAAGCAGAACAAGCAAG-3' R:5'- GGCCTCATGGGTAAAGGAGT-3' 55 35 NM_002507.3 
CD45 F:5'-GTGACCCCTTACCTACTCACACCACTG-3' R:5'-TAAGGTAGGCATCTGAGGTGTTCGCTG-3' 65 35 NM_002838.4 
p53 F:5'- AGACCGGCGCACAGAGGAAG-3' R:5'- CTTTTTGGACTTCAGGTGGC-3' 55 35 NM_001126118.1 
p21waf1 F:5'- GGATGTCCGTCAGAACCCAT-3' R:5'- CCCTCCAGTGGTGTCTCGGTG-3' 60 35 NM_001291549.1 
p16INK4A F:5'- CTTCCTGGACACGCTGGT-3' R:5'- GCATGGTTACTGCCTCTGGT-3' 55 35 NM_001195132.1 
β-actin F:5'- AGGGCAGTGATCTCCTTCTGCATCCT-3' R:5'- CCACACTGTGCCCATCTACGAGGGGT-3' 65 35 NM_001101.3 
BMI1 F:5'- CTGGTTGCCCATTGACAGCG -3' R:5'- AAATCCCGGAAAGAGCAGCC-3' 59 35 NM_005180.8 
CD166 F:5'- TCA TAC CTT GCC GAG TTG ACG-3' R:5'- TCT GGT ACT GGC CAT CAA TCC-3' 57 35 NM_001243283.1 
P29 F:5'- ATG TGT CG ACC TGC CTT GG-3' R:5'- CCA TGA CCT CGT TGT TCC CA-3' 57 35 NM_002211.3 
CD117 F:5'- AAATCCATCCCCACACCCTG -3' R:5'- CTTTTGTCGGCCTTGGTTGG -3' 59 35 XM_005265742.1 
Nanog F:5'- TGCCTCACACGAGACTGTC-3' R:5'- TGCTATTCTTCGGCCAGTTG-3' 59 35 XM_011520851.1 
SSEA4 F:5'- CAAAGAGGGGGACCCCTAGA-3' R:5'- GACGGGGGAAATGTTACCGT-3' 59 35 NM_006927.3 
hTERT F:5'- CGGAAGAGTGTCTGGAGCAA-3' R:5'- GGATGAAGCGGAGTCTGG-3' 59 35 XM_011514106.1 
Slug F:5'- GAGCATACAGCCCCATCACT-3' R:5'- CTCCCCCGTGTGAGTTCTAA-3' 59 35 NM_003068.4 
CD146 F:5'- ACAAGACCAAGATCCACAGCGAGT-3' R:5'- ATGCACACAATCACAGCCACGATG-3' 59 35 NM_006500.2 
Oct4 F:5'- AGGAGTCGGGTGGAGAG-3' R:5'- CGTTTGGCTGAATACCTTCC-3' 59 35 NM_002701.5 
 55 
2.3.6.3 Agarose Gel Electrophoresis 
Agarose gels were prepared by adding 1.4g of agarose powder to 0.5x 
Tris/borate/EDTA (TBE) buffer (70ml), followed by microwave heating for 1min 
with swirling every 20s.  When solutions became clear, ethidium bromide (7μl, 
10mg/ml, Promega) was added and gels poured into casting trays with a comb 
mounted and left for 25min to set at room temperature.  When gel set, the combs and 
borders were removed and the trays containing the gels transferred to the 
electrophoresis tank containing sufficient volumes of 0.5xTBE buffer.  A 100 base 
pair (bp) DNA ladders (10μl, Promega) was loaded into the first and last wells of 
each gel, with PCR samples (10μl) loaded into the wells between.  PCR products 
and 100bp DNA ladders were separated on 2% agarose gels (80mV, 45min), in 1x 
TBE running buffer.  Gel images were captured under UV light (312nm) and PCR 
products visualised and analysed, using a Gel Doc 3000 Scanner and Image Analysis 
Software (Bio-Rad Laboratories). 
 
2.3.7 Telomere Length Analysis 
2.3.7.1 DNA Extraction 
DPSCs at various PDs throughout their proliferative lifespans, were seeded in T-75 
flasks at 5,000 cells/cm2 and grown to 80-90% confluence.  DPSCs were detached 
using StemPro® Accutase® and centrifuged at 1800rpm for 5min.  Supernatants were 
discarded and the pellets re-suspended in PBS (200μl), mixed with proteinase K 
(20μl) and incubated at 56°C for 10min, followed by centrifugation (8,000g, 1min).  
100% ethanol (200μl) was added and briefly centrifuged (8,000g, 15s).  Genomic 
DNA was isolated from the resulting mixtures using QIAmp® DNA Mini Kits 
(Qiagen), according to manufacturer’s instructions.  Once mixtures were placed in 
QIAamp® Mini Spin Columns, these were centrifuged (8,000g, 1min) and collected 
in 2ml collection tubes.  Buffer AW1 (500μl) was added to each column and 
centrifuged (8,000rpm, 1min).  New collection tubes were then used and Buffer 
AW2 (500μl) added, followed by centrifugation (14,000rpm, 3min).  Columns were 
then transferred to 1.5ml microcentrifuge tubes, Buffer AE (200μl) added and left at 
room temperature for 1min, followed by centrifugation (8,000rpm, 1min).  DNA 
yields were subsequently quantified at 260nm (NanoVue) and samples stored at -
20°C, until required. 
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2.3.7.2 Terminal Restriction Fragment Assay and Southern Blot Analysis 
DPSC telomere length analyses were performed using the TeloTAGGG Telomere 
Restriction Fragment Length (TRF) Assay Kit (Roche), according to manufacturer’s 
instructions.  DNA samples (1μg) and positive DIG-labelled, Control DNA samples 
(in Kit) were digested with 2μl of x10 digestion buffer and 1μl of Hinf1/Rsa1 (both 
40U/µl, in Kit), following incubation at 37°C for 2h.  After 2h, reactions were 
stopped using 4μl of loading buffer.  0.8% agarose gels were prepared using highly 
pure, nucleic acid grade agarose (Agarose MP, Geneflow, Lichfield, UK), containing 
0.2µg/ml ethidium bromide.  When hardened, combs were removed, and gels were 
covered with 1x TAE buffer.  DNA samples (20μl), a digoxigenin (DIG)-labelled, 
Molecular Weight Marker (20μl, in Kit) and positive DIG-labelled, Control DNA 
samples (20μl), were separated by agarose gel electrophoresis (80V, 5min and 15V, 
overnight), in 1x TAE buffer.  Gels were subsequently treated with 0.25M 
hydrochloric acid solution (ThermoFisher Scientific) for 10min and rinsed (x2) with 
double-distilled water, before treatment (2x15min) with Denaturation Solution 
(0.5M sodium hydroxide, 1.5M sodium chloride solution).  This was followed by 
rinsing (x2) with double-distilled water, and treatment with Neutralisation Solution 
(0.5M Tris-HCl buffer, pH 7.5, containing 3M sodium chloride, 2x15min). 
 Separated products were transferred onto positively charged nylon 
membranes (Roche) by Southern blotting using 20x standard sodium citrate (SSC) 
buffer (3M sodium chloride/0.3M sodium citrate solution, pH 7.0).  Nylon 
membranes were fixed by UV-crosslinking for 2x10s (Stratalinker, Agilent 
Technologies, Stockport, UK) and washed with SSC (x2), prior to hybridisation 
using a hybridisation oven (VWR International), with DIG Easy Hyb (25ml, in Kit), 
at 42oC for 1h under gentle rotation on a rotisserie.  This was replaced with 
Hybridisation Solution (10ml) mixed with Telomere Probe (2µl, in Kit) and 
incubated at 42oC for 3h, under gentle rotation.  Membranes were washed (x2) with 
Stringent Wash Buffer I (25ml), at room temperature for 5min, under gentle rotation.  
This solution was replaced with Stringent Wash Buffer II (25ml) and the membranes 
washed (x2) at 50°C for 20min under gentle rotation.  Stringent Wash Buffer II was 
replaced by incubation in Blocking Solution (25ml, in Kit), at room temperature for 
30min, followed by incubation in Anti-DIG-AP Working Solution (25ml, in Kit), at 
room temperature for 30min, both under gentle rotation.  Membranes were 
subsequently washed in Washing Buffer (2x25ml, in Kit), at room temperature for 
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15min each under gentle rotation followed by treatment with Detection Buffer 
(25ml, in Kit).  Finally, membranes were incubated in Chemiluminescent Substrate 
Solution (in Kit), at room temperature for 5min under gentle rotation, before being 
exposed (1min) to High Performance Chemiluminescence Film (Hyperfilm®, GE 
Healthcare) and developed using a CURIX 60 X-Ray Film Processor (AGFA, 
Brentford, UK). 
Average DPSC telomere lengths at each PD analysed were calculated from 
the Southern blot images, using ImageJ® Software (http://rsb.info.nih.gov/ij/), to 
quantify the densitometric intensity profile of the entire length of the separated 
products within each particular lane.  In line with TRF Assay Kit instructions, each 
lane was overlaid along its entire length with a grid consisting of 30 equal squares, 
where telomere-specific signal was detectable.  The background intensity of each 
lane was calculated by selecting squares within each lane containing no telomere-
specific signal and by subtracting these averaged values from the squares containing 
telomeric signal.  For each square containing detectable telomeric signal, the total 
signal density within each square (ODi) and the corresponding molecular weight at 
the mid-point of each square (Li) (based on the DIG-labelled, Molecular Weight 
Marker bands, kb), were calculated.  Southern blots were performed in triplicate and 
average telomere lengths calculated using the following formula, where ODi is the 
chemiluminescent signal and Li is the length of the telomeres at position i: 
 
Σ (ODi) 
Σ (ODi / Li) 
 
2.4 Statistical Analysis 
Statistical analyses were performed via use of GraphPad Prism Software (GraphPad 
Software Inc., La Jolla, USA).  Graphical data for each experimental 
condition/sample group are exhibited as average±standard error of the mean (SEM).  
For SA-β-Gal data, statistical significance was determined using Analysis of 
Variance (ANOVA), with post-hoc Tukey’s multiple comparisons tests.  
Significance was considered at p<0.05. 
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2.5 Results 
2.5.1 Dental Pulp Stem Cell Population Doublings Under Oxidative Stress 
A number of different DPSC sub-populations were successfully isolated and 
characterised from 3 individual patient donors (Patients A, C and D), using the 
procedures described above.  However, in order to assess the relative susceptibilities 
of DPSC sub-populations to oxidative stress-induced senescence, the effects of 
increasing H2O2 concentrations (0, 50μM, 100μM, 200μM) on PDs were assessed 
throughout the proliferative life-spans to senescence, for 4 separate DPSC sub-
populations (A1, A2, C3 and D4), from patients A, C and D (Figures 2.1-2.4, 
respectively).  Overall, PDs and proliferative capacity showed marked variations in 
the susceptibilities of DPSCs to oxidative stress-induced senescence, with each 
demonstrating differences in PDs irrespective of whether DPSCs were derived from 
the same or different patients. 
DPSC population (A1, Patient A), exhibited the highest achievable PDs 
overall and consequently, a high degree of resistance to oxidative stress-induced 
senescence (Figure 2.1).  Over 160 days in culture, untreated controls DPSCs (A1) 
were determined to achieve >80PDs.  A1 DPSCs treated with increasing H2O2 
concentrations (50μM, 100μM, 200μM), exhibited slower PDs after 10 days in 
culture in a dose-dependent manner and the earlier onset of stress-induced 
senescence, compared to control DPSCs.  However, DPSCs exposed to oxidative 
stress were still capable of undergoing considerable PDs, prior to senescence being 
reached (i.e. <0.5PDs/week).  Indeed, A1 DPSCs achieved 76PDs over 160 days, 
62PDs over 145 days and 58PDs over 145 days, in 50µM, 100µM and 200µM H2O2, 
respectively. 
 In contrast to A1, DPSC population (A2, Patient A) was capable of much 
reduced PDs, as untreated controls only exhibited 34PDs over 120 days in culture 
and therefore, demonstrated low proliferative capacity overall (Figure 2.2).  As such, 
although A2 DPSCs exposed to 50µM H2O2 had limited effect on PDs (32PDs over 
120 days) and therefore, exhibited some resistance to oxidative stress-induced 
senescence at this concentration; increasing exposure to H2O2 concentrations at 
100µM and 200µM induced significantly slower PDs after 8 days in culture in a 
dose-dependent manner and the earlier onset of stress-induced senescence, 
compared to control DPSCs and those treated with 50µM H2O2.Indeed, A2 DPSCs 
only achieved 30PDs over 110 days and 27PDs over 98 days, in 100µM and 200µM 
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Figure 2.1.  Characterisation of DPSC (A1, Patient A) population doublings (PDs) 
during extended culture to senescence, under increasing H2O2 concentrations 
(50μM, 100μM, 200μM), compared to untreated controls.  A1 demonstrated high 
proliferative capacity, with untreated controls achieving >80PDs over 160 days in 
culture.  DPSCs exposed to increasing H2O2 concentrations exhibited slower PDs 
after 10 days in culture, prior to senescence: 50µM H2O2 (76PDs over 160 days), 
100µM H2O2 (62PDs over 145 days) and 200µM H2O2 (58PDs over 145 days). 
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Figure 2.2.  Characterisation of DPSC (A2, Patient A) population doublings (PDs) 
during extended culture to senescence, under increasing H2O2 concentrations 
(50μM, 100μM, 200μM), compared to untreated controls.  A2 demonstrated low 
proliferative capacity, with untreated controls achieving 34PDs over 120 days in 
culture.  Although DPSCs exposed to 50µM H2O2 had limited effect on PDs (32PDs 
over 120 days), increasing H2O2 concentrations exhibited slower PDs after 8 days in 
culture, prior to senescence: 100µM H2O2 (30PDs over 110 days) and 200µM H2O2 
(27PDs over 98 days). 
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H2O2, respectively. 
 DPSC populations (C3, Patient C) and (D4, Patient D) were also deemed to 
be low proliferative capacity DPSCs overall, based on the much reduced PDs these 
were capable of achieving overall (Figures 2.3 and 2.4, respectively).  For C3, this 
was confirmed as untreated controls only exhibited 20PDs over 43 days in culture 
(Figure 2.3).  Although C3 DPSCs exposed to 50µM H2O2 had limited effect on PDs 
(>18PDs over 43 days), C3 exhibited lower resistance to oxidative stress-induced 
senescence with increasing exposure to H2O2 concentrations at 100µM (15PDs over 
29 days) and 200µM (12PDs over 25 days) after 13 days in culture and the earlier 
onset of stress-induced senescence, compared to control DPSCs and those treated 
with 50µM H2O2.  Similar PD profiles were obtained with D4 DPSCs (Figure 2.4), 
with untreated control DPSCs only capable of 11PDs over 40 days in culture.  
Consequently, D4 DPSCs exhibited low resistance to oxidative stress-induced 
senescence, evident by D4 achieving dose-dependently reduced PDs with increasing 
exposure to H2O2 concentrations at 50µM (7PDs over 40 days), 100µM (6PDs over 
35 days) and 200µM (4PDs over 30 days) after 2 days in culture and the earlier onset 
of stress- induced senescence, compared to control DPSCs. 
Therefore, based on comparing all 4 DPSC sub-populations, distinct 
differences in oxidative stress-induced senescence were identified between 
individual DPSC sub-populations overall.  It was evident that DPSC population (A1, 
Patient A) was highly proliferative and extremely resistant to oxidative stress-
induced senescence, compared to the other DPSC populations analysed, A2 (Patient 
A), C3 (Patient C) and D4 (Patient D), which underwent early/accelerated 
senescence.  However, in all 4 populations, reduction in PDs induced by oxidative 
stress were largely manifested in a dose-dependent manner, with the highest H2O2 
concentrations (100µM and 200µM) inducing the most significant decreases in PDs. 
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Figure 2.3.  Characterisation of DPSC (C3, Patient C) population doublings (PDs) 
during extended culture to senescence, under increasing H2O2 concentrations 
(50μM, 100μM, 200μM), compared to untreated controls.  C3 demonstrated low 
proliferative capacity, with untreated controls achieving 20PDs over 43 days in 
culture.  Although DPSCs exposed to 50µM H2O2 had limited effect on PDs 
(>18PDs over 43 days), increasing H2O2 concentrations exhibited significantly 
decreased PDs after 13 days in culture, prior to senescence: 100µM H2O2 (15PDs 
over 29 days) and 200µM H2O2 (12PDs over 25 days). 
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Figure 2.4.  Characterisation of DPSC (D4, Patient D) population doublings (PDs) 
during extended culture to senescence, under increasing H2O2 concentrations 
(50μM, 100μM, 200μM), compared to untreated controls.  D4 demonstrated low 
proliferative capacity, with untreated controls achieving 11PDs over 40 days in 
culture.  DPSCs exposed to increasing H2O2 concentrations exhibited significantly 
slower proliferation PDs after 2 days in culture, prior to senescence: 50µM H2O2 
(7PDs over 40 days), 100µM H2O2 (6PDs over 35 days) and 200µM H2O2 (4PDs 
over 30 days). 
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2.5.2 Senescence-Associated β-Galactosidase Staining 
To confirm cellular senescence, SA-β-Gal staining was performed when PDs were 
<0.5/week.  Once DPSCs from the four treatment groups had reached senescence, 
SA-β-Gal staining was performed on all experimental groups simultaneously for 
comparison purposes.  Senescent DPSCs became positively stained due to X-gal 
being converted to blue stain at pH 6 by the β-galactosidase enzyme (Dimri et al., 
1995; Krishnamurthy et al., 2004).  Calculation of the % positive blue stained DPSCs 
by light microscopy. 
 As described above (Section 2.5.1), A1 DPSCs exhibited the highest PDs 
resistance to oxidative stress-induced senescence overall.  Consequently, high % 
positive SA-β-Gal staining was only particularly evident in A1 DPSCs upon 
confirmation of the induction of senescence (<0.5PDs/week) after reaching 58PDs 
in culture treated with 200 μM H2O2 (89% positivity, Figure 2.5).  Similarly, A1 
DPSCs treated with 100μM H2O2 demonstrated high % positive SA-β-Gal staining 
(87%), after reaching 62PDs.  However, less positive SA-β-Gal staining was 
determined for A1 DPSCs treated with 50μM H2O2 (39% at 73PDs), although 
significantly less SA-β-Gal positivity was detectable in untreated A1 controls, even 
following 80PDs in culture (25%, p<0.001).  In contrast to A1, low proliferative 
DPSC populations, A2, C3 and D4, demonstrated high levels of positive SA-β-Gal 
staining at much earlier PDs, especially with increasing H2O2 exposure in line with 
these being identified as low proliferative DPSC sub-populations overall.  Despite 
untreated DPSC sub-population, A2, demonstrating 30% positive SA-β-Gal staining 
at 30PDs (Figure 2.6), these increased further with 50μM H2O2 at 29PDs (35%, 
p<0.001), 100μM H2O2 at 28PDs (86%, p<0.001) and 200μM H2O2 at 26PDs (91%, 
p<0.001).  Such increases in SA-β-Gal staining were equally prominent at earlier 
PDs with DPSC populations, C3 and D4 (Figures 2.7 and 2.8, respectively).  
Although untreated sub-population, C3, only exhibited 18% SA-β-Gal positivity at 
19PDs (Figure 2.7), detectable staining significantly increased with 50μM H2O2 at 
19PDs (20%, p<0.05), 100μM H2O2 at 16PDs (69%, p<0.001) and 200μM H2O2 at 
12PDs (89%, p<0.001).  This was also the case with D4 DPSCs, with both untreated 
and 50μM H2O2 treated D4 displaying 95% positive SA-β-Gal staining at 7PDs and 
10PDs, respectively (p>0.05) and 100% positive staining at 100μM and 200μM 
H2O2 concentrations (at 6PDs and 2PDs, respectively; p<0.001 versus untreated 
controls).  
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Figure 2.5.  Comparison of % positive SA-β-Gal staining for DPSC (A1, Patient A) 
at 144 days, following extended culture to senescence under increasing H2O2 
concentrations (50μM, 100μM, 200μM), compared to untreated controls.  Scale bar 
100μm, ×10 magnification.  N=3, average±SEM, ***p<0.001. 
 
Untreated Controls (25% at 80PDs)        50μM H2O2 (39% at 73PDs) 
 
100μM H2O2 (87% at 62PDs)          200μM H2O2 (89% at 58PDs) 
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Figure 2.6.  Comparison of % positive SA-β-Gal staining for DPSC (A2, Patient A) 
at 95 days, following extended culture to senescence under increasing H2O2 
concentrations (50μM, 100μM, 200μM), compared to untreated controls.  Scale bar 
100μm, ×10 magnification.  N=3, average±SEM, ***p<0.001. 
 
Untreated Controls (30% at 30PDs)        50μM H2O2 (35% at 29PDs) 
 
100μM H2O2 (86% at 28PDs)          200μM H2O2 (91% at 26PDs) 
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Figure 2.7.  Comparison of % positive SA-β-Gal staining for DPSC (C3, Patient C) 
at 25 days, following extended culture to senescence under increasing H2O2 
concentrations (50μM, 100μM, 200μM), compared to untreated controls.  Scale bar 
100μm, ×10 magnification.  N=3, average±SEM, *p<0.05 and ***p<0.001. 
 
Untreated Controls (18% at 19PDs)        50μM H2O2 (20% at 19PDs) 
 
100μM H2O2 (69% at 16PDs)          200μM H2O2 (89% at 12PDs) 
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Figure 2.8.  Comparison of % positive SA-β-Gal staining for DPSC (D4, Patient D) 
at 42 days, following extended culture to senescence under increasing H2O2 
concentrations (50μM, 100μM, 200μM), compared to untreated controls.  Scale bar 
100μm, ×10 magnification.  N=3, average±SEM, ***p<0.001. 
 
Untreated Controls (95% at 7PDs)        50μM H2O2 (95% at 10PDs) 
 
100μM H2O2 (100% at 6PDs)          200μM H2O2 (100% at 2PDs) 
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2.5.3 Senescence Marker Gene Expression 
Analysis of cellular senescence-related genes (p53, p21waf1, p16INK4a and hTERT) 
expression for DPSCs sub-populations, A1, A2, C3 and D4, demonstrated that all 
DPSCs assessed were negative for hTERT expression at all PDs analysed (Figure 
2.9).  Highly proliferative DPSC sub-population, A1, displayed undetectable p53 
and p16INK4a expression at early PDs (10-25PDs), irrespective of H2O2 treatment.  
However, low level p21waf1 expression was apparent for A1, both at early (10-
25PDs) and later (45-60PDs) PDs, independent of H2O2 treatment.  Low level 
p16INK4a expression was also detectable for A1, but only at later (45-60PDs) PDs.  
Similar to A1, low proliferative DPSC population, A2, demonstrated low levels of 
p21waf1 and p16INK4a expression at early PDs (2-10PDs), irrespective of H2O2 
treatment, although p53 expression was undetectable at early PDs (2-10PDs).  
However, both low proliferative DPSC populations, C3 and D4, demonstrated high 
levels of detectable p53, p21waf1 and p16INK4a expression at early PDs (2-10PDs), 
again independent of H2O2 treatment. 
 
2.5.4 Telomere Length Analysis 
Average telomere lengths of DPSCs sub-populations, A2, C3 and D4, in the absence 
and presence of H2O2 treatment (50μM, 100μM, 200μM), were measured at early 
PDs (2-10PDs), with additional quantification of telomere lengths in DPSCs, A1, at 
early (10-25PDs) and later PDs (45-60PDs).  Telomere lengths were determined 
using TRF length analysis and Southern blotting.  Band densities and lengths varied 
considerably between the different DPSC sub-populations, with untreated highly 
proliferative DPSC sub-population, A1, possessing longer average telomere lengths 
(12.8kb) at early PDs (10-25PDs), compared with low proliferative DPSCs, A2 
(9.8kb), C3 (9.6kb) and D4 (7.5kb), at comparable PDs (2-10PDs, Figures 2.10-2.13, 
for DPSCs, A1, A2, C3 and D4, respectively).  Untreated high proliferative DPSC 
sub-population, A1, possessed an average telomere length of 12.8kb, although 
reductions in telomere lengths (2-5kb) were calculated with H2O2 treatment at early 
PDs (10-25PDs, Figure 2.10).  At later PDs (45-60PDs), untreated A1 DPSCs 
demonstrated minor reductions (1-2kb) in telomere lengths (11.2kb), versus early 
PDs, with further reductions (3-4kb) with H2O2 treatment.  However, low 
proliferative DPSCs, A2, C3, and D4, demonstrated less obvious decreases in 
telomere lengths (≤1kb), with H2O2 treatment (Figures 2.11-2.13, respectively).  
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Figure 2.9.  Comparison of senescence marker (p53, p21waf1, p16INK4a and hTERT) 
gene expression by DPSC sub-populations, A1, A2, C3 and D4, following extended 
culture to senescence under increasing H2O2 concentrations (50μM, 100μM, 
200μM), compared to untreated controls.  β-actin was used as the housekeeping 
gene. Total human RNA was used as a positive control for all genes analysed.  Water 
and RT-negative experimental controls had no expression. 
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Figure 2.10.  Southern blot analysis of average telomere lengths in DPSC sub-
population, A1, at early (10-25PDs) and later (40-65PDs) PDs, following extended 
culture to senescence under increasing H2O2 concentrations (50μM, 100μM, 
200μM), compared to untreated controls.  A digoxigenin (DIG)-labelled, Molecular 
Weight Marker (Ladder) and a positive DIG-labelled, Control DNA sample (Ctrl), 
were also included. 
 
 
 
  
A1 
Mean TRF (kb) ± SE 
Control 
50µM 
H2O2 
100µM 
H2O2 
200µM 
H2O2 
PD 
 
Early 
 
12.8±0.4 
 
9.9±0.3 
 
7.9±0.1 
 
8.4±0.4 
 
Late 
 
11.2±0.2 
 
7.8±0.2 
 
7.4±0.3 
 
7.5±0.3 
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Figure 2.11.  Southern blot analysis of average telomere lengths in DPSC sub-
population, A2, at early (2-10PDs) PDs, following extended culture to senescence 
under increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to 
untreated controls.  A digoxigenin (DIG)-labelled, Molecular Weight Marker 
(Ladder) and a positive DIG-labelled, Control DNA sample (Ctrl), were also 
included. 
 
 
 
A2 
Mean TRF (kb) ± SE 
Control 
50µM 
H2O2 
100µM 
H2O2 
200µM 
H2O2 
 
PD 
 
Early 
 
9.8±0.1 
 
9.1±0.1 
 
8.7±0.3 
 
8.8±0.1 
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Figure 2.12.  Southern blot analysis of average telomere lengths in DPSC sub-
population, C3, at early (2-10PDs) PDs, following extended culture to senescence 
under increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to 
untreated controls.  A digoxigenin (DIG)-labelled, Molecular Weight Marker 
(Ladder) and a positive DIG-labelled, Control DNA sample (Ctrl), were also 
included. 
 
 
 
C3 
Mean TRF (Kb) ± SE 
Control 
50µM 
H2O2 
100µM 
H2O2 
200µM 
H2O2 
 
PD 
 
Early 
 
9.6±0.3 
 
9.0±0.5 
 
8.6±0.2 
 
8.6±0.4 
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Figure 2.13.  Southern blot analysis of average telomere lengths in DPSC sub-
population, D4, at early (2-10PDs) PDs, following extended culture to senescence 
under increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to 
untreated controls.  A digoxigenin (DIG)-labelled, Molecular Weight Marker 
(Ladder) and a positive DIG-labelled, Control DNA sample (Ctrl), were also 
included. 
 
 
 
D4 
Mean TRF (kb) ± SE 
Control 
50µM 
H2O2 
100µM 
H2O2 
200µM 
H2O2 
 
PD 
 
Early 
 
7.5±0.4 
 
7.2±0.4 
 
6.8±0.3 
 
7.0±0.4 
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2.5.5 Stem Cell Marker Gene Expression 
RT-PCR analysis was performed to confirm that sub-populations, A1, A2, C3 and 
D4, were DPSCs and to elucidate whether increasing H2O2 treatment (50μM, 
100μM, 200μM) and oxidative stress-induced senescence accelerated the loss of 
stem cell characteristics in DPSCs.  All DPSC sub-populations examined showed 
varying degrees of positive gene expression for MSC markers, CD73 (ecto-5-
nucleotidase), CD90 (Thy-1) and CD105 (endoglin), at early PDs (Figure 2.14).  In 
contrast, hematopoietic stem cell marker, CD45 (hematopoietic surface antigens), 
was undetectable in all DPSCs assessed and at all PDs analysed.  However, MSC 
marker, CD29 (integrin β1), expression was evident to varying degrees in low 
proliferative DPSCs, A2, C3 and D4, only.  CD90 expression was largely retained 
in high (A1) and low (A2, C3 and D4) proliferative DPSCs through culture 
expansion and irrespective of H2O2 treatment, CD73 and CD105 expression showed 
declined detection at later PDs (40-65PDs), shown to be dependent and independent 
of H2O2 treatment, respectively.  CD29 expression in low proliferative DPSCs, A2, 
C3 and D4, were also unaffected by H2O2 treatment.  However, reductions in CD73 
and CD105 expression were less evident in low proliferative DPSCs, A2, C3 and 
D4. 
RT-PCR analysis was also performed to assess the expression of various 
other stem cell markers, including those representative of embryonic and neural crest 
lineages, in DPSC sub-populations, A1, A2, C3 and D4 and whether increasing H2O2 
treatment (50μM, 100μM, 200μM) and oxidative stress-induced senescence, 
accelerated the loss of these stem cell markers.  All DPSC sub-populations examined 
showed strong positive expression for self-renewal and multipotent adult stem cell 
marker, BMI-1, at early PDs (Figure 2.15).  Although MSC marker (CD146), 
multipotent stem cell marker (CD271) and stem cell differentiation regulator 
(CD166), were absent or negligibly expressed in high proliferative DPSCs, all low 
proliferative DPSCs exhibited strong CD146 and CD271 expression, as did DPSCs, 
C3 and D4 in terms of CD166 expression.  Embryonic stem marker, Oct4, was absent 
in high proliferative DPSCs, but expressed by all low proliferative DPSCs analysed.  
Other embryonic stem cell markers, SSEA4 and Slug, were positively expressed in 
high proliferative DPSCs and low proliferative DPSCs, C3 and D4, but both absent 
from low proliferative DPSC, A2.  Negligible expression of the pluripotent (Nanog) 
or neural crest (CD117, c-kit), stem cell markers were found in all DPSCs examined.  
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Figure 2.14.  Comparison of mesenchymal and hematopoietic stem cell marker gene 
expression by DPSC sub-populations, A1, A2, C3 and D4, following extended 
culture to senescence under increasing H2O2 concentrations (50μM, 100μM, 
200μM), compared to untreated controls.  β-actin was used as the housekeeping 
gene. Total human RNA was used as a positive control for all genes analysed.  Water 
and RT-negative experimental controls had no expression. 
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Figure 2.15.  Comparison of embryonic and neural crest stem cell marker gene 
expression by DPSC sub-populations, A1, A2, C3 and D4, following extended 
culture to senescence under increasing H2O2 concentrations (50μM, 100μM, 
200μM), compared to untreated controls.  β-actin was used as the housekeeping 
gene. Total human RNA was used as a positive control for all genes analysed.  Water 
and RT-negative experimental controls had no expression. 
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Overall, expression of these stem cell markers was largely unaffected by 
increasing H2O2 treatment or culture expansion.  However, SSEA4 and Slug 
expression declined at later PDs (45-60PDs) in high proliferative DPSCs, whilst 
increasing H2O2 treatment reduced the expression of Oct4 and CD271 in low 
proliferative DPSCs (A2 and C3 and D4, respectively). 
 
2.6 Discussion 
Previous findings have confirmed major variations in proliferative capacity and 
replicative (telomere-dependent) senescence within different DPSC sub-
populations, as a consequence of inherent differences in average telomere lengths 
between high and low proliferative DPSCs (Alraies et al., 2017).  Therefore, this 
Chapter examined whether DPSCs also differed in their respective susceptibilities to 
oxidative stress-induced (telomere-independent) senescence, via the analysis of 
various parameters associated with the establishment of the senescence phenotype, 
following continual H2O2 treatment in culture. 
Animal and human studies have established the effects of increasing patient 
donor age on the impairment of DPSC proliferative and regenerative capabilities 
(Ma et al., 2009; Bressan et al., 2012; Feng et al., 2013, 2014; Horibe et al., 2014; 
Iezzi et al., 2019).  However, consistent with only 20% of purified DPSCs undergo 
>20PDs, compared with heterogeneous DPSC populations being capable of 
>120PDs, highlighting the presence of DPSC sub-populations in dental pulp tissues 
with contrasting proliferative and differentiation capabilities (Gronthos et al., 2000, 
2002; Huang et al., 2009), recent studies have reported key differences in telomere 
lengths of individual DPSC sub-populations within a young donor age group (18-30 
years) and their correlations to the distinct differentiation capabilities of each 
population even when DPSCs are isolated from the same pulpal tissue sample 
(Alraies et al., 2017).  Whilst highly proliferative DPSCs reached >80PDs before 
undergoing telomere-dependent senescence, other low proliferative DPSCs only 
achieved <40PDs, correlating with DPSCs with high proliferative capacities 
possessing longer telomeres than those from low proliferative DPSCs.  Unlike low 
proliferative DPSCs, these highly proliferative DPSCs exhibited prolonged stem cell 
marker expression and retained multipotent differentiation capabilities, which only 
became impaired at much later PDs (>60PDs).  Therefore, it has been proposed that 
such high proliferative DPSCs are responsible for the extensive expansion potential 
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of heterogeneous populations (>120PDs) in vitro (Gronthos et al., 2000, 2002; 
Huang et al., 2009), as DPSCs with less proliferative potential are selectively lost 
from the mixed population during extended sub-culture (Waddington et al., 2009; 
Harrington et al., 2014; Alraies et al., 2017). 
 In addition to significant variations in the susceptibilities of DPSC sub-
populations to telomere-dependent senescence (Alraies et al., 2017), the data 
presented in this Chapter confirmed that similar variations also exist in the relative 
susceptibilities of DPSCs to oxidative stress-induced (telomere-independent) 
senescence.  All DPSC populations examined exhibited accelerated susceptibilities 
to oxidative stress-induced senescence in a H2O2 dose-dependent manner (Xiao et 
al., 2014), especially at 100µM and 200µM concentrations.  However, as with 
telomere-dependent senescence, highly proliferative DPSCs, such as A1, exhibited 
the highest resistance to H2O2-induced senescence, compared to untreated controls 
(>80PDs); being capable of achieving 50-76PDs even following continual treatment 
with 50µM, 100µM and 200µM H2O2 over 145-162 days in culture.  In contrast, low 
proliferative DPSCs, such as A2, C3 and D4, showed greater acceleration and the 
earlier induction of oxidative stress-induced senescence, even in untreated controls.  
Indeed, DPSC population, A2, was only capable of achieving 27-32PDs with 50-
200µM H2O2 treatments, compared to untreated controls (34PDs), whilst 
populations, C3 and D4, only accomplished 12-19PDs and 4-7PDs with 50-200µM 
H2O2 treatments, respectively, versus their untreated counterparts (20PDs and 
11PDs, respectively). 
Chen and Ames (1994), provided the first experimental evidence to 
demonstrate the onset of oxidative stress-induced cellular senescence in cells, using 
sub-lethal doses of H2O2.  Since then, many studies have confirmed the varying 
negative effects of H2O2 treatments on the viability, proliferation, senescence 
induction and differentiation capacities of MSCs derived from various sources 
(Brandl et al., 2011; Denu et al., 2016; Vono et al., 2018).  However, it has now been 
established that MSCs are more resistant to H2O2-induced senescence, compared to 
non-somatic cell types, such as fibroblasts (Brandl et al., 2011; Choo et al., 2014).  
Consequently, much higher non-lethal H2O2 concentrations are routinely utilised to 
promote oxidative stress-induced senescence in various MSC populations without 
affecting telomere length, as evident herein (50-200µM); due to its impact on the 
cell cycle, such as by increasing p16INK4A levels (Chen et al., 2001, de Magalhães et 
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al., 2002).  However, it should be noted that cells may have accelerated responses 
towards H2O2 in vitro, due to contrasting effects of endogenously-generated, 
intracellular H2O2 compared to that externally supplemented.  When produced 
intracellularly, it is found to be a constant rate production resulting in a steadily 
increase in H2O2 level, whereas H2O2 added to culture medium in a single dose will 
be rapidly consumed by cellular- and medium-based, antioxidants (Liochev, 2013). 
 In support of these contrasting PD findings, DPSC sub-population, A1, was 
further shown to possess fewer SA-β-Gal positive cells and lacked the expression of 
p53 and p16INK4a, at PDs where low proliferative DPSCs, especially C3 and D4, 
demonstrated overall increases in the detection of these and other senescence-
associated markers, such as p21waf1, particularly with increasing H2O2 
concentrations.  As with telomere-dependent senescence, senescence mediators, 
such as p53 and p16INK4a, are also associated with oxidative stress-induced, 
telomere-independent senescence (Campisi and d'Adda di Fagagna, 2007).  MSC 
senescence is acknowledged as a multi-step process driven by p53, which promotes 
growth arrest by inducing p21waf1 expression, thereby inhibiting G1-S phase 
progression.  p53 and p21waf1 act as tumor suppressors to regulate cell proliferation 
to rates that provide genomic stability during MSC division (Macloud et al., 1995).  
Therefore, p53 and p21waf1 expression regulate MSC expansion in an 
undifferentiated state.  MSC senescence can also initiate p16INK4a checkpoints, 
suppressing proliferation and triggering senescence.  Consequently, as both p53 and 
p16INK4a are both regarded as the principal mediators of senescence in MSCs 
(Shibata et al., 2007; Muthna et al., 2010; Mehrazarin et al., 2011; Feng et al., 2014); 
and as p21waf1 also has a role in maintaining stem cell renewal due to its positive 
effects on cell cycle progression (Kippin et al., 2005; Ju et al., 2007); this may 
explain the presence of early p21waf1 expression in all DPSC sub-populations 
analysed.  Nonetheless, the contrasting p53 and p16INK4a expression between high 
(A1) and low (A2, C2 and D4) proliferative capacity DPSCs, further confirms the 
earlier onset of oxidative stress-induced senescence with low proliferative DPSC 
sub-populations, versus high proliferative DPSCs at equivalent PDs. 
 The principle reason previously identified to be responsible for the 
contrasting proliferative responses and susceptibilities to telomere-dependent 
senescence in DPSC sub-populations, were the respective average telomere lengths 
between these populations (>18kb versus 5-13kb for high and low proliferative 
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DPSCs respectively, Alraies et al., 2017) with such superior telomere dynamic 
characteristics in high proliferative DPSCs sub-populations permitting extended PDs 
in culture, whilst protecting these DPSC from the onset of replicative senescence.  
However, in line with previous findings that oxidative stress-induced senescence can 
occur irrespective to telomere length and without telomere shortening (Fumagalli et 
al., 2012; Bielak-Zmijewska et al., 2014, 2018), all DPSCs analysed generally 
retained their average telomere length profiles during extended culture, both in the 
absence and presence of oxidative stress.  Intriguingly, the DPSC sub-population 
whose telomere lengths were mostly influenced by extended culture and H2O2 
treatment, was the high proliferative DPSC, A1.  As such, this may imply that A1 
may have also undergone telomere-dependent senescence mechanisms to some 
extent during extended culture.  Alternatively, it has been proposed that prolonged 
MSC culture under low chronic stress or mild/short-term sub-lethal H2O2 doses, can 
promote the gradual shortening of telomeres due to telomeric oxidative damage and 
single strand breaks leading to accelerated telomere shortening (von Zglinicki et al., 
1995, 2000, 2002, Duan et al., 2005; Brandl et al., 2011).  Although we can only 
speculate as to the extent to which telomere-dependent and telomere-independent 
mechanisms contributed to senescence induction in DPSC sub-population, A1, based 
on the overall telomere erosion identified for A1 was limited to 2-5kb over 75-100 
days in culture (i.e. between 10-25PDs and 45-60PDs), oxidative stress-induced, 
telomere-independent senescence is likely to be the principle senescence mechanism 
involved during A1 culture. 
 Although cellular senescence can be telomere-initiated reflecting DNA 
damage, resulting in shorter and dysfunctional telomeres (di Fagagna et al., 2003; 
Brandl et al., 2011), many in vitro studies are now challenging this concept, instead 
reporting that although telomere shortening may be absent, random DNA damage 
occurs throughout each chromosome, which initiates the senescence response.  
Although this damage is repairable throughout most of the chromosomal region, 
telomeric regions damage are difficult to repair (Fumagalli et al., 2012).  
Consequently, although it was suggested that telomere-independent senescence was 
directly mediated by oxidative damage (Parrinello et al., 2003), more recent studies 
argue that telomeric DNA damage/telomere-associated foci are more responsible, as 
these have been shown to increase with age regardless of telomere length, eventually 
causing senescence (Hewitt et al., 2012, Jurk et al., 2014). 
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 In agreement with the majority of previous studies (Egbuniwe et al., 2011; 
Mehrazarin et al., 2011a; Murakami et al., 2013; Alraies et al., 2017), no or 
negligible hTERT expression was identified in the high and low proliferative DPSC 
sub-populations assessed herein.  While hTERT expression is often an indication of 
the cell pluri-/multi-potency, down-regulation result in progressive telomere 
shortening and cellular senescence (Zimmermann et al., 2003, Flores and Blasco, 
2010).  Such findings imply that hTERT expression and activity appears not to be 
responsible for the maintenance of telomere lengths in high proliferative DPSCs or 
the variations in proliferative capabilities.  Therefore, other intrinsic telomere 
protective mechanisms may be responsible for these contrasting differences in 
telomere length, proliferation rates and regenerative potential between high and low 
proliferative DPSCs, such as differential oxidative stress responses and antioxidant 
profiles between DPSC populations (Liu et al., 2011; Shyh-Chang et al., 2013; Li et 
al., 2017). 
This Chapter also evaluated the expression of various mesenchymal, 
hematopoietic, embryonic and neural crest stem cell markers in high and low 
proliferative DPSC sub-populations and assessed the impact of oxidative stress-
induced senescence on their overall stem cell characteristics.  In accordance with 
previous studies, all DPSC sub-populations demonstrated positive expression of 
MSC markers, CD73 (ecto-5-nucleotidase), CD90 (Thy-1) and CD105 (endoglin) 
and negative for haematopoietic stem cell marker, CD45 (Huang et al., 2009; 
Waddington et al., 2009; Kawashima, 2012; Harrington et al., 2014; Alraies et al., 
2017).  However, MSC marker, CD29 (integrin β1), expression was only evident to 
varying degrees in low proliferative DPSCs (Pittenger et al., 1999).  Furthermore, 
although CD90 expression was largely retained in high and low proliferative DPSCs 
through culture expansion and irrespective of H2O2 treatment, CD73 and CD105 
expression showed declined detection at later PDs, as previously described (Alraies 
et al., 2017), whilst reductions in CD73 and CD105 expression were less apparent 
for low proliferative DPSCs, in a H2O2-dependent and -independent manner, 
respectively.  Therefore, the loss of these MSC marker expression by DPSC sub-
population, A1, with prolonged culture expansion in the absence or presence of H2O2 
treatment, may result in altered differentiation capabilities, as previously described 
(Rallapalli et al., 2009; Sivasankar and Ranganathan, 2015; Moraes et al., 2016; 
Alraies et al., 2017). 
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Overall, all sub-populations analysed were confirmed as being DPSCs, based 
on positive MSC marker (CD73, CD90 and CD105) expression and absence of 
haematopoietic marker (CD45) expression.  However, despite displaying expression 
of established MSC markers, DPSC sub-populations presented more diverse 
expression for other stem cell markers analysed, a likely consequence of DPSC 
heterogeneity, with each sub-population having contrasting phenotypic properties 
and/or biological activities (Gronthos et al., 2000, 2002; Huang et al., 2009; Ducret 
et al., 2016; Ledesma-Martínez et al., 2016).  Indeed, this is a key consideration, in 
terms of whether the contrasting senescence properties between high and low 
proliferative DPSC sub-populations reflect their isolation from different mesodermal 
or neuro-ectodermal origins or stem cell niches within the dental pulp (Sloan and 
Waddington, 2009).  Other studies have reported the presence of various embryonic 
stem cell marker gene expression profiles for DPSCs, including Oct4, Nanog, 
SSEA4, CD146 and CD166 (Aghajani et al., 2016, Akpinar et al., 2014, Shoi et al., 
2014), in addition to neural crest markers, such as CD271 and Slug (LaBonne and 
Bronner-Fraser, 2000; Martens et al., 2012; Sonoda et al., 2015).  All DPSC sub-
populations showed strong positive gene expression for self-renewal and multipotent 
adult stem cell marker, BMI-1, at early PDs.  Loss of BMI-1 expression has been 
proposed to be a marker of impaired odontogenic differentiation capacity in 
senescent DPSCs (Mehrazarin et al., 2011).  Therefore BMI-1 may be a factor in 
maintaining the differentiation and regenerative abilities of dental mesenchymal 
cells. 
The established MSC multi-lineage differentiation marker, CD146 (Xu et al., 
2008; Russell et al., 2010) and multipotent stem cell marker (CD271), were both 
positively expressed in all low proliferative DPSCs only.  CD146 presents an early 
expressed MSC marker within the dental pulp, being linked to MSC multipotency 
(Miura et al., 2003; Russell et al., 2010).  CD146 is also regarded as a pericyte 
marker, indicating the presence of DPSCs from the perivascular niche within the cell 
rich zone (Shi and Gronthos 2003; Lizier et al., 2012).  Therefore, despite CD146 
expression in suggested to decline during DPSC expansion (Sivasankar and 
Ranganathan, 2015), CD146 positive expression in all low proliferative DPSC sub-
populations examined, may indicate that these DPSCs are of perivascular origin.  
The absence of CD271 (nerve growth factor receptor p75, LNGFR), expression in 
high proliferative DPSCs has been reported previously (Alraies et al., 2017) and may 
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suggest that such populations are not neural crest- or sub-odontoblast layer-derived, 
as CD271+ cells are regarded as being of neural crest origin, located within the cell-
rich, sub-odontoblast region of dental pulp (Martens et al., 2012; Alvarez et al., 
2015).  Studies have also reported that CD271low+/CD90high+ DPSCs population 
present a highly enriched clonogenic population and exhibit log-term proliferation 
and multi-lineage differentiation potential in vitro (Mikami et al., 2011; Yasui et al., 
2016), although not all studies have demonstrated complete inhibition of multipotent 
differentiation in CD271-expressing DPSCs (Alvarez et al., 2014; Pisciotta et al., 
2015).  Nonetheless, positive CD271 expression in low proliferative capacity DPSCs 
(A2, C3 and D4), may provide further support to these cells being neural crest-
derived and more lineage restricted than high proliferative capacity DPSCs, such as 
A1.  Stem cell differentiation regulator, CD166 (Sloan and Waddington, 2009; Kang 
et al., 2016), was negligibly expressed in high proliferative DPSCs, although low 
proliferative DPSC sub-populations, C3 and D4, expressed strong CD166 
expression. 
 In terms of embryonic stem cell markers, Oct4, was absent in high 
proliferative DPSCs, but expressed by all low proliferative DPSCs analysed.  In 
contrast, other embryonic stem cell markers assessed, SSEA4 and Slug, were 
positively expressed in high proliferative DPSCs and low proliferative DPSCs, C3 
and D4, but both absent from low proliferative DPSC, A2.  No or negligible 
expression of the pluripotent stem cell (Nanog) was found in all DPSCs examined.  
Oct4, SSEA4 and Nanog are embryonic stem cell markers that indicate pluripotency 
(Huang et al., 2009; Ishkitiev et al., 2010, Kawanabe et al., 2012; Ponnaiyan, 2014).  
Previous study have shown weak Oct4 and Slug expression in high and low 
proliferative DPSC sub-populations (Alraies et al., 2017).  Oct4 and Nanog are 
known to play key role in maintaining the process of self-renewal and pluripotency 
in embryonic stem cells (Wang et al., 2006).  Both Oct4 and Nanog are also reported 
to maintain the MSC characteristics of DPSCs (Lizier et al., 2012), with depletion 
of Oct4/Nanog expression decreasing DPSC proliferation and osteogenic 
differentiation properties, whilst Oct4/Nanog overexpression enhances proliferation 
and multipotent differentiation properties (Huang et al., 2014).  Despite such 
findings, Oct4 function in MSCs has been subject of debate and although it is 
essential for maintaining pluripotency, it may also have other function (Ulloa-
Montoya et al., 2007; Lengner et al., 2008). 
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 SSEA-4 is an embryonic stem cell-associated antigen, suggested to regulate 
stem cell differentiation (Gang et al., 2007).  Kawanabe et al. (2012), found that 
SSEA-4+ DPSCs represent 45% of the total dental pulp cells.  SSEA-4+ DPSCs 
were further shown to be clonogenic and to possess with multi-lineage (osteogenic, 
chondrogenic and neurogenic) differentiation capacities in vitro.  Embryonic/neural 
crest marker, Slug, is required for neural crest migration and specification and 
implicated in promoting commitment to a mesenchymal lineage (LaBonne and 
Bronner-Fraser, 2000; Batlle et al., 2013).  No or negligible expression of the neural 
crest marker, CD117 (c-kit), was found in all DPSCs examine (Miettinen and Lasota, 
2005).  CD117+ cells have been reported in both the cell-rich zone and the dental 
pulpal core.  However, while CD117+/CD44- cells in the cell-rich zone may indicate 
stemness, CD117+/CD44+ stromal cells in the pulpal core may indicate 
undifferentiated perivascular or perineural cells (Rusu et al., 2014).  Furthermore, 
cells in this layer have a role participating in stromal network of the dental pulp and 
contact nerves (Rusu et al., 2014).  Consequently, this may indicate a possibility of 
functional role of DPSCs in signalling and neurotransmission within dental pulp. 
Overall, expression of these stem cell markers was largely unaffected by 
increasing H2O2 treatment or culture expansion.  However, SSEA4 and Slug 
expression declined at later PDs (45-60PDs) in high proliferative DPSCs, whilst 
increasing H2O2 treatment reduced the expression of Oct4 and CD271 in low 
proliferative DPSCs (A2 and C3 and D4, respectively).  Oct4 expression has been 
previously highlighted as being susceptible to extended in vitro cell expansion 
(Takahashi and Yamanaka, 2006; Boroujeni et al., 2012; Tsai et al., 2012), in 
addition to increased DPSC exposure to oxidative stress and senescence induction 
in culture (Forristal et al., 2013; Mas-Bargues et al., 2017). Intriguingly, despite 
BMI-1 expression also being proposed to be sensitive to oxidative stress and 
senescence, due to its role in repressing p16INK4a expression and maintaining cellular 
hyper-proliferation (Itahana et al., 2003; Park et al., 2004; Mas-Bargues et al., 2017), 
no obvious differences in BMI-1 expression were identified between the high and 
low proliferative DPSCs assessed herein, despite the apparent variations identified 
in their overall susceptibilities to oxidative stress-induced senescence. 
Therefore, as with the previously reported scenario with DPSC susceptibility 
to telomere-dependent senescence (Alraies et al., 2017), this Chapter has confirmed 
that significant variations also exist in the susceptibilities of DPSCs to oxidative 
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stress-induced (telomere-independent) senescence.  As DPSCs exhibit negligible 
hTERT expression, this suggests that other intrinsic mechanisms help protect high 
proliferative DPSCs from oxidative stress and cellular senescence.  As oxidative 
stress-induced senescence is well-established to be accompanied by an accumulation 
of oxidative stress-related damage to cellular biomolecules, including DNA, proteins 
and lipids (Beckman and Ames, 1998), further investigations assessed oxidative 
damage responses in these high and low DPSC sub-populations, to further explain 
the senescence findings presented in this Chapter. 
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Chapter 3 
 
Assessment of Dental Pulp Stem Cell Susceptibility to 
Oxidative Stress-Induced Biomarker Formation 
 
3.1 Introduction 
The previous Chapter confirmed that distinct differences exist in the relative 
susceptibilities of dental pulp stem cell (DPSC) sub-populations to oxidative stress-
induced (telomere-independent) senescence.  While both high and low proliferative 
DPSC populations exhibited accelerated susceptibilities to oxidative stress-induced 
senescence in a hydrogen peroxide (H2O2) dose-dependent manner, low proliferative 
DPSC sub-populations demonstrated a markedly earlier onset of oxidative stress-
induced senescence, compared to high proliferative DPSCs. 
Oxidative stress is a well-established promoter of telomere-independent 
cellular senescence, also known as premature senescence or stress-induced 
premature senescence, SIPS (Campisi and d'Adda di Fagagna F, 2007), which refers 
to the balance between the production of intracellular reactive oxygen species 
(ROS), such as superoxide and hydroxyl radical species (O2.- and .OH, respectively) 
and non-radical species, such as hydrogen peroxide (H2O2) and cellular antioxidant 
defence mechanisms.  Thus, elevated ROS levels at the expense of antioxidant levels 
accelerate cellular senescence via telomere-independent mechanisms (Ben-Porath 
and Weinberg, 2004; Victorelli and Passos, 2017).  However, exposure to oxidative 
stress can also promote biomolecular damage, due to continuous production of ROS 
that readily interact with cellular macromolecules, causing accumulative damage to 
cellular components (Comporti, 1989; Chaudhari et al., 2014).  Although DNA is a 
strong candidate of oxidative modification and damage (Cooke et al., 2003; Evans 
et al., 2004), proteins (Halliwell, 1999; Levine and Stadtman, 2001) and lipids 
(Halliwell, 1999; Spiteller, 2001), are also highly susceptible to oxidative stress-
induced, damage.  The resulting damage to these components was found to 
ultimately promote cell senescence, causing several pathologies that impair tissue 
function (Sikora et al., 2011). 
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Several pathological conditions can occur as a consequence of oxidative 
damage to DNA.  For this reason, oxidative DNA damage has been widely studied 
in various cell lines.  For instance, fibroblasts exhibit higher levels of 8-hydroxy-
deoxy-guanosine (8-OHdG) in senescent cells than in young cells, indicating 
increased oxidative DNA damage (Chen et al., 1995).  Notably, oxidative DNA 
damage results in different types of DNA lesions depending on the ROS involved, 
the duration of exposure and the cellular reparative ability (Halliwell and Chirico, 
1993).  ROS interactions with DNA are mainly attributed to .OH species causing 
DNA base modification, deoxyribose sugar damage, formation of DNA protein 
cross-links, single and double strand breaks and the formation of apurinic lesions, 
many of which are mutagenic (Shibutani et al., 1991; Finkel and Holbrook, 2000).  
DNA bases are particularly vulnerable to oxidation by ROS, with guanine base 
having the lowest reduction/oxidation potential of the four bases (Neeley and 
Essigmann, 2006).  Consequently, .OH species induce DNA damage at the C-8 
position of guanine base yielding 8-OHdG as an oxidation product, which has led to 
8-OHdG becoming a well-established marker of in vitro and in vivo oxidative DNA 
damage (Toussaint et al., 2000; Tahara et al., 2001; David et al., 2007).  Nonetheless, 
ROS can also attack other positions in the structures of guanine or other 
purine/pyrimidine DNA bases, yielding a wide range of oxidative DNA base damage 
products (Cooke et al., 2003; Evans et al., 2004).  In contrast to .OH species, less 
reactive species, such as O2.- and H2O2, cause indirect DNA damage by acting as a 
source for other ROS, such as .OH species (Halliwell, 1999; Poulsen et al., 2000; 
Ames, 2001; Kasprzak, 2002).  Indeed, DNA oxidation is a complex process and 
many studies have reported that ROS can promote site-specific damage (Enright et 
al., 1996).  Accordingly, the cellular repair responses towards ROS-induced DNA 
lesions are also complex, as different DNA repair mechanisms may exist depending 
on the source and extent of oxidative damage induced (Giorgio et al., 2007; Hazane-
Puch et al., 2010). 
Previous research has recognized a strong association between protein 
oxidation and oxidative stress, senescence and aging, with numerous studies utilising 
oxidative protein damage as a marker of oxidative stress in research on many 
different pathological conditions (Flint Beal, 2002), such as diabetes (Almogbel and 
Rasheed, 2017), Alzheimer’s disease (Greilberger et al., 2010) and arthritis (Pullaiah 
et al., 2018).  Protein oxidation results from ROS accumulation (Berlett and 
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Stadtman, 1997).  Upon oxidation, protein damage is presented as modifications to 
amino acid structure leading to fragmentation to lower molecular weight products.  
ROS modification of amino acids results in the formation of numerous oxidized by-
products, including oxo acids, aldehydes, hydroperoxides and hydroxylated 
derivatives, due to a range of chemical reactions, including the hydroxylation of 
amino acid side chains, decarboxylation and deamination reactions.  Studies have 
highlighted a number of amino acids that are more susceptible to modification by 
ROS, including proline, histidine, lysine, arginine and tyrosine, resulting in 
formation of chemically stable moieties (Dean et al, 1997; Dalle-Donne et al., 2003).  
Additionally, carbonyl derivatives can be produced indirectly on the nucleophilic 
side chains of cysteine, histidine and lysine by secondary reaction with aldehydes 
produced during lipid peroxidation, or with reactive carbonyl derivatives generated 
during glycation and glycoxidation reactions (Berlett and Stadtman, 1997; Halliwell, 
1999; Uchida, 2000).  Indeed, the increased presence of protein carbonyl groups as 
a consequence of oxidative stress exposure and amino acid side chain modifications, 
is the most widely used biomarker to implicate oxidative protein damage in the 
aetiology and/or progression of various diseases and conditions (Dalle-Donne et al., 
2003), and many studies have documented age-associated accumulation of oxidized 
proteins in fibroblasts (Sitte et al., 2000; Grune et al, 2005; Torres and Perez, 2008; 
Baraibar et al., 2012; Rodríguez-Sureda et al., 2015). 
The phospholipid constituents of cell membranes are also liable to oxidative 
damage due to their high unsaturated fatty acid contents, resulting in lipid 
peroxidation (Halliwell, 1999; Spiteller, 2001; Kohen and Nyska, 2002).  Although 
lipid peroxidation is a normal physiological process necessary for renovation of 
biological membranes, excessive activation is linked to many pathologies.  Lipid 
peroxidation of membranes affects several aspects of cellular machinery, such as the 
loss of membrane fluidity and integrity leading to impaired cellular function 
(Halliwell, 1999).  The end products formed, such as malondialdehyde (MDA), 4-
hydroxynonenal (4-HNE) and the prostaglandin-like products, isoprostanes, are now 
commonly used as markers of oxidative lipid peroxidation (Halliwell and Chirico, 
1993; Spiteller, 2001; Kohen and Nyska, 2002). 
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3.2 Chapter Aims 
The previous Chapter confirmed significant variations in oxidative stress-induced 
(telomere-independent) senescence susceptibilities between DPSC sub-populations.  
However, as oxidative stress-induced senescence is commonly associated with the 
increased induction of cellular oxidative biomolecular damage, this Chapter 
examined whether high and low proliferative DPSC sub-populations also differed in 
their respective susceptibilities to oxidative stress-induced biomarker formation via 
the analysis of established oxidative stress marker levels of DNA (8-OHdG), protein 
(carbonyl content) and lipid (peroxidation) damage.  By confirming such differences 
between high and low proliferative DPSCs, this would provide further evidence to 
support high proliferative DPSCs being more resistant to SIPS, compared to low 
proliferative DPSCs, thereby enhancing our understanding of DPSC biology and its 
inter-relationship between oxidative stress and cellular ageing. 
 
3.3 Materials and Methods 
3.3.1 Isolation, Culture and Expansion of Dental Pulp Stem Cells Under Oxidative 
Stress Conditions 
Human DPSCs were isolated, cultured and expanded in the absence and presence of 
sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM, ThermoFisher 
Scientific, Paisley, UK), as previously described (Chapters 2.3.1, 2.3.2 and 2.3.3). 
 
3.3.2 Oxidative DNA Damage Detection 
Oxidative DNA damage (in the form of 8-OHdG levels), in high and low 
proliferative DPSC sub-populations in the absence and presence of sub-lethal doses 
of exogenous H2O2 (0, 50µM, 100µM or 200μM), was detected by 
immunohistochemistry using an OxyDNA Assay Kit (Merck Millipore, Watford, 
UK).  This is a fluorescence-based Kit, based on direct binding of a fluorescent probe 
to 8-OHdG in the DNA of fixed permeabilised cells.  8-OHdG detection was 
performed, as per manufacturer’s instructions. 
DPSCs at selected population doublings (PDs) throughout their proliferative 
life-spans, in the absence and presence of sub-lethal doses of exogenous H2O2 (0, 
50µM, 100µM or 200μM, Chapter 2), were seeded into 8-well chamber slides (VWR 
International Ltd., Lutterworth, UK), at 5,000 cells/cm2 (n=3 wells/experimental 
group) and maintained at 37ºC/5% CO2 overnight.  Following culture medium 
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removal, DPSCs were washed (x1) at room temperature in phosphate buffered saline 
(PBS, 300μl/well) and fixed in 4% paraformaldehyde solution in PBS (150μl/well, 
Santa Cruz Biotechnology, Dallas, USA), for 10min and re-washed (x1) in PBS 
(300μl/well).  Subsequently, cells were permeabilised in 0.1% Triton X-100 
(250μl/well, Sigma-Aldrich Company Ltd.) for 5min and washed (x1) in Wash 
Solution (in Kit).  To visualise oxidized DNA, DPSCs were incubated in fluorescein 
isothiocyanate (FITC)-Conjugate (100µl/well, in Kit), for 1h at room temperature 
under darkness, prior to washing (3min x5) at room temperature under agitation in 
Wash Solution (300μl/well) and rinsing (x1) in double-distilled water (500μl/well).  
DPSCs were then incubated in Hoechst Solution (300μl/well, 1:2000 in 0.1% bovine 
serum albumin-PBS, Sigma-Aldrich Company Ltd.), for 5min at room temperature 
under darkness.  DPSCs were subsequently washed (x2) in double-distilled water 
(300μl/well) and the chambers removed.  Slides were mounted with Gerhard Menzel 
coverslips (Thermo Fisher Scientific) using Fluor Save Reagent (Merck Millipore), 
for 10min under darkness.  Slides were viewed using Leica Dialux 20 Fluorescent 
Microscope (Leica Microsystems UK Ltd., Milton Keynes, UK).  Images were 
captured at a magnification of x200 using HCImage acquisition and analysis 
software (Hamamatsu Corporation, Sewickley, USA) and processed using Adobe 
Photoshop software (Adobe Systems, San Jose, USA).  Oxidative DNA damage was 
demonstrated as increased DNA green fluorescence intensities in the cytoplasmic 
(mitochondrial DNA) and nuclear DNA regions, due to bound FITC-Conjugate.  
Control wells were also included consisting of PBS, instead of FITC-Conjugate.  
Each experiment performed on n=3 separate occasions. 
 
3.3.3 Oxidative Protein Damage Detection 
Oxidative protein damage (in the form of protein carbonyl content), in high and low 
proliferative DPSC sub-populations in the absence and presence of sub-lethal doses 
of exogenous H2O2 (0, 50µM, 100µM or 200μM), was detected by 
immunohistochemistry using an OxyICCÔ Oxidized Protein Detection Kit (Merck 
Millipore).  This is a fluorescence-based Kit, based on the chemical derivatisation of 
protein carbonyl groups using 2,4-dinitrophenylhydrazine (DNPH), which can then 
be detected by a specific biotinylated anti-DNPH primary antibody and 
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tetramethylrhodamine (TRITC)-conjugated streptavidin secondary antibody.  
Protein carbonyl group detection was performed, as per manufacturer’s instructions. 
DPSCs at selected PDs throughout their proliferative life-spans, in the 
absence and presence of sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 
200μM, Chapter 2), were seeded into 8-well chamber slides at 5,000 cells/cm2 (n=3 
wells/experimental group) and maintained at 37ºC/5% CO2 overnight.  Following 
culture medium removal, DPSCs were washed (x2) at room temperature in PBS 
(300μl/well) and fixed in 100% cold methanol (300μl/well, ThermoFisher 
Scientific), for 5min and re-washed (x3) in PBS (300μl/well).  Subsequently, freshly 
diluted DNPH solution was added (300μl/well) and DPSCs incubated for 45min at 
room temperature, under darkness.  DPSCs were washed (x4) in PBS (300μl/well), 
blocked with Blocking Buffer (300μl/well, in Kit) and incubated overnight at 4°C.  
Cells were washed (x3) in PBS (300μl/well) and incubated in streptavidin 
(300μl/well, pre-diluted 1:1000 in Block Buffer, in Kit), for 1h at 37oC.  DPSCs were 
washed (x3) in PBS (300μl/well) and incubated in Hoechst Solution (300μl/well, 
1:2000 in 0.1% bovine serum albumin-PBS), for 5min at room temperature under 
darkness.  The chambers were removed, and slides mounted with Gerhard Menzel 
coverslips using Fluor Save Reagent, for 10min under darkness.  Slides were viewed 
using Leica Dialux 20 Fluorescent Microscope, with images captured at a 
magnification of x200 using HCImage acquisition and analysis software and 
processed using Adobe Photoshop software.  Oxidative protein damage was 
demonstrated as the increase in the red fluorescence intensity of the rhodamine 
conjugate.  Control wells were also included consisting of PBS instead of anti-DNPH 
primary antibody.  Each experiment performed on n=3 separate occasions. 
 
3.3.4 Oxidative Lipid Damage Detection 
Oxidative lipid damage (in the form of lipid peroxidation), in high and low 
proliferative DPSC sub-populations in the absence and presence of sub-lethal doses 
of exogenous H2O2 (0, 50µM, 100µM or 200μM), was detected by 
immunohistochemistry using an Image-iT® Lipid Peroxidation Kit (ThermoFisher 
Scientific).  This is a fluorescence-based Kit, which allows the detection of lipid 
peroxidation in live cells through the oxidation of boron dipyrromethene 
(BODIPY®) 581/591 C11 reagent.  BODIPY® 581/591 C11 reagent is an oxidation 
sensitive fatty acid which localises to the membranes of live cells and upon oxidation 
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by lipid hydroperoxides (Drummen et al., 2002), displays a shift in peak fluorescence 
emission of its phenylbutadiene segment from ~590nm to ~510nm.  This 
fluorescence shift from red to green (Pap et al., 1999), providing a ratiometric 
indication of lipid peroxidation by fluorescence microscopy analysis.  Lipid 
peroxidation detection was performed, as per manufacturer’s instructions. 
DPSCs at selected PDs throughout their proliferative life-spans, in the 
absence and presence of sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 
200μM, Chapter 2), were seeded into 8-well chamber slides at 5,000 cells/cm2 (n=3 
wells/experimental group) and maintained at 37ºC/5% CO2 overnight.  Culture 
medium was removed and replaced with fresh culture medium, containing Image-
iT® Lipid Peroxidation Sensor (10µM, 300μl/well, Component A, in Kit) and 
incubated at 37°C for 30min.  Following culture medium removal, DPSCs were 
washed (x3) at room temperature in PBS (300μl/well) and incubated in Hoechst 
Solution (300μl/well, 1:2000 in 0.1% bovine serum albumin-PBS), for 5min at room 
temperature under darkness.  The chambers were removed, and slides mounted with 
Gerhard Menzel coverslips using Fluor Save Reagent, for 10min under darkness.  
Slides were viewed using Leica Dialux 20 Fluorescent Microscope.  Slides were 
viewed at two separate wavelengths, one at excitation/emission 581/591nm (Texas 
Red filter) for the detection of reduced BODIPY® 581/591 C11 reagent and the other 
at excitation/emission of 488/510nm (FITC filter) for the oxidized BODIPY® 
581/591 C11 reagent.  Images were captured at a magnification of x200 using 
HCImage acquisition and analysis software and processed using Adobe Photoshop 
software.  Oxidative lipid damage was demonstrated as the increase in the green 
fluorescence intensity due to FITC detection.  Control wells were also included 
consisting of PBS instead of Image-iT® Lipid Peroxidation Sensor.  Each experiment 
performed on n=3 separate occasions. 
 
3.4 Results 
3.4.1 Oxidative DNA Damage in Dental Pulp Stem Cells Under Oxidative Stress 
A number of different DPSC sub-populations previously isolated and characterised 
from 3 individual patient donors (patients A, C and D), for oxidative stress-induced 
senescence susceptibilities (Chapter 2), were also assessed for their susceptibilities 
to oxidative DNA damage (8-OHdG detection) throughout their proliferative life-
spans, following treatment with increasing H2O2 concentrations (0, 50μM, 100μM, 
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200μM).  These included previously identified high proliferative (highly resistant to 
oxidative stress-induced senescence) sub-population, A1 and low proliferative 
(highly susceptible to oxidative stress-induced senescence) sub-populations, A2, C3 
and D4.  Overall, oxidative DNA detection showed marked variations in the 
susceptibilities to oxidative stress-induced damage between high and low 
proliferative DPSCs, with each demonstrating differences in the extent of positive 
nuclear DNA fluorescent staining detected, irrespective of whether DPSCs were 
derived from the same or different patients. 
Highly proliferative DPSC population (A1, Patient A) at early PDs (2-
10PDs), exhibited the least amounts of FITC detection for oxidative DNA damage 
overall, especially in untreated and 50μM H2O2-treated cultures (Figure 3.1, A-C 
and D-F, respectively).  Although low intensity background staining was evident in 
the cellular cytoplasmic regions due to increased cell permeability and mitochondrial 
DNA detection, limited intense positive staining was evident in the nuclear DNA 
regions of these cultures.  However, increased detection of nuclear DNA fluorescent 
staining intensities were identified for A1 at early PDs (2-10PDs), treated with 
100μM and 200µM H2O2 (arrowed, Figure 3.1, G-I and J-L, respectively).  It was 
also apparent that there was a strong co-localisation between the oxidative DNA 
damage (FITC) staining and the Hoechst nuclear stain, thereby further confirming 
that the oxidative DNA damage detected was particularly exclusive to the nuclei of 
A1 at early PDs (2-10PDs), treated with 100μM and 200µM H2O2. 
 In contrast, low proliferative DPSC sub-populations (A2, Patient A, C3, 
patient C and D4, patient D) at early PDs (2-10PDs), all exhibited enhanced 
susceptibilities to increased nuclear oxidative DNA damage, even in untreated 
controls, with increased detection of cytoplasmic and nuclear FITC staining, with 
nuclear staining further showing strong co-localisation with the corresponding 
Hoechst nuclear stain (arrowed, Figures 3.2, 3.3 and 3.4 for A2, C3 and D4, 
respectively).  Highly proliferative DPSC population, A1, only exhibited similar 
cytoplasmic and nuclear FITC staining intensities and oxidative DNA damage 
detection to low proliferative DPSC sub-populations, at much later PDs (45-60PDs), 
both in untreated and H2O2-treated cultures (arrowed, Figure 3.5).  FITC-Conjugate-
free/Hoechst-treated controls confirmed the absence of non-specific binding and 
oxidative DNA damage detection (image P, Figures 3.1-3.5, respectively).  
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Figure 3.1.  Immunocytochemical detection of oxidative DNA damage in DPSC (A1, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A1 demonstrated low intensity, positive FITC staining 
in the cytoplasmic and nuclear regions of untreated and 50μM H2O2-treated cultures, although increased detection of nuclear DNA fluorescent 
staining was identified in cultures treated with 100μM and 200µM H2O2 (arrowed).  Oxidative DNA damage (FITC) staining also showed a strong 
co-localisation with the Hoechst nuclear stain, confirming that oxidative DNA damage was particularly exclusive to the cell nuclei.  FITC-
Conjugate-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative DNA damage detection (image P).  Scale 
bar 100μm, ×200 magnification. 
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Figure 3.2.  Immunocytochemical detection of oxidative DNA damage in DPSC (A2, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A2 demonstrated increased nuclear oxidative DNA 
damage, even in untreated controls, with increased detection of cytoplasmic and nuclear fluorescent staining (arrowed).  Oxidative DNA damage 
(FITC) staining also showed a strong co-localisation with the Hoechst nuclear stain, confirming that oxidative DNA damage was particularly 
exclusive to the cell nuclei.  FITC-Conjugate-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative DNA 
damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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Figure 3.3.  Immunocytochemical detection of oxidative DNA damage in DPSC (C3, Patient C), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  C3 demonstrated increased nuclear oxidative DNA 
damage, even in untreated controls, with increased detection of cytoplasmic and nuclear fluorescent staining (arrowed).  Oxidative DNA damage 
(FITC) staining also showed a strong co-localisation with the Hoechst nuclear stain, confirming that oxidative DNA damage was particularly 
exclusive to the cell nuclei.  FITC-Conjugate-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative DNA 
damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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Figure 3.4.  Immunocytochemical detection of oxidative DNA damage in DPSC (D4, Patient C), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  D4 demonstrated increased nuclear oxidative DNA 
damage, even in untreated controls, with increased detection of cytoplasmic and nuclear fluorescent staining (arrowed).  Oxidative DNA damage 
(FITC) staining also showed a strong co-localisation with the Hoechst nuclear stain, confirming that oxidative DNA damage was particularly 
exclusive to the cell nuclei.  FITC-Conjugate-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative DNA 
damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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Figure 3.5.  Immunocytochemical detection of oxidative DNA damage in DPSC (A1, Patient A), at late population doublings (45-60PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A1 demonstrated increased nuclear oxidative DNA 
damage, even in untreated controls, with increased detection of cytoplasmic and nuclear fluorescent staining (arrowed).  Oxidative DNA damage 
(FITC) staining also showed a strong co-localisation with the Hoechst nuclear stain, confirming that oxidative DNA damage was particularly 
exclusive to the cell nuclei.  FITC-Conjugate-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative DNA 
damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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3.4.2 Oxidative Protein Damage in Dental Pulp Stem Cells Under Oxidative Stress 
High proliferative DPSC sub-population, A1 and low proliferative DPSC sub-
populations, A2, C3 and D4 were also assessed for their susceptibilities to oxidative 
protein damage (protein carbonyl contents) throughout their proliferative lifespans, 
following treatment with increasing H2O2 concentrations (0, 50μM, 100μM, 
200μM).  Overall, oxidative protein detection showed marked variations in the 
susceptibilities to oxidative stress-induced damage between high and low 
proliferative DPSCs, with each demonstrating differences in the extent of positive 
protein carbonyl fluorescent staining detected, irrespective of whether DPSCs were 
derived from the same or different patients. 
Highly proliferative DPSC population, A1, at early PDs (2-10PDs), exhibited 
the least amounts of rhodamine detection for oxidative protein damage overall, with 
comparable minimal intensity positive cellular staining detectable in both untreated 
and H2O2-treated cultures (Figure 3.6).  However, the presence of viable DPSCs 
within these cultures were confirmed by Hoechst nuclear stain.  In contrast, low 
proliferative DPSC sub-populations, A2, C3 and D4, at equivalent early PDs (2-
10PDs), all exhibited increased rhodamine detection and enhanced susceptibilities 
to increased oxidative protein damage overall, even in untreated controls (Figures 
3.7, 3.8 and 3.9 for A2, C3 and D4, respectively).  Positive rhodamine detection in 
these low proliferative DPSC sub-populations was exhibited as intensely diffuse 
staining distributed throughout the cells, indicative of extensive oxidative protein 
damage.  Highly proliferative DPSC population, A1, only exhibited similar 
extensive rhodamine staining intensities and oxidative protein damage detection to 
low proliferative DPSC sub-populations, at much later PDs (45-60PDs, Figure 3.10).  
This was particularly evident in H2O2-treated cultures, although lesser rhodamine 
staining was detectable in untreated controls, even at much later PDs (45-60PDs).  
Rhodamine-free/Hoechst-treated controls confirmed the absence of non-specific 
binding and oxidative protein damage detection (image P, Figures 3.6-3.10, 
respectively). 
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Figure 3.6.  Immunocytochemical detection of oxidative protein damage in DPSC (A1, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A1 demonstrated comparable minimal intensity positive 
cellular staining detectable in both untreated and H2O2-treated cultures overall.  However, the presence of viable DPSCs within these cultures were 
confirmed by Hoechst nuclear stain.  Rhodamine-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative 
protein damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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Figure 3.7.  Immunocytochemical detection of oxidative protein damage in DPSC (A2, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A2 demonstrated increased rhodamine detection and 
enhanced susceptibilities to increased oxidative protein damage overall, even in untreated controls.  Positive rhodamine detection was exhibited 
as intensely diffuse staining distributed throughout the cells, indicative of extensive oxidative protein damage.  The presence of viable DPSCs 
within these cultures were confirmed by Hoechst nuclear stain.  Rhodamine-free/Hoechst-treated controls confirmed the absence of non-specific 
binding and oxidative protein damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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Figure 3.8.  Immunocytochemical detection of oxidative protein damage in DPSC (C3, Patient C), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  C3 demonstrated increased rhodamine detection and 
enhanced susceptibilities to increased oxidative protein damage overall, even in untreated controls.  Positive rhodamine detection was exhibited 
as intensely diffuse staining distributed throughout the cells, indicative of extensive oxidative protein damage.  The presence of viable DPSCs 
within these cultures were confirmed by Hoechst nuclear stain.  Rhodamine-free/Hoechst-treated controls confirmed the absence of non-specific 
binding and oxidative protein damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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Figure 3.9.  Immunocytochemical detection of oxidative protein damage in DPSC (D4, Patient D), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  D4 demonstrated increased rhodamine detection and 
enhanced susceptibilities to increased oxidative protein damage overall, even in untreated controls.  Positive rhodamine detection was exhibited 
as intensely diffuse staining distributed throughout the cells, indicative of extensive oxidative protein damage.  The presence of viable DPSCs 
within these cultures were confirmed by Hoechst nuclear stain.  Rhodamine-free/Hoechst-treated controls confirmed the absence of non-specific 
binding and oxidative protein damage detection (image P).  Scale bar 100μm, ×200 magnification. 
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Figure 3.10.  Immunocytochemical detection of oxidative protein damage in DPSC (A1, Patient A), at late population doublings (45-60PDs) 
under increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A1 demonstrated increased rhodamine detection 
and enhanced susceptibilities to increased oxidative protein damage overall.  This was particularly evident in H2O2-treated cultures, although lesser 
rhodamine staining was detectable in untreated controls.  Positive rhodamine detection was exhibited as intensely diffuse staining distributed 
throughout the cells, indicative of extensive oxidative protein damage.  The presence of viable DPSCs within these cultures were confirmed by 
Hoechst nuclear stain.  Rhodamine-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative protein damage 
detection (image P).  Scale bar 100μm, ×200 magnification. 
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3.4.3 Oxidative Lipid Damage in Dental Pulp Stem Cells Under Oxidative Stress 
High proliferative DPSC sub-population, A1 and low proliferative DPSC sub-
populations, A2, C3 and D4 were also assessed for their susceptibilities to oxidative 
lipid damage (lipid peroxidation) throughout their proliferative lifespans, following 
treatment with increasing H2O2 concentrations (0, 50μM, 100μM, 200μM).  Overall, 
oxidative lipid detection showed marked variations in the susceptibilities to 
oxidative stress-induced damage between high and low proliferative DPSCs, with 
each demonstrating differences in the extent of positive lipid peroxidation 
fluorescent staining detected, irrespective of whether DPSCs were derived from the 
same or different patients. 
Highly proliferative DPSC population, A1, at early PDs (2-10PDs), exhibited 
the lowest detectable fluorescence colour shift from red (Texas Red) to green 
(FITC), indicative of the increased oxidative lipid damage overall, especially in 
untreated and 50μM H2O2-treated cultures, where no or negligible FITC staining was 
determined (Figure 3.11).  However, increased dose-dependent detection of positive 
FITC staining intensities were apparent for A1 at early PDs (2-10PDs), treated with 
100μM and 200µM H2O2.  In contrast, low proliferative DPSC sub-populations, A2, 
C3 and D4, at equivalent early PDs (2-10PDs), all exhibited the increased detection 
of shifts from Texas Red-FITC staining and enhanced susceptibilities to increased 
oxidative lipid damage overall, even in untreated controls (Figures 3.12, 3.13 and 
3.14 for A2, C3 and D4, respectively).  Positive FITC detection in these low 
proliferative DPSC sub-populations was exhibited as diffuse staining distributed 
throughout the cells, being particularly localised to the cell membranes indicative of 
extensive oxidative lipid damage in these regions.  Highly proliferative DPSC 
population, A1, only exhibited similar significant shifts in Texas Red-FITC staining 
intensities and oxidative lipid damage detection to low proliferative DPSC sub-
populations, at much later PDs (45-60PDs, Figure 3.15).  A1 demonstrated increased 
oxidative lipid damage, even in untreated controls, with increased detection of FITC 
staining, particularly localised to the cell membranes.  Image-iT® Lipid Peroxidation 
Sensor-free/Hoechst-treated controls confirmed the absence of non-specific binding 
and oxidative lipid damage detection (image P, Figures 3.11-3.15, respectively). 
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Figure 3.11.  Immunocytochemical detection of oxidative lipid damage in DPSC (A1, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A1 demonstrated the lowest detectable fluorescence 
colour shift from red (Texas Red) to green (FITC), indicative of the increased oxidative lipid damage overall, especially in untreated and 50μM 
H2O2-treated cultures, where no or negligible FITC staining was determined.  However, increased dose-dependent detection of positive FITC 
staining intensities were apparent for A1 at early PDs (2-10PDs), treated with 100μM and 200µM H2O2.  Image-iT® Lipid Peroxidation Sensor-
free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative lipid damage detection.  Scale bar 100μm, ×200 
magnification. 
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Figure 3.12.  Immunocytochemical detection of oxidative lipid damage in DPSC (A2, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A2 demonstrated increased detection of shifts from 
Texas Red-FITC staining and enhanced susceptibility to oxidative lipid damage, even in untreated controls.  Positive FITC detection in these low 
proliferative DPSC sub-populations was exhibited as diffuse staining distributed throughout the cells, particularly localised to the cell membranes.  
Image-iT® Lipid Peroxidation Sensor-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative lipid damage 
detection.  Scale bar 100μm, ×200 magnification. 
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Figure 3.13.  Immunocytochemical detection of oxidative lipid damage in DPSC (C3, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  C3 demonstrated increased detection of shifts from 
Texas Red-FITC staining and enhanced susceptibility to oxidative lipid damage, even in untreated controls.  Positive FITC detection in these low 
proliferative DPSC sub-populations was exhibited as diffuse staining distributed throughout the cells, particularly localised to the cell membranes.  
Image-iT® Lipid Peroxidation Sensor-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative lipid damage 
detection.  Scale bar 100μm, ×200 magnification. 
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Figure 3.14.  Immunocytochemical detection of oxidative lipid damage in DPSC (D4, Patient A), at early population doublings (2-10PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  D4 demonstrated increased detection of shifts from 
Texas Red-FITC staining and enhanced susceptibility to oxidative lipid damage, even in untreated controls.  Positive FITC detection in these low 
proliferative DPSC sub-populations was exhibited as diffuse staining distributed throughout the cells, particularly localised to the cell membranes.  
Image-iT® Lipid Peroxidation Sensor-free/Hoechst-treated controls confirmed the absence of non-specific binding and oxidative lipid damage 
detection.  Scale bar 100μm, ×200 magnification. 
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Figure 3.15.  Immunocytochemical detection of oxidative lipid damage in DPSC (A1, Patient A), at late population doublings (45-60PDs) under 
increasing H2O2 concentrations (50μM, 100μM, 200μM), compared to untreated controls.  A1 demonstrated increased oxidative lipid damage, 
even in untreated controls, with the increased detection fluorescence colour shift from red (Texas Red) to green (FITC), indicative of the increased 
oxidative lipid damage overall.  Image-iT® Lipid Peroxidation Sensor-free/Hoechst-treated controls confirmed the absence of non-specific binding 
and oxidative lipid damage detection.  Scale bar 100μm, ×200 magnification. 
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3.5 Discussion 
It is a well-established concept that oxidative stress-induced (telomere-independent) 
senescence, is preceded or accompanied by increased oxidative stress-induced, 
biomolecular damage (Ben-Porath and Weinberg, 2004; Campisi and d'Adda di 
Fagagna F, 2007; Victorelli and Passos, 2017), with the associated elevations in ROS 
levels at the expense of endogenous antioxidant defences leading to accumulative 
damage to cellular components, including DNA, proteins and lipids (Halliwell, 
1999; Levine and Stadtman, 2001; Spiteller, 2001; Cooke et al., 2003; Evans et al., 
2004; Sikora et al., 2011; Chaudhari et al., 2014).  In line with such previous 
findings, this Chapter confirmed that in addition to distinct differences in the 
respective susceptibilities of DPSC sub-populations to telomere-dependent 
senescence (Alraies et al., 2017) and telomere-independent senescence (Chapter 2), 
oxidative stress-induced senescence in DPSCs was associated with concomitant 
increased in oxidative stress-induced damage to DNA, proteins and lipids and that 
DPSC sub-populations also differ in their respective susceptibilities to oxidative 
damage.  Therefore, these results provide additional biomolecular evidence to 
support the difference in DPSCs susceptibilities and response to oxidative stress-
induced senescence overall. 
 Although it is established that mesenchymal stem cells (MSCs) are more 
resistant to H2O2-induced senescence, compared to non-somatic cell types, such as 
fibroblasts (Brandl et al., 2011; Choo et al., 2014), collectively, the most obvious 
differences identified herein were the relative susceptibilities of high and low 
proliferative DPSC sub-populations to oxidative stress-induced damage overall, with 
high proliferative DPSC, A1, exhibiting significantly reduced oxidative DNA, 
protein and lipid damage overall at early PDs (2-10PDs), versus the elevated levels 
of damage identified in low proliferative DPSC, A2, C3 and D4, at equivalent PDs.  
Indeed, elevated oxidative damage was even evident in low proliferative DPSC sub-
populations in the absence of culture supplementation with sub-lethal doses of 
exogenous H2O2.  On the contrary, high proliferative DPSC, A1, only demonstrated 
similar oxidative biomolecular damage to these low proliferative DPSC sub-
populations, at much later PDs in their proliferative lifespans.  Such findings imply 
that high proliferative DPSC, A1, possesses higher resistance to H2O2-induced 
oxidative stress, which gradually diminishes during more extensive in vitro cell 
culture expansion. 
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Oxidative DNA damage and impaired DNA repair capabilities are 
established to accompany cellular senescence (Chen et al., 1995, 2003; Duan et al., 
2005; Hazane et al., 2006; Hazane-Puch et al., 2010).  Therefore, considering the 
increased susceptibilities of low proliferative DPSC sub-populations (A2, C3 and 
D4) to oxidative stress-induced senescence (Chapter 2), it is conceivable that these 
increases in oxidative DNA damage contribute to the early-onset of p53, p21waf1 and 
p16INK4a induction and senescence in these DPSCs (Ben-Porath and Weinberg, 2004; 
Campisi and d'Adda di Fagagna, 2007).  Indeed, in addition to differences in 
detectable levels of oxidative DNA damage between high and low proliferative 
DPSC sub-populations, it was apparent that there was a strong correlation between 
the localisation of the oxidative DNA damage and Hoechst nuclear stain, thereby 
further confirming that the oxidative DNA damage detected was particularly present 
within the nuclei of the DPSCs analysed.  Such findings are comparable with the 
conclusions of previously reported studies, which have examined the effects of 
oxidative stress on the induction of nuclear DNA damage and senescence in various 
cell types, including MSCs (Yu et al., 2018) and fibroblasts (Roper et al., 2004; Kil 
et al., 2006; Martirosyan et al., 2006). 
 In addition to the nuclear oxidative DNA damage observed, both high and 
low proliferative DPSC sub-populations demonstrated cytoplasmic staining that was 
more visibly evident in all cells, compared to nuclear immunofluorescence, 
potentially indicating additional mitochondrial DNA damage.  The susceptibility of 
mitochondrial DNA to oxidative damage has been described in several reports 
(Richter et al., 1988; Beckman and Ames, 1996; Yakes and Van Houten, 1997; 
Soultanakis et al., 2000), from which it has been proposed that mitochondrial DNA 
is more sensitive to oxidative damage than nuclear DNA, undergoing more extensive 
and persistent damage (Beckman and Ames, 1996; Yakes and Van Houten, 1997).  
Several reasons have been suggested for this, such as the higher sensitivity of 
mitochondrial DNA to ROS (Yakes and Van Houten, 1997), being in closer 
proximity to the electron transport chain and organized in a histone-free nucleoid, 
hence making it more exposed to oxidant attack than nuclear DNA (Bogenhagen, 
2012; Blasiak et al., 2013).  In addition, although mitochondrial-generated ROS 
normally cause mild mitochondrial DNA damage that is rapidly repaired, during 
chronic ROS exposure, the mitochondrial ability to repair DNA may be less efficient 
than the nucleus, due to malfunction of the electron transport system resulting in 
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more extensive mitochondrial DNA damage (Yakes and Van Houten, 1997; Blasiak 
et al., 2013). 
 Oxidative protein damage has also been well-documented as a marker of 
oxidative damage associated with cellular senescence and aging, due to direct protein 
modification and increased accumulation of oxidized cellular proteins, due to 
dysfunctions in the intracellular proteosome system under oxidative stress (Sitte et 
al., 2000; Chondrogianni and Gonos, 2004; Grune et al, 2005; Torres and Perez, 
2008).  Indeed, protein carbonyl groups are considered advantageous markers of 
oxidative stress compared to other oxidation products, due to their relatively simple 
formation and the relative stability of the oxidized protein.  Previous research has 
reported that in vitro H2O2 treatment resulted in elevated levels of protein carbonyl 
residues in fibroblasts, compared to untreated fibroblasts (Dimon-Gadal et al., 2000; 
Grune et al, 2005; Jung et al., 2009).  The current findings suggest an enhanced 
susceptibility of low proliferative DPSC sub-populations to oxidative protein 
damage, as protein damage was even observed early in untreated controls.  In 
contrast, high proliferative DPSCs untreated with H2O2 showed resistance to 
oxidative protein damage, both early and late in their proliferative lifespans, with 
protein damage only observed in this sub-population upon prolonged dose-
dependent exposure to higher H2O2 concentrations.  These findings are in line with 
previous findings, in which H2O2-induced senescence in fibroblasts induced 
senescence, accompanied by significant increases in oxidized protein levels in a 
dose-dependent manner at both early and late stages in their proliferative lifespans 
(Jung et al., 2009).  These results indicate the early existence of protein damage in 
the low proliferative DPSC sub-populations, reflecting enhanced susceptibility to 
oxidative stress compared to the high proliferative DPSCs. 
 Lipid peroxidation is another well-used cellular oxidative stress biomarker, 
due to the key role it plays in impairing cellular function (Halliwell, 1999) and the 
generation of harmful adducts, such as MDA and 4-HNE, that not only attack lipids, 
but DNA and proteins (Halliwell and Chirico, 1993; Spiteller, 2001; Kohen and 
Nyska, 2002).  Although the results presented here demonstrated increased lipid 
peroxidation particularly localised to the cell membranes of low proliferative DPSC 
sub-populations, versus high proliferative DPSCs at equivalent PDs, the oxidative 
lipid damage detected appeared to be lower in intensity, compared to the 
corresponding DNA and protein damage.  These findings concur with previous 
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studies, stating that oxidative damage biomarkers may occur concomitantly upon 
ROS accumulation.  However, the extent of their damage and the time course over 
which such damage appears can vary greatly.  For example, it is known that lipid 
peroxidation products are detoxified quickly within minutes, once formed (Levine 
et al., 1990; Siems et al., 1997; England et al., 2000).  On the other hand, the 
degradation process for oxidized proteins is much slower, occurring over hours or 
days (Grune et al., 1995; 1996).  Furthermore, oxidative stress biomarker level 
variations may occur depending on cell type, as H2O2-induced lipid peroxidation has 
been reported to occur more significantly in non-somatic cells, such as fibroblasts 
and endothelial cells, compared to embryonic stem cells (Barandalla et al., 2016). 
The results described in the present Chapter provide strong evidence for the 
variation in susceptibility of DPSC sub-populations to biomolecular damage, as a 
consequence of ROS accumulation and oxidative stress.  However, as enhanced 
oxidative stress-induced bimolecular damage and senescence are a consequence of 
excessive ROS production and exposure, at the expense of cellular antioxidant 
defence mechanisms, the significant variations in the contrasting susceptibilities of 
high and low proliferative DPSC sub-populations to oxidative stress overall, may be 
related to differential antioxidant expression and activity profiles between these 
DPSCs, i.e. that high proliferative DPSC sub-populations possess superior 
antioxidant expression and activity profiles, compared to low proliferative DPSCs.  
Indeed, enzymic antioxidant status is critical in maintaining the intracellular redox 
balance and cell survival (i.e. cells with higher antioxidant capacities are more 
resistant to oxidative stress and senescence (Serra et al, 2000, 2003; Lorenz et al, 
2001; Blander et al, 2003; Richter and von Zglinicki, 2007).  As such, in order to 
address the hypothesis, the antioxidant expression/activities of well-established 
enzymic antioxidants with renowned roles in regulating cellular senescence were 
next investigated in these high and low proliferative DPSC sub-populations, as 
detailed in Chapter 4. 
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Chapter 4 
 
Assessment of Enzymic Antioxidant Expression Profiles 
Between Dental Pulp Stem Cell Sub-Populations 
 
4.1 Introduction 
The previous Chapters have clearly demonstrated that significant variations exist in 
the relative susceptibilities of dental pulp stem cell (DPSC) sub-populations to 
oxidative stress-induced biomolecular damage and telomere-independent 
senescence, with low proliferative DPSC sub-populations demonstrating 
significantly greater oxidative damage to cellular constituents, such as DNA, 
proteins and lipids and the earlier onset of oxidative stress-induced senescence, 
compared to high proliferative DPSCs.  As differences in cellular susceptibilities to 
oxidative stress-induced biomolecular damage and senescence are often associated 
with contrasting enzymic antioxidant profiles between different cell types, variation 
in the relative susceptibilities of DPSC sub-populations to oxidative stress-induced 
damage and senescence may indicate differences in the respective antioxidant 
defence capabilities of DPSCs, in terms of the enzymic antioxidant expression and 
activity profiles between these sub-populations. 
Oxidative stress is a well-established mediator of biomolecular damage and 
telomere-independent senescence in various cell types, including mesenchymal stem 
cells (MSCs, Ben-Porath and Weinberg, 2004; Liu et al., 2011; Shyh-Chang et al., 
2013; Chaudhari et al., 2014; Li et al., 2017; Victorelli and Passos, 2017).  Such 
events are associated with cellular overproduction and/or increased exposure to 
reactive oxygen species (ROS), such as superoxide radical species (O2.-), hydroxyl 
radical species (.OH) and hydrogen peroxide (H2O2), leading to an imbalance with 
the endogenous cellular antioxidant defence mechanisms.  Thus, elevated ROS 
levels at the expense of antioxidant levels accelerate oxidative damage accumulation 
and telomere-independent senescence.  Under normal physiological conditions, ROS 
are generated via a wide range of cellular mechanisms, mainly occurring in the 
mitochondria, in addition to NADPH oxidase complexes (Balaban et al., 2005; 
Chaudhari et al., 2014). 
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To counteract the excessive accumulation of ROS and to regulate cellular 
redox homeostasis, cells possess antioxidant defence mechanisms.  These defences 
vary from simple, low molecular weight compounds, such as ascorbate and a-
tocopherol, to enzymes, such as superoxide dismutases (SODs), catalase and 
glutathione-metabolising enzymes, including glutathione peroxidases (GPXs), 
transferases, reductases and synthetases.  These enzymic and non-enzymic 
antioxidants protect cells from damage by directly scavenging ROS or by 
sequestering transition metal ions (Waddington et al., 2000).  Enzymic antioxidant 
defence mechanisms are mainly orchestrated by Nf-E2 related factor 2 (Nrf2), which 
activates the various antioxidant responsive element (ARE)-dependent genes that 
encode enzymic antioxidants, ultimately mitigating oxidative stress (Kensler et al., 
2007; Nguyen et al., 2009; Ma, 2013).  SODs catalyse O2.-dismutation into H2O2.  
Three SOD isoenzymes which have been identified in cells. SOD1 occurs in the 
cytoplasm, the intermembrane space of mitochondria and in the nucleus, SOD2 is 
located to the mitochondria matrix and SOD3 is secreted into the extracellular matrix 
(Zelko et al., 2002; Fattman et al., 2003; Nozik-Grayck et al., 2005; Fukai and Ushio-
Fukai, 2011).  Most aerobic cells contain catalase, which catalyses the dismutation 
of H2O2 and mostly localised intracellularly in peroxisomes within the cytosol 
(Kirkman and Gaetani, 2007).  GPXs provide another mechanism to remove 
excessive intracellular H2O2 levels, by catalysing the oxidation of reduced 
glutathione (GSH) by H2O2.  GPXs are tetrameric proteins localised within the 
cytoplasm, with each subunit containing an atom of selenium present at the active 
site as selenocysteine (Deponte, 2013, Lu, 2013).  Reduced GSH is produced by the 
formation of γ-glutamylcysteine from glutamate and cysteine, followed by the 
formation of GSH from γ-glutamylcysteine, catalysed by γ-glutamylcysteine 
synthetase and glutathione synthetase (GSS), respectively (Lu, 2013).  Glutathione 
S-transferases (GSTs) are located within the cytoplasm, mitochondria and 
microsomal compartments of cells, where these catalyse the conjugation of GSH via 
sulfhydryl groups, to electrophilic centres on a wide variety of substrates, in order to 
detoxify compounds and make them more water-soluble (Wu and Dong, 2012; 
Board and Menon, 2013, Lu, 2013).  Reduced GSH is regenerated by the activity of 
glutathione reductase (GSR), at the expense of reduced nicotinamide adenine 
dinucleotide phosphate (NADPH, Deponte, 2013).  The GST superfamily also 
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contains glutathione transferase ζ (GSTZ1) amongst other isoforms, which catalyses 
the reaction of GSH with xenobiotics and endobiotics (Board and Anders, 2011).  
Although GSTZ1 is located in the cytosol, it is also localised within cellular 
mitochondria.  Some properties of cytosolic and mitochondrial GSTZ1 differ, these 
are not related to differences in amino acid sequence or post-translationally modified 
residues (Zhong et al., 2018). 
 Despite possessing such an array of tightly-regulated, cellular antioxidant 
defence mechanisms, imbalance between ROS overproduction and cellular 
antioxidant capacity are strongly correlated with increased oxidative stress-induced 
biomolecular damage and the induction of telomere-independent senescence in a 
variety of cell types, particularly fibroblasts (Serra et al., 2000, 2003; Lorenz et al., 
2001; Blander et al., 2003; Brown and Stuart, 2007; Richter and von Zglinicki 2007; 
Hammad et al., 2018).  However, more recent studies into the effects of oxidative 
stress on embryonic stem cell (ESC) behaviour have confirmed that stem cells have 
contrasting responses to oxidative stress than somatic cells, due to the activation of 
different antioxidant defence mechanisms (Barandalla et al., 2016).  Furthermore, 
correlations between the susceptibilities of MSCs from various sources to cellular 
senescence, with their relative enzymic antioxidant expression and activity 
capabilities, have also been established (Valle-Prieto and Conget, 2010; Ko et al., 
2012; Jeong and Cho, 2015; Yu et al., 2018; Chen et al., 2019).  This is also the case, 
in terms of MSC susceptibilities to oxidative stress-induced biomolecular damage, 
with cellular resistance to oxidative damage being attributed to their relatively high 
enzymic antioxidant capacities (He et al., 2004; Ko et al., 2012; Yu et al., 2018; Chen 
et al., 2019).  Thus, although the reasons behind such contrasting oxidative stress 
responses between different stem cell populations is still under debate, the majority 
of theories are increasingly focussed on the roles of antioxidants as being major 
influences in providing stem cell resistance to oxidative stress, via their possession 
of superior enzymic antioxidant induction capabilities (Liu et al., 2011; Shyh-Chang 
et al., 2013; Urao and Ushio-Fukai, 2013; Benameur et al., 2015; Sheshadri and 
Kumar, 2016). 
 
4.2 Chapter Aims 
The previous Chapters confirmed significant variations in oxidative stress-induced 
biomolecular damage and telomere-independent senescence between DPSC sub-
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populations.  However, given the strong correlations identified between cellular 
susceptibilities to oxidative stress-induced damage and telomere-independent 
senescence, with endogenous enzymic antioxidant expression and activity levels, 
this Chapter examined whether the differences in enzymic antioxidant capabilities 
further contributed to the contrasting susceptibilities of high and low proliferative 
DPSC sub-populations to oxidative stress-induced biomolecular damage and 
telomere-independent senescence.  Confirming differences in enzymic antioxidant 
capacities between high and low proliferative DPSCs would provide a greater 
understanding of DPSC biology and its inter-relationship with oxidative stress and 
cellular ageing. 
 
4.3 Materials and Methods 
4.3.1 Isolation, Culture and Expansion of Dental Pulp Stem Cells Under Oxidative 
Stress Conditions 
Human DPSCs were isolated, cultured and expanded in the absence and presence of 
sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM, ThermoFisher 
Scientific, Paisley, UK), as previously described (Chapters 2.3.1, 2.3.2 and 2.3.3). 
 
4.3.2 Enzymic Antioxidant Gene Expression Analysis 
4.3.2.1 Real Time Quantitative Polymerase Chain Reaction (RT-QPCR) 
Expression of enzymic antioxidants genes (SOD1, SOD2, SOD3, CAT1, GPX1, 
GPX2, GPX3, GPX4, GPX5, GSR, GSS and GSTZ1), in high and low proliferative 
DPSC sub-populations in the absence and presence of sub-lethal doses of exogenous 
H2O2 (0, 50µM, 100µM or 200μM), were investigated using Real Time Quantitative 
Polymerase Chain Reaction (RT-QPCR) techniques.  DPSCs at selected population 
doublings (PDs) throughout their proliferative life-spans, in the absence and 
presence of sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM), were 
seeded, RNA extracted and complimentary DNA (cDNA) synthesised, as previously 
described (Chapters 2.3.6.1 and 2.3.6.2). 
 
4.3.2.2 TaqMan QPCR 
Following RNA extraction and the preparation of cDNA, cDNA was amplified using 
the Applied Biosystems™ ViiA™ 7 Real-Time PCR System (ThermoFisher 
Scientific), via the use of Applied Biosystems™ TaqMan® primer probes (Table 2.1, 
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all purchased from ThermoFisher Scientific) according to manufacturer’s protocols.  
Post-thermal cycling, QPCR was performed in MicroAmp™ Fast Optical 96-Well 
Reaction Plates (ThermoFisher Scientific).  Each reaction had a final volume of 
20μl/well, consisting of cDNA (4μl), TaqMan® Fast Universal PCR Master Mix 
(2X) no AmpErase® UNG (10µl), RNase-free water (4μl), TaqMan® Gene 
Expression Assay Primer/Probe Mix (FAM™ reporter/MGB-NFQ quencher, 1μl) 
and eukaryotic 18S Ribosomal RNA (rRNA) Endogenous Control (VIC® 
reporter/TAMRA™ quencher, 1μl).  The TaqMan® target and reference gene 
expression assay mixes (Table 4.1), contained forward and reverse PCR primers and 
TaqMan® probes.  Negative control reactions were also included for each plate, with 
RNase-free water replacing cDNA to account for any undesired reagent 
contamination and undesirable signal.  Reaction Plates were then covered with 
MicroAmp™ Optical Adhesive Film (ThermoFisher Scientific), to reduce 
possibility of cross contamination between wells and centrifuged at 500g for 30s, 
before transferring the plates to the Applied Biosystems™ ViiA™ 7 Real-Time PCR 
System, for cDNA amplification.  Reactions were run with an initial denaturing step 
of 95°C for 20s, followed by 40 cycles at a denaturing step temperature of 95ºC (1s) 
and 1 cycle at an annealing temperature of 60ºC (20s). 
 
4.3.2.3 Quantification of Gene Expression 
The comparative cycle threshold (ΔΔCT) method was used to calculate the relative 
quantification (RQ) of gene expression, with 18S rRNA used as a reference gene for 
normalisation.  CT values, where amplification is within the curve’s linear range, 
were used in this process.  CTs of the standard reference gene (18S rRNA) were 
subtracted from target gene CT values, to obtain delta CT (dCT) values (known as 
the cycle threshold differences).  Subsequently, mean dCT values for the 
experimental and control group samples were calculated.  Expression of each target 
gene in experimental group samples relative to the mean control group expression 
values were subsequently determined, using the following equation: 
 
2-(dCT(Experimental Target) - dCT(Mean Control Group)) 
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Table 4.1.  Applied Biosystems™ TaqMan® gene expression assay mixes.  Catalogue 
and assay IDs are provided in lieu of primer sequences, as Applied Biosystems™ do 
not supply this information. 
 
Gene Target 
 
TaqMan® Gene Expression Assay 
SOD1 Hs00533490_m1 
SOD2 Hs00167309_m1 
SOD3 Hs04973910_s1 
CAT Hs00156308_m1 
GPX1 Hs00829989_Gh 
GPX2 Hs01591589_m1 
GPX3 Hs01041668_m1 
GPX4 Hs00989766_m1 
GPX5 Hs00559733_m1 
GSR Hs00167317_m1 
GSS Hs00609286_m1 
GSTZ1 Hs01041668_m1 
18S rRNA 4310893E 
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Resulting RQ values for every sample group/experimental condition were 
averaged and standard error of the mean (SEM) values were calculated.  Each 
experiment was performed on n=3 independent occasions. 
 
4.3.3 Enzymic Antioxidant Protein Level Analysis 
The gene expression levels of particular enzymic antioxidants (SOD1, SOD2, SOD3 
and GSTZ1), in high and low proliferative DPSC sub-populations in the absence and 
presence of sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM), were 
also verified at the protein level by Western blotting.  DPSCs at selected population 
doublings (PDs) throughout their proliferative life-spans, were seeded at 5,000 
cells/cm2 in T-75 flasks and maintained at 37ºC/5% CO2 in αMEM medium 
(ThermoFisher Scientific), in the absence and presence of sub-lethal doses of 
exogenous H2O2 (0, 50µM, 100µM or 200μM, ThermoFisher Scientific).  Culture 
medium was changed every two days.  Cells were grown to 80-90% confluence, the 
culture medium was removed, and the cells were washed briefly in ice-cold 
phosphate buffered saline (PBS, x1).  DPSCs were subsequently harvested for total 
protein extraction. 
 
4.3.3.1 Protein Extraction 
Total protein was extracted using Pierce® Radio-Immunoprecipitation Assay (RIPA) 
extraction buffer (ThermoFisher Scientific), according to the manufacturer’s 
instructions.  Prior to use, one cOmplete™ Protease Inhibitor Cocktail tablet (Roche 
Ltd., Welwyn Garden City, UK), was dissolved in 25 ml ice-cold RIPA buffer (Table 
4.2).  DPSCs were lysed by the addition of RIPA/inhibitor buffer (400μl/flask), 
followed by scraping the contents of each flask into sterile Eppendorf® safe-lock 
tubes (1.5ml, Eppendorf Ltd., Stevenage, UK), to minimise contamination.  To 
maximise protein yields, samples were sonicated with Digital SLPe™ Cell Disruptor 
(Branson Ultrasonics Corp., Slough, UK), then briefly vortexed before centrifuging 
at 10,000xg for 15min at 4°C.  Resulting supernatants were subsequently transferred 
into fresh pre-chilled 1.5ml Eppendorf tubes and samples were stored at -80°C until 
required.  In order to determine extract protein concentrations, supernatants were 
assessed using the Pierce® Bicinchoninic Acid (BCA) Protein Assay Kit 
(ThermoFisher Scientific), according to manufacturer’s instructions.  Bovine serum 
albumin (BSA) standard curves were prepared ranging between 125-2000µg/ml, 
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with PBS serving as the diluent.  Standards and samples were vortexed briefly and 
centrifuged at 8000xg for 30s, at 4°C.  Both standards and extracted supernatants 
were then added to a 96-well plate (10μl/well, in duplicate) and Pierce® Working 
Reagent (200μl/well, in Kit) added.  Plates were then shaken for 30s and incubated 
at 37°C for 30min.  Protein quantification was performed through measuring 
endpoint absorbance at 562nm, using a FLUOstar® Omega Plate Reader (BMG 
Labtech, Aylesbury, UK).  Absorbance values were calculated and the BSA standard 
curves used to determine the protein contents in each extract, with mean extract 
protein concentrations expressed as μg/ml. 
 
4.3.3.2 Western Blotting 
DPSC protein extracts were separated and proteins of interest identified, using 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and 
Western blot analysis.  Aliquots of each protein extract (10μg) were loaded into 
sterile Eppendorf® PCR tubes (0.2ml, Eppendorf Ltd.) and 4x reducing buffer (Bio-
Rad Laboratories, Hemel Hempstead, UK, Table 4.2) added to each sample (3 parts 
sample:1 part reducing buffer).  Tubes were briefly vortexed, centrifuged for 30s, 
incubated at 95°C for 5min and left to cool on ice.  Protein samples and pre-stained 
Precision Plus Protein™ Kaleidoscope™ ladders (Bio-Rad Laboratories), were 
separated on pre-formed 4-15% TGX™ gels using the Mini-Protean® Tetra Cell 
System (Bio-Rad Laboratories), at 100V for 80min.  The Tetra Cell tank was filled 
with 1X running buffer (Table 4.2). 
 During the electrophoresis period, membranes were prepared by 
consecutively soaking cut to size pieces of Hybond™-P polyvinylidene difluoride 
(PVDF) blotting membrane (GE Healthcare, Amersham, UK), in methanol, double-
distilled water and transfer buffer (Table 4.2) for 5min each.  Electroblot sponges 
were also prepared by soaking in transfer buffer.  Post-separation, gels were removed 
from casts and assembled into a transfer ‘sandwich’ comprising the transfer cassette, 
electroblot sponges, gels, PVDF membranes and the extra thick filter paper.  The 
completed transfer cassettes were placed with an ice block into the Mini Trans-Blot® 
Electrophoretic Transfer Cell System (Bio-Rad Laboratories) and filled with ice-
cold 1X transfer buffer (Table 4.2).  Protein samples and pre-stained Kaleidoscope™ 
ladders were electroblotting onto PVDF membranes at 100V for 1h.  The protein 
transfer efficiency was determined for each blot by staining the PVDF membranes 
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with Ponceau S solution (Sigma, Poole, UK), for 5min at room temperature on a 
plate rocker, followed by removal of stain after effective transfer confirmation by 
washing with double-distilled water (x3, 10min each). 
Post-transfer, membranes were incubated with blocking buffer (Table 4.2), 
on a plate rocker for 1h at room temperature, to prevent non-specific protein binding.  
Membranes were subsequently rinsed on a plate rocker with 1% Tris-buffered saline 
(TBS)-Tween (x1, Table 4.2), for 1min at room temperature.  Membranes were 
incubated with the appropriate primary antibody, diluted in blocking buffer.  Primary 
antibodies utilised and incubation conditions are listed in Table 4.3 (all raised in 
rabbit, Abcam, Cambridge, UK).  Normalised protein loading on each blot was 
confirmed using a β-actin Loading Control (1:20,000, Abcam).  After primary 
antibody incubation, membranes were washed with 1% TBS-Tween (3x5min) at 
room temperature on a plate rocker and incubated in horseradish peroxidase (HRP)-
conjugated, swine anti-rabbit secondary antibody (1:5000, Dako, Ely, UK), in 
blocking buffer on a plate rocker for 1 h at room temperature.  Membranes were then 
washed with 1% TBS-Tween (3x5min) at room temperature on a plate rocker, 
followed by two additional washes with TBS alone (5min each, Table 4.2), to reduce 
background.  Proteins were visualised utilising the enhanced chemiluminescence 
(ECL) method.  Membranes were incubated in ECL™ Prime Detection Reagent 
(VWR International, Lutterworth, UK) for 3min in the dark at room temperature, to 
ensure full coverage and reactivity, prior to placing in a Hypercassette™ (GE 
Healthcare).  Autoradiographic films (Hyperfilm™-ECL, ThermoFisher Scientific) 
was placed on the membranes and exposed for the required amount of time, prior to 
being developed using a Curix-60 Auto-Developer (AGFA Healthcare, Greenville, 
USA).  Immunoblot images were captured, and densitometry performed using 
ImageJ® Software (NIH Software, Version 1.49).  Each experiment was performed 
on n=3 independent occasions. 
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Table 4.2.  List of buffers used during protein extraction, SDS-PAGE separation and 
Western blot transfer and probing. 
 
Buffer Contents 
 
Pierce® RIPA/cOmplete™ 
inhibitor lysis and extraction 
buffer (25ml). 
25mM Tris-HCl (pH 7.6), 150mM NaCl, 1% 
NP-40, 1% sodium deoxycholate, 0.1% SDS, 1 
cOmplete™ protease inhibitor cocktail tablet. 
Reducing buffer (1ml). 
900µl 4x Laemmli sample buffer, 100µl β-
mercaptoethanol. 
Running buffer (10X). 
0.25M Tris-HCl (30.3g/l), 1.92M glycine 
(144g/l), 1% SDS (10g), pH 8.3. 
Transfer buffer (10X). 
0.25M Tris-HCl (30.3g/l), 1.92M glycine 
(144g/l), pH 8.3. 
Transfer buffer (1X). 
100ml Transfer buffer (10X), 200ml methanol, 
700ml double-distilled water. 
Tris-buffered saline (TBS, 
10X). 
0.25M Tris-HCl (30.3g/l), 0.15M NaCl (80g/l), 
pH 7.4. 
1% TBS-Tween  1l TBS (1X), 1ml Tween® 20. 
Blocking buffer (50ml) 
5% powdered skimmed milk (2.5g/50ml), 50ml 
1% TBS-Tween. 
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Table 4.3.  Summary of the primary antibodies and conditions used during Western 
blot analysis (all supplied by Abcam, Cambridge, UK). 
 
Primary 
Antibody 
Type and 
Host 
Dilution Expected 
Molecular 
Weight 
 
Incubation 
Conditions 
SOD1 Polyclonal, 
rabbit 
1:1000 17kDa 4°C, 
overnight 
SOD2 Polyclonal, 
rabbit 
1:1000 26kDa 4°C, 
overnight 
SOD3 Polyclonal, 
rabbit 
1:1000 31kDa 4°C, 
overnight 
GSTZ1 Polyclonal, 
rabbit 
1:500 24kDa 4°C, 
overnight 
β-actin Polyclonal, 
rabbit 
1:20,000 42kDa 1h, room 
temperature 
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4.3.4 Enzymic Antioxidant Activity Analysis 
The total activities of particular enzymic antioxidants (SODs, catalase and GPX), in 
high and low proliferative DPSC sub-populations in the absence and presence of 
sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM), were also verified 
in cell extracts using commercial activity assays, according to manufacturer’s 
instructions.  Upon collection of cell extracts for total SOD, catalase and GPX 
activity analyses, the protein concentrations of each extract were quantified using 
the Pierce® BCA Protein Assay Kit described above, according to manufacturer’s 
instructions.  Each sample was loaded in duplicates and all experiments were carried 
out in triplicates. 
 
4.3.4.1 Superoxide Dismutase Activity 
Total SOD activities were determined using SOD Activity Colorimetric Assay Kits 
(Abcam).  The Kit is based upon the reduction of the tetrazolium salt, WST-1, to 
formazan dye in the presence of O2.-, produced by xanthine oxidase activity.  WST-
1 rates of reduction are linearly related to xanthine oxidase inhibition by SODs, with 
the extent of inhibition being quantifiable spectrophotometrically at 450nm. 
 High and low proliferative DPSCs at selected population doublings (PDs) 
throughout their proliferative life-spans, were seeded at 5,000 cells/cm2 in T-75 
flasks and maintained at 37ºC/5% CO2 in αMEM medium, in the absence and 
presence of sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM).  
Culture medium was changed every two days.  Cells were harvested at densities of 
2x106 cells/flask and lysed in ice-cold 0.1M Tris-HCl buffer, pH 7.4, containing 
0.5% Triton X-100, 5mM β-mercaptoethanol and 0.1mg/ml phenylmethylsulfonyl 
fluoride (PMSF).  Upon lysis, extracts were centrifuged at 14,000xg for 5min at 4°C; 
and the resultant supernatants collected into 1.5ml Eppendorf tubes on ice. 
Samples, standards (SOD Human Standard, in Kit) and internal assay 
controls (in Kit) were aliquoted into wells of 96-well plates (20μl/well in duplicate), 
followed by the addition of Enzyme Working Solution (20μl, in Kit) to each well.  
The plates were mixed and incubated at 37°C for 20min, prior to absorbance values 
being read using a FLUOstar® Omega Plate Reader, at 450nm.  Sample readings 
were obtained for each extract using standard curves and relative total SOD activities 
calculated using the following equation, with A= absorbance.  Each experiment was 
performed on n=3 independent occasions. 
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Total SOD Activity = (Ablank1 – Ablank3) – (Asample – Ablank2) x 100 
(Ablank1 – Ablank3) 
 
4.3.4.2 Catalase Activity 
Total catalase activities were determined using Catalase Specific Activity Assay Kits 
(Abcam).  The Kit measures catalase activity based on spectrophotometric changes 
in absorbance which occur due to catalase rapidly removing H2O2 preventing it 
reacting with luminescent substrate.  The extent to which catalase prevents H2O2 
reacting with the luminescent substrate can subsequently be determined 
spectrophotometrically at 450nm. 
 High and low proliferative DPSCs at selected population doublings (PDs) 
throughout their proliferative life-spans, were seeded at 5,000 cells/cm2 in T-75 
flasks and maintained at 37ºC/5% CO2 in αMEM medium, in the absence and 
presence of sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM).  
Culture medium was changed every two days.  DPSCs (2x106 cells in total for each 
experimental condition) were harvested by scraping adherent cells from the culture 
flasks.  Flasks were rinsed with PBS (x2) and the cellular contents solubilised in 
Extraction Buffer (200μl, in Kit), on ice for 20 min.  Extracts were centrifuged at 
16,000xg for 20min at 4°C; and the cell pellets discarded.  The remaining 
supernatants were collected into 1.5ml Eppendorf tubes on ice. 
 Samples and standards (native catalase from human erythrocytes, Abcam) 
were aliquoted into wells of 96-well plates (100μl/well in triplicate) and incubated 
at room temperature for 3h, on a plate rocker at 300rpm.  Wells were subsequently 
washed with Wash Buffer (300μl x2, in Kit), followed by the addition of Anti-
Catalase Primary Detector Antibody (100μl, in Kit) to each well.  The plates were 
mixed and incubated at room temperature for 1h, on a plate rocker at 300rpm.  Wells 
were washed with Wash Buffer (300μl x2), to remove unbound detector antibody.  
HRP-Conjugated Secondary Antibody (100μl, in Kit) was added to each well and 
plates incubated at room temperature for 1h.  Wells were washed with Wash Buffer 
(300μl x3), prior to the addition of HRP Development Solution (100μl, in Kit) to 
each well.  Absorbance values were read over a 15min period, using a FLUOstar® 
Omega Plate Reader at 600nm.  Sample readings were obtained for each extract 
using standard curves and relative total catalase activities calculated.  Each 
experiment was performed on n=3 independent occasions. 
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4.3.4.3 Glutathione Peroxidase Activity 
Total GPX activities were determined using Glutathione Peroxidase Assay Kit 
(Cambridge Bioscience, Cambridge, UK).  The Kit indirectly measures GPX 
activity, based on spectrophotometric changes in absorbance which occur due to the 
oxidation of NADPH to NADP+.  GPX reduces hydroperoxide to oxidized 
glutathione (GSSG), which is then recycled to its reduced state by GR in the presence 
of NADPH.  The oxidation of NADPH can subsequently be determined 
spectrophotometrically, due to decreases in absorbance at 340nm. 
 High and low proliferative DPSCs at selected population doublings (PDs) 
throughout their proliferative life-spans, were seeded at 5,000 cells/cm2 in T-75 
flasks and maintained at 37ºC/5% CO2 in αMEM medium, in the absence and 
presence of sub-lethal doses of exogenous H2O2 (0, 50µM, 100µM or 200μM).  
Culture medium was changed every two days.  Cells were harvested at densities of 
2x106 cells/flask and washed with ice-cold 50mM Tris-HCl buffer, pH 7.5, 
containing 5mM EDTA and 1mM dithiothreitol (DTT), prior to resuspension cold 
Assay Buffer (200μl, in Kit) and homogenisation on ice.  Homogenised extracts were 
centrifuged for at 10,000g for 15min at 4°C to remove insoluble material and the 
resultant supernatants collected into 1.5ml Eppendorf tubes on ice. 
 Samples, standards (glutathione peroxidase from human erythrocytes, 
Sigma) and internal assay controls (in Kit) were aliquoted into wells of 96-well 
plates (20μl/well in triplicate), with Assay Buffer (120μl, 50mM Tris-HCl, pH 7.6, 
containing 5mM EDTA, in Kit) and Co-Substrate Mixture (50μl, consisting of 
NADPH, glutathione and GR, in Kit).  Reactions were initiated by the addition of 
Cumene Hydroperoxide (20μl, in Kit) to each well and the plates agitated.  
Absorbance values were read over a 6min period, using a FLUOstar® Omega Plate 
Reader at 340nm.  Sample readings were obtained for each extract using standard 
curves and total GPX activities calculated using the following equations, with A= 
absorbance.  Each experiment was performed on n=3 independent occasions. 
 
∆A340/min = (∆A340 @ Time 2 - ∆A340 @ Time 1) / Time 2 (min) – Time 1 
(min) 
 
GPX activity = (|∆A340/min| / 0.00373μM-1) × (0.19ml / 0.02ml) = nmol/min/ml 
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4.4 Statistical Analysis 
Statistical analyses were performed via use of GraphPad Prism Software (GraphPad 
Software Inc., La Jolla, USA).  Graphical data for each experimental 
condition/sample group are exhibited as average±standard error of the mean (SEM).  
For QPCR data, statistical significance was determined using Analysis of Variance 
(ANOVA), with post-hoc Tukey’s multiple comparisons tests.  Significance was 
considered at p<0.05. 
 
4.5 Results 
4.5.1 Enzymic Antioxidant Gene Expression 
A number of different DPSC sub-populations previously isolated and characterised 
from 3 individual patient donors (patients A, C and D), for oxidative stress-induced 
biomolecular damage and senescence susceptibilities (Chapters 2 and 3), were also 
assessed for their respective enzymic antioxidant expression and activity capabilities 
throughout their proliferative life-spans, following treatment with increasing H2O2 
concentrations (0, 50μM, 100μM, 200μM).  These included previously identified 
high proliferative (highly resistant to oxidative stress-induced senescence) sub-
population, A1 and low proliferative (highly susceptible to oxidative stress-induced 
senescence) sub-populations, A2, C3 and D4.  Overall, marked differences in the 
expression and activities of particular enzymic antioxidants were identified between 
high and low proliferative DPSCs, irrespective of whether DPSCs were derived from 
the same or different patients. 
 QPCR analysis demonstrated distinct differences in the antioxidant gene 
expression profiles between high and low proliferative DPSC sub-populations.  For 
the SOD genes analysed (SOD1, SOD2 and SOD3), although SOD1 and SOD3 
expression were undetectable in all high proliferative DPSC sub-populations at early 
PDs (10-25PDs) and late PDs (40-60PDs) analysed (data not shown), significantly 
higher SOD1 and SOD3 expression were detectable in low proliferative DPSCs at 
early PDs (2-10PDs, both p<0.001), albeit at low levels with no significant increases 
in SOD expression with increasing H2O2 treatment (p>0.05, Figure 4.1).  Despite no 
significant differences in SOD2 expression between high and low proliferative 
DPSCs at early PDs (10-25PDs and 2-10PDs, respectively) in the absence of H2O2 
treatment (p>0.05, Figure 4.2), high proliferative DPSCs at early PDs (10-25PDs) 
demonstrated significantly higher (10-15 fold) inductions in SOD2 expression when 
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treated with increasing H2O2 concentrations (p<0.001-0.05), compared to H2O2-
treated low proliferative DPSC sub-populations at early PDs (2-10PDs, p<0.001-
0.05).  However, high proliferative DPSCs at late PDs (45-60PDs) lost the ability to 
induce significant SOD2 expression upon treatment with H2O2, with no significant 
differences in SOD2 expression identified (p>0.05), compared to low proliferative 
DPSCs at early PDs (2-10PDs).  Therefore, this resulted in H2O2-treated high 
proliferative DPSCs at late PDs (45-60PDs) having significantly lower SOD2 
expression levels, compared to their early PDs (10-25PDs) counterparts (p<0.001-
0.05). 
Comparison of catalase gene expression demonstrated that expression was 
maintained at relatively low levels in all high and low DPSCs analysed (Figure 4.3).  
Although negligible basal catalase expression was determined in high proliferative 
DPSC sub-populations at early PDs (10-25PDs) in the absence of H2O2 treatment, 
low proliferative DPSCs at early PDs (2-10PDs) exhibited higher expression levels 
overall (p<0.05).  However, whereas high proliferative DPSCs at early PDs (10-
25PDs) demonstrated minor, non-significant inductions in catalase expression 
equivalent to levels in low proliferative DPSCs, when treated with increasing H2O2 
concentrations (p>0.05), further inductions in catalase expression were not evident 
with H2O2-treated low proliferative DPSC sub-populations at early PDs (p>0.05, 2-
10PDs).  Similar to low proliferative DPSCs at early PDs (2-10PDs), high 
proliferative DPSCs at late PDs (45-60PDs) without H2O2 treatment, also 
demonstrated higher basal levels of catalase expression than at early PDs (10-25PDs, 
p<0.05), although high proliferative DPSCs at late PDs (45-60PDs) also failed to 
promote further significant inductions in catalase expression with H2O2 treatment 
(p>0.05), except at 200μM H2O2 treatment, compared to their early PDs (10-25PDs) 
counterparts (p<0.01). 
 In terms of the expressions of antioxidant genes involved in glutathione 
metabolism, GPX1, GPX2, GPX3, GPX4, GPX5, GSR and GSS expression were 
undetectable in all high proliferative DPSC sub-populations at early PDs (10-25PDs) 
and late PDs (40-60PDs) analysed (data not shown).  Similarly, GPX2 and GPX5 
expression were undetectable in all low proliferative DPSC sub-populations at early 
PDs (2-10PDs) analysed (data not shown).  However, despite exhibiting GPX1, 
GPX3, GPX4, GSR and GSS expression in low proliferative DPSCs at early PDs (2-
10PDs, all p<0.001 versus high proliferative DPSCs at early and late PDs), 
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expression levels were only detectable at relatively low levels overall (Figures 4.4 
and 4.5).  Furthermore, GPX1 and GPX3 both demonstrated no significant 
inductions in expression by low proliferative DPSCs at early PDs (2-10PDs) with 
increasing H2O2 treatment (p>0.05, Figures 4.4).  However, significant increases in 
GPX4 expression were shown by low proliferative DPSCs at early PDs (2-10PDs) 
with 200μM H2O2 treatment, compared to their untreated, 50μM H2O2 and 100μM 
H2O2 treated counterparts (p<0.001-0.01, Figures 4.4).  Furthermore, GSR and GSS 
expression were significantly increased in low proliferative DPSCs at early PDs (2-
10PDs), following treatment with 100μM and 200μM H2O2 and 100μM H2O2 
treatments, respectively (all p<0.05, Figure 4.5). 
 Despite no significant differences in the expression of another glutathione 
metabolism enzyme, GSTZ1, between high and low proliferative DPSCs at early 
PDs (10-25PDs and 2-10PDs, respectively) in the absence of H2O2 treatment 
(p>0.05, Figure 4.6), high proliferative DPSCs at early PDs (10-25PDs) 
demonstrated significant inductions (100-125 fold) in GSTZ1 expression when 
treated with increasing H2O2 concentrations (p<0.001), compared to H2O2-treated 
low proliferative DPSC sub-populations at early PDs (2-10PDs).  However, high 
proliferative DPSCs at late PDs (45-60PDs) lost the ability to induce significant 
GSTZ1 expression upon treatment with H2O2, with no significant differences in 
GSTZ1 expression identified (p>0.05), compared to low proliferative DPSCs at 
early PDs (2-10PDs).  Therefore, H2O2-treated high proliferative DPSCs at late PDs 
(45-60PDs) possessed significantly lower GSTZ1 expression levels, compared to 
their early PDs (10-25PDs) counterparts (all p<0.001). 
 
 
  
 135 
Figure 4.1.  QPCR analysis of (A) SOD1 and (B) SOD3 gene expression by low 
proliferative DPSC sub-populations at early PDs (2-10PDs), following extended 
culture to senescence under increasing H2O2 concentrations (50μM, 100μM, 
200μM).  N=3, average±SEM, p>0.05.  SOD1 and SOD3 expression were 
undetectable in all high proliferative DPSCs analyzed. 
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Figure 4.2.  QPCR analysis of SOD2 gene expression by high (10-25PDs and 45-
60PDs) and low (2-10PDs) proliferative DPSC sub-populations at early (E) and late 
(L) PDs, following extended culture to senescence under increasing H2O2 
concentrations (50μM, 100μM, 200μM).  N=3, average±SEM, *p<0.05, 
***p<0.001. 
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Figure 4.3.  QPCR analysis of catalase gene expression by high (10-25PDs and 45-
60PDs) and low (2-10PDs) proliferative DPSC sub-populations at early (E) and late 
(L) PDs, following extended culture to senescence under increasing H2O2 
concentrations (50μM, 100μM, 200μM).  N=3, average±SEM, *p<0.05, **p<0.01. 
 
 
  
High (E) High (L) Low(E)
0.0
0.5
1.0
1.5
2.0
2.5
H2O2 Treatment Concentrations µM
R
el
at
iv
e 
E
xp
re
ss
io
n 
of
 C
A
T
1 
m
R
N
A
0
50
100
200
* *
**
 138 
Figure 4.4.  QPCR analysis of (A) GPX1, (B) GPX3 and (C) GPX4 gene expression 
by low proliferative DPSC sub-populations at early PDs (2-10PDs), following 
extended culture to senescence under increasing H2O2 concentrations (50μM, 
100μM, 200μM).  N=3, average±SEM, **p<0.01, ***p<0.001.  GPX1, GPX3 and 
GPX4 expression were undetectable in all high proliferative DPSCs analyzed. 
 
A) 
 
B) 
 
 
 
0 50 10
0
20
0
0.0
0.5
1.0
1.5
2.0
H2O2 Treatment Concentration µM
R
el
at
iv
e 
E
xp
re
ss
io
n
 o
f G
P
X
1 
m
R
N
A
0 50 10
0
20
0
0.0
0.5
1.0
1.5
2.0
H2O2 Treatment Concentration µM
R
el
at
iv
e 
E
xp
re
ss
io
n
 o
f G
P
X
3 
m
R
N
A
 139 
C) 
 
  
0 50 100 200
0.00
0.01
0.02
0.03
H2O2 Treatment Concentration µM
R
el
at
iv
e 
E
xp
re
ss
io
n
 o
f G
P
X
4 
m
R
N
A
***
**
**
 140 
Figure 4.5.  QPCR analysis of (A) GSR and (B) GSS gene expression by low 
proliferative DPSC sub-populations at early PDs (2-10PDs), following extended 
culture to senescence under increasing H2O2 concentrations (50μM, 100μM, 
200μM).  N=3, average±SEM, *p<0.05.  GSR and GSS expression were 
undetectable in all high proliferative DPSCs analyzed. 
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Figure 4.6.  QPCR analysis of GSTZ1 gene expression by high (10-25PDs and 45-
60PDs) and low (2-10PDs) proliferative DPSC sub-populations at early (E) and late 
(L) PDs, following extended culture to senescence under increasing H2O2 
concentrations (50μM, 100μM, 200μM).  N=3, average±SEM, ***p<0.001. 
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4.5.2 Enzymic Antioxidant Protein Levels 
In line with the significant inductions in SOD2 and GSTZ1 expression levels 
identified in H2O2-treated high proliferative DPSCs at early PDs (10-25PDs) by 
QPCR, compared to low proliferative DPSCs at early PDs (2-10PDs) and high 
proliferative DPSCs at late PDs (45-60PDs), Western blot analysis was performed 
to validate SOD isoform and GSTZ1 findings at a protein level. 
Western blot analysis of SOD1 levels demonstrated low levels of detectable 
SOD1 protein in high proliferative DPSCs at early PDs (10-25PDs), with no 
significant inductions in SOD1 levels at early PDs with increasing H2O2 treatment, 
although significant reductions in SOD1 protein levels were evident following 50µM 
H2O2 treatments (p<0.01).  High proliferative DPSCs at late PDs (45-60PDs) 
exhibited similar SOD1 levels to their early PD counterparts on the whole, although 
significant increases in detectable SOD1 were identified with 50µM H2O2 treatments 
(p<0.001).  In contrast, untreated low proliferative DPSC sub-populations at early 
PDs (2-10PDs) demonstrated significantly higher SOD1 protein levels (p<0.01-
0.05), compared to high proliferative DPSCs at early (10-25PDs) and late PDs (45-
60PDs).  Furthermore, low proliferative DPSC sub-populations at early PDs (2-
10PDs) showed further significant increases in SOD1 levels with 100μM and 200μM 
H2O2 treatments (p<0.05 and p<0.01, respectively).  Consequently, H2O2-treated low 
proliferative DPSCs at early PDs (2-10PDs) possessed significantly higher SOD1 
protein levels (all p<0.001), versus high proliferative DPSCs at early (10-25PDs) 
and late PDs (45-60PDs). 
Analysis of SOD2 showed much higher levels of detectable SOD2 protein in 
high proliferative DPSCs at early PDs (10-25PDs), compared to low proliferative 
DPSCs at early PDs (2-10PDs, p<0.001, Figure 4.8).  Although SOD2 levels 
significantly declined in high proliferative DPSCs at early PDs with 50µM H2O2 
treatment (p<0.001), significant inductions in SOD2 levels were identified with 
100µM and 200µM H2O2 treatments (both p<0.001).  In contrast, SOD2 levels were 
virtually undetectable in low proliferative DPSCs at early PDs (2-10PDs), both in 
the absence and presence of H2O2 treatment (all p<0.001 versus untreated and H2O2-
treated high proliferative DPSCs at early PDs).  SOD2 levels in untreated high 
proliferative DPSCs at late PDs (45-60PDs) showed significant reductions compared 
to their early PD counterparts (p<0.001).  Furthermore, despite significant increases 
in SOD2 levels with 50µM H2O2 treatments (p<0.001), significant decreases in 
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SOD2 levels were shown with 100μM and 200μM H2O2 treatments, compared to 
untreated controls (p<0.01 and p<0.001, respectively).  However, despite such 
reductions, SOD2 levels in untreated and H2O2-treated high proliferative DPSCs at 
late PDs (45-60PDs) were still significantly higher than those quantified for 
untreated and H2O2-treated low proliferative DPSCs at early PDs (2-10PDs, all 
p<0.001). 
SOD3 protein levels were undetectable in all high and low proliferative 
DPSCs analysed, irrespective of early or late PDs and H2O2 treatments (Figure 4.9).  
Consequently, no significant differences in densitometry were shown (all p>0.05). 
GSTZ1 demonstrated significantly higher levels of detectable protein in high 
proliferative DPSCs at early PDs (10-25PDs), compared to low proliferative DPSCs 
at early PDs (2-10PDs), with further significant increases in GSTZ1 levels evident 
following each H2O2 treatment (all p<0.001, Figure 4.10).  In contrast, GSTZ1 levels 
were undetectable in low proliferative DPSCs at early PDs (2-10PDs), both in the 
absence and presence of H2O2 treatment (all p<0.001 versus untreated and H2O2-
treated high proliferative DPSCs at early PDs).  This was also the case in high 
proliferative DPSCs at late PDs (45-60PDs), with no GSTZ1 protein detectable in 
control and H2O2-treated cultures (all p<0.001 versus untreated and H2O2 treated 
high proliferative DPSCs at early PDs). 
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Figure 4.7.  Western blot and densitometric analysis of SOD1 protein levels in high 
(10-25PDs and 45-60PDs) and low (2-10PDs) proliferative DPSC sub-populations 
at early (E) and late (L) PDs, following extended culture to senescence under 
increasing H2O2 concentrations (50μM, 100μM, 200μM).  For all Western blots, 
images from one representative experiment of three are shown.  Densitometry data 
was normalised versus β-actin loading controls, with values subsequently 
normalised versus untreated high proliferative DPSCs at early PDs (10-25PDs).  
N=3, average±SEM, *p<0.05, **p<0.01, ***p<0.001.  A.U. = Arbitrary units. 
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Figure 4.8.  Western blot and densitometric analysis of SOD2 protein levels in high 
(10-25PDs and 45-60PDs) and low (2-10PDs) proliferative DPSC sub-populations 
at early (E) and late (L) PDs, following extended culture to senescence under 
increasing H2O2 concentrations (50μM, 100μM, 200μM).  For all Western blots, 
images from one representative experiment of three are shown.  Densitometry data 
was normalised versus β-actin loading controls, with values subsequently 
normalised versus untreated high proliferative DPSCs at early PDs (10-25PDs).  
N=3, average±SEM, **p<0.01, ***p<0.001.  A.U. = Arbitrary units. 
 
 
 
  
High (E) High (L) Low(E)
0.0
0.5
1.0
1.5
H2O2 Treatment Concentrations µM
SO
D
2 
/ β
-A
ct
in
 (R
el
at
ive
 D
en
sit
y, 
A.
U
.)
0
50
100
200
*********
******
***
******
******
********
 146 
Figure 4.9.  Western blot and densitometric analysis of SOD3 protein levels in high 
(10-25PDs and 45-60PDs) and low (2-10PDs) proliferative DPSC sub-populations 
at early (E) and late (L) PDs, following extended culture to senescence under 
increasing H2O2 concentrations (50μM, 100μM, 200μM).  For all Western blots, 
images from one representative experiment of three are shown.  Densitometry data 
was normalised versus β-actin loading controls, with values subsequently 
normalised versus untreated high proliferative DPSCs at early PDs (10-25PDs).  
N=3, average±SEM.  A.U. = Arbitrary units. 
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Figure 4.10.  Western blot and densitometric analysis of GSTZ1 protein levels in 
high (10-25PDs and 45-60PDs) and low (2-10PDs) proliferative DPSC sub-
populations at early (E) and late (L) PDs, following extended culture to senescence 
under increasing H2O2 concentrations (50μM, 100μM, 200μM).  For all Western 
blots, images from one representative experiment of three are shown.  Densitometry 
data was normalised versus β-actin loading controls, with values subsequently 
normalised versus untreated high proliferative DPSCs at early PDs (10-25PDs).  
N=3, average±SEM, ***p<0.001.  A.U. = Arbitrary units. 
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4.5.3 Enzymic Antioxidant Activity Levels 
In line with the relative expression and protein level difference identified for 
particular SOD, catalase and glutathione-related enzymes in high proliferative 
DPSCs at early PDs (10-25PDs), compared to low proliferative DPSCs at early PDs 
(2-10PDs) and high proliferative DPSCs at late PDs (45-60PDs), the total SOD, 
catalase and GPX activities within these DPSC sub-populations were quantified 
using commercial assays. 
 Total SOD activities were significantly increased in low proliferative DPSCs 
at early PDs (2-10PDs), compared to high proliferative DPSCs at early PDs (10-
25PDs) and late PDs (45-60PDs), in the absence of H2O2 treatment (both p<0.001, 
Figure 4.11A).  In contrast, high proliferative DPSCs at early PDs (10-25PDs) 
demonstrated significantly increased total SOD activities when treated with 
increasing H2O2 concentrations (all p<0.001), compared to H2O2-treated low 
proliferative DPSCs at early PDs (2-10PDs), which failed to induce further increases 
in SOD activities.  However, high proliferative DPSCs at late PDs (45-60PDs) did 
not exhibit any increases in total SOD activities upon treatment with H2O2, with no 
significant differences in total SOD activities identified (all p>0.05), compared to 
low proliferative DPSCs at early PDs (2-10PDs).  Therefore, H2O2-treated high 
proliferative DPSCs at late PDs (45-60PDs) demonstrated significantly lower total 
SOD activities, compared to their early PDs (10-25PDs) counterparts (all p<0.001). 
Although total catalase activities were similarly at low levels in high and low 
proliferative DPSCs at early PDs (10-25PDs and 2-10PDs, respectively) in the 
absence of H2O2 treatment (p>0.05), significantly increased catalase activities were 
identified in high proliferative DPSCs at late PDs (45-60PDs) in the absence of H2O2 
treatment, compared to high and low proliferative DPSCs at early PDs (both 
p<0.001, Figure 4.11B).  However, high proliferative DPSCs at early PDs (10-
25PDs) only demonstrated significantly increased total catalase activities when 
treated with 50μM H2O2 concentrations (p<0.01), compared to untreated high 
proliferative DPSCs at early PDs (2-10PDs), although levels were only equivalent 
to (i.e. at 100μM H2O2 concentrations, p>0.05) or significantly lesser than (i.e. at 
50μM and at 200μM H2O2 concentrations, p<0.05 and p<0.001, respectively), 
catalase activities determined for untreated and H2O2-treated high proliferative 
DPSCs at late PDs (45-60PDs).  In contrast, low proliferative DPSCs at early PDs 
(2-10PDs) exhibited low total catalase activities in the absence of increasing H2O2 
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treatment and an inability to induce further elevations in catalase activities upon 
increasing H2O2 treatment (all p>0.05).  Consequently, total catalase activities for 
low proliferative DPSCs at early PDs (2-10PDs) treated with increasing H2O2 
concentrations were significantly lower than high proliferative DPSCs at late PDs 
(40-65PDs) in the absence and presence of H2O2 treatment (p<0.001-0.05). 
 Total GPX activities were only detectable in low proliferative DPSCs at early 
PDs (2-10PDs, all p<0.001 versus high proliferative DPSCs at early and late PDs, 
Figures 4.11C), although non-significant inductions in total GPX activities were 
apparent following increasing H2O2 treatment (all p>0.05). 
 
4.6 Discussion 
The findings of previous Chapters 2 and 3, that significant variations exist in the 
relative susceptibilities of high and low proliferative DPSC sub-populations to 
oxidative stress-induced biomolecular damage and senescence, led to the hypothesis 
that differential enzymic antioxidant expression and activity profiles between high 
and low proliferative DPSCs contributed to such differences in the abilities to 
counteract oxidative stress exposure.  From the findings presented in this Chapter 
and in support of this hypothesis, high proliferative DPSCs were demonstrated to 
possess distinct, and in some cases, superior abilities to induce enzymic antioxidant 
expression and activities upon H2O2 treatment, compared to low proliferative 
DPSCs. 
 The ability of cells to induce upregulated antioxidant expression to 
counteract increasing ROS exposure, is a fundamental concept of oxidative stress 
and its role in disease, senescence and ageing (Tan et al., 2018).  Indeed, enzymic 
antioxidant status has been shown to be critical in maintaining the intracellular redox 
balance and normal cellular functions, supported by studies demonstrating 
correlations between enzymic antioxidant expression/activity levels and cellular 
susceptibilities to oxidative stress-induced biomolecular damage and senescence in 
various cell types, including fibroblasts (Serra et al., 2000, 2003; Lorenz et al., 2001; 
Blander et al., 2003; Brown and Stuart, 2007; Richter and von Zglinicki 2007; 
Hammad et al., 2018) and MSCs (Valle-Prieto and Conget, 2010; Ko et al., 2012; 
Jeong and Cho, 2015; Yu et al., 2018; Chen et al., 2019).  Thus, there is ever-
increasing support for enzymic antioxidants as being major contributors to stem cell 
resistance to oxidative stress, via their possession of superior enzymic antioxidant   
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Figure 4.11.  Activity assay analysis of (A) total SOD, (B) catalase and (C) GPX 
activities in high (10-25PDs and 45-60PDs) and low (2-10PDs) proliferative DPSC 
sub-populations at early (E) and late (L) PDs, following extended culture to 
senescence under increasing H2O2 concentrations (50μM, 100μM, 200μM).  N=3, 
average±SEM, *p<0.05, **p<0.01, ***p<0.001.  GPX activities were undetectable 
in all high proliferative DPSCs analyzed. 
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induction capabilities (Liu et al., 2011; Shyh-Chang et al., 2013; Urao and Ushio-
Fukai, 2013). 
 SOD profiles demonstrated distinct differences between high and low 
proliferative DPSCs, with SOD1 and SOD3 only being detectable in low 
proliferative DPSCs at low levels, with no significant inductions in expression with 
increasing H2O2 treatment.  In contrast, despite similar basal SOD2 expression 
profiles in high and low proliferative DPSCs at early PDs (10-25PDs and 2-10PDs, 
respectively) in the absence of H2O2 treatment, only high proliferative DPSCs at 
early PDs (10-25PDs) demonstrated the ability to significantly induce SOD2 
expression (10-15 fold) with increasing H2O2 treatment.  However, this SOD2 
induction capability was absent in low proliferative DPSCs at early PDs (2-10PDs).  
Such findings imply that SODs predominantly localised within cytoplasmic (SOD1) 
and extracellular (SOD3) regions do not contribute significantly to the antioxidant 
status of high proliferative DPSCs, although in line with the findings of previous 
Chapters 2 and 3, the induction of comparable SOD1 and SOD3 expression levels in 
untreated and H2O2-treated, low proliferative DPSCs may imply that these sub-
populations are already experiencing increasing levels of oxidative stress and are 
reliant on these SODs to address these conditions (Zelko et al., 2002; Fukai and 
Ushio-Fukai, 2011; Tan et al., 2018).  In contrast, the relatively high levels of SOD2 
induction identified in high proliferative DPSCs, strongly suggests that SOD2 is a 
prominent mediator of antioxidant activity within these sub-populations.  Indeed, 
similar contrasts between SOD1 and SOD2 expression profiles have previously been 
identified in high and low proliferative bone marrow-derived, MSCs (Bertolo et al., 
2017).  The relative total SOD activities determined between high and low 
proliferative DPSCs also appear to reflect these differences in expression.  In light 
of the absence or limited detection of SOD1 and SOD3 expression and protein levels 
in high proliferative DPSCs at early PDs (10-25PDs), it is probable that the vast 
majority of the total SOD activity induced in high proliferative DPSCs by H2O2 
treatment is accounted for by the significant upregulation in SOD2 expression.  In 
contrast, gene expression and protein analyses suggest that SOD1 is the principle 
contributor to the lesser elevated total SOD activities identified in low proliferative 
DPSCs at early PDs (2-10PDs). 
 Mitochondria are the main cellular source of O2.- production as a by-product 
of oxidative phosphorylation, due to electron transport chain leakage.  As a result, 
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mitochondrial-specific SOD2 is acknowledged as the primary antioxidant enzyme 
that protects cells from excessive ROS within the mitochondria and mitochondrial 
DNA against oxidative damage (Kienhöfer et al., 2009; Pervaiz et al., 2009; Sun et 
al., 2015; Sheshadri and Kumar, 2016).  Unlike SOD1 and SOD3, the importance of 
SOD2 in mammals is highlighted by the fact that disruption/knockout leads to 
postnatal lethality, whilst SOD2 gene mutations result in premature ageing (Fukai 
and Ushio-Fukai, 2011; Sheshadri and Kumar, 2016).  As mitochondria are also 
regarded as a principle source of endogenous ROS production during cellular 
senescence due to further alterations in oxidative phosphorylation, mitochondrial 
membrane potential and function (Passos and von Zglinicki, 2006; Passos et al., 
2007; Geißle et al., 2012; Correia-Melo et al., 2016; Bertolo et al., 2017), these 
findings also imply that mitochondrial-derived ROS are significant mediators of 
cellular senescence in low proliferative DPSCs, whilst high proliferative DPSCs are 
able to resist oxidative stress-induced, senescence due to adaptations in SOD2 
expression.  As SOD1 and SOD2 are ubiquitously expressed by aerobic cells, the 
lack of SOD1 detection in high proliferative DPSCs is intriguing, although the 
absence of SOD3 expression in high proliferative DPSCs in particular, can be 
explained by its more specific expression profiles in cells and tissues where the 
required antioxidant activity exceeds that contributed by SOD1 and SOD2 (Zelko et 
al., 2002; Fattman et al., 2003; Nozik-Grayck et al., 2005; Fukai and Ushio-Fukai, 
2011).  However, although high proliferative DPSCs lacked SOD1 expression at the 
gene level, SOD1 was detectable in low quantities at a protein level which decreased 
further with H2O2 treatment.  Such discrepancies between SOD1 gene and protein 
levels may be explained by very low or undetectable QPCR signals or unstable 
SOD1 mRNA levels that are subject to increased turnover, which were still 
accompanied by more stable protein signals detectable by Western blotting. 
 While SODs play a major role in the detoxification of O2.- and H2O2 
formation, catalase and GPXs take major part in the enzymatic catabolism of these 
ROS, although excessive H2O2 accumulation is controlled via the coordinated 
actions of SOD2 and GSH within mitochondria (Kienhöfer et al., 2009; Pervaiz et 
al., 2009).  Catalase profiles also demonstrated differences between high and low 
proliferative DPSCs, although only relatively low levels of catalase expression were 
detectable in high and low proliferative DPSCs overall.  Despite being present at 
low/negligible levels in high proliferative DPSCs at early PDs (10-25PDs) in the 
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absence of H2O2 treatment, low proliferative DPSCs at early PDs (2-10PDs) 
exhibited higher expression and activity levels overall.  However, neither high nor 
low proliferative DPSCs at early PDs were capable of consistently inducing 
significant inductions in catalase expression and activities with increasing H2O2 
treatment, with similar levels identified between the sub-populations overall. 
Similar catalase expression/activity profiles have been reported in high and 
low proliferative bone marrow-derived, MSCs (Bertolo et al., 2017).  However, 
despite being a well-established and potent H2O2 detoxifying antioxidant, evidence 
suggests that catalase is particularly susceptible to down-regulated expression and/or 
enzymic inactivation following chronic ROS exposure, as reduced catalase activities 
have been reported in a number of tissues associated with excessive oxidative stress 
and disease (Góth and Eaton, 2000; Shi et al., 2007; Sadi et al., 2008; Waddington 
et al., 2011).  Such findings suggest that low proliferative DPSCs at early PDs (2-
10PDs) are exposed to chronic levels of oxidative stress, leading to an impaired 
ability to maintain catalase activities and degrade H2O2, resulting in enhanced 
oxidative stress-induced bimolecular damage and senescence.  This would result in 
excessive H2O2 accumulation, especially as low proliferative DPSCs exhibited SOD 
activities capable of further increasing H2O2 formation via O2.- dismutation (Zelko 
et al., 2002; Fukai and Ushio-Fukai, 2011).  Similar events may also be responsible 
for the dose-dependent reductions in total catalase activities in high proliferative 
DPSCs at early PDs (10-25PDs), with increasing H2O2 treatment, albeit to a much 
lesser extent than observed in low proliferative DPSCs at early PDs (2-10PDs).  
Therefore, although catalase appears to have a relatively minor role in mediating 
antioxidant responses in high proliferative DPSCs, as with SOD findings above, the 
induction of low levels of catalase expression in untreated low proliferative DPSCs 
may imply that these sub-populations are already experiencing increasing levels of 
oxidative stress and induce catalase expression as a consequence (Tan et al., 2018).  
However, despite increased catalase expression attempting to reduce intracellular 
H2O2 within the cytosol, the excessive oxidative stress that low proliferative DPSCs 
are exposed to inactivates catalase enzymic activities, preventing H2O2 removal. 
 The profiles of antioxidant enzymes associated with glutathione metabolism 
(GPX1, GPX2, GPX3, GPX4, GPX5, GSR and GSS), demonstrated that GPX, GSR 
and GSS expression or total GPX activities were undetectable in high proliferative 
DPSC sub-populations at early PDs (10-25PDs) and late PDs (40-60PDs).  
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Therefore, these findings imply that these glutathione-related antioxidant enzymes 
play negligible roles in the antioxidant status of high proliferative DPSCs.  Similarly, 
although low proliferative DPSCs at early PDs (2-10PDs) exhibited GPX1, GPX3, 
GPX4, GSR and GSS expression and GPX4, GSR and GSS induction with 
increasing H2O2 treatment, the relatively low levels of gene expression and the total 
GPX activities detected overall further suggest that these GPXs, GSR and GSS are 
not major contributors to the antioxidant defence mechanisms of low proliferative 
DPSCs, to high proliferative DPSCs.  However, high proliferative DPSCs at early 
PDs (10-25PDs) exhibited significant inductions in another glutathione metabolism 
enzyme, GSTZ1, at both gene and protein levels, compared to low proliferative 
DPSCs at early PDs (2-10PDs), with increasing H2O2 treatment in an attempt to 
adapt to the elevated oxidative stress. 
 While catalase convert H2O2 into water and oxygen without the requirement 
for cofactors, GPXs catalyse the decomposition of organic hydroperoxides (LOOH) 
and H2O2 utilising multiple cofactors, including GSH and GSR (Liu et al., 2004; 
Weydert and Cullen, 2010).  Hence, GR does not act on ROS directly, but rather 
enable the GPX to function.  In addition to GPXs playing crucial roles in oxidative 
stress defence mechanisms, GST has a primary function in the metabolism of ROS, 
via the conjugation of GSH to electrophilic centres on a wide variety of substrates, 
in order to detoxify xenobiotics (Wu and Dong, 2012; Board and Menon, 2013, Lu, 
2013).  The principle role of GSTZs is in catalysing GSH-dependent detoxification 
of xenobiotics and endobiotics (Board and Anders, 2011).  Although GSTZ1 is 
located in the cytosol, it is also localised within the mitochondria.  Indeed, relevant 
to the current study, increased mitochondrial GSTZ1 expression and activity has 
been shown to correlate with chronological ageing in human tissues, in contrast to 
cytosolic GSTZ1 (Zhong et al., 2018). 
There is growing evidence that cellular oxidative stress tolerance is mainly 
due to the activity of the intrinsically expressed antioxidant enzymes (Liu et al., 
2011; Shyh-Chang et al., 2013; Urao and Ushio-Fukai, 2013; Benameur et al., 2015; 
Sheshadri and Kumar, 2016).  Although reports have shown the contrasting abilities 
of MSCs to resist oxidative stress, all agree that such variations are associated with 
the expression and activity levels of antioxidant enzymes, including SOD1, SOD2, 
catalase, GPX1 and GSH; with SOD2 in particular being implicated as having a 
prominent protective role (Valle-Prieto and Conget, 2010; Ko et al., 2012; Sheshadri 
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and Kumar, 2016).  Indeed, in line with the induction of significantly elevated SOD2 
and GSTZ1 expression in high proliferative DPSCs in particular, mouse embryonic 
fibroblasts from SOD2-/- mice demonstrate early-onset senescence, whilst MSCs 
from young mice lacking SOD2 exhibit increased senescent (Yang et al., 2013; Sart 
et al., 2015).  Furthermore, highly proliferative bone marrow-derived MSCs possess 
lower mitochondrial membrane potential and reduced oxidative stress-induced 
senescence, due to the induction of elevated SOD2 expression (Bertolo et al., 2017).  
In contrast, endothelial progenitor cells are resistant to oxidative stress, due to high 
intrinsic SOD2 expression (He et al., 2004), whereas umbilical cord-derived MSCs 
have been shown to possess dramatically higher mitochondrial content, elevated O2.- 
and correspondingly increased SOD2 levels, compared to bone marrow-derived 
MSCs, leading to superior proliferation rates (Pietilä et al., 2012; Gan et al., 2015).  
Furthermore, human DPSCs have previously been shown to significantly increase 
SOD2 expression, in response to culture under increased oxygen tension (Mas-
Bargues et al., 2017). 
 High SOD2 expression/activity levels have also been implicated as having 
essential roles in regulating ESC self-renewal and pluripotency, in addition to 
supporting superior MSC differentiation capabilities, via the regulation of ROS 
homeostasis (Chen et al., 2008; Pietilä et al., 2012; Gan et al., 2015; Sheshadri et al., 
2015; Sheshadri and Kumar, 2016; Bertolo et al., 2017).  Therefore, in addition to 
alleviating oxidative stress and promoting greater cell expansion in high proliferative 
DPSCs, their high induction of SOD2 expression and activities could also contribute 
to the maintenance of stem cell characteristics and multipotent differentiation 
capabilities in these DPSC sub-populations (Alraies et al., 2017).  Thus, the relative 
levels of SOD2 expression appears to offer a useful characterisation of DPSCs and 
other MSC populations for in vitro assessment and translational development for 
clinical use.  In contrast to SOD2, although GSTZ1 is an established antioxidant, 
few studies have correlated its expression with cellular susceptibilities to oxidative 
stress-induced biomolecular damage or senescence.  However, increased GSTZ1 
expression, especially mitochondrial GSTZ1, has been strongly associated with 
decreased human ageing and prolonged longevity, partly due to restrictions in 
cellular telomere shortening (Starr et al., 2008; Di Cianni et al., 2013; Zhong et al., 
2018).  Furthermore, GSTZ1-/- have also been shown to possess alterations in 
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mitochondrial ultrastructure, size and activity, confirming the important protective 
effects that GSTZ1 play in mitochondria (Lim et al., 2004; Board and Anders, 2011). 
 Although the expression and activities of certain enzymic antioxidants 
(SOD2 and GSTZ1) were demonstrated to be significantly induced beyond basal 
levels by increasing H2O2 treatment in high proliferative DPSCs at early PDs (10-
25PDs), it was apparent that high proliferative DPSCs at late PDs (45-60PDs) did 
not share these abilities to induce antioxidant expression.  However, high 
proliferative DPSCs at late PDs (45-60PDs) without H2O2 treatment demonstrated 
higher levels of catalase expression and activity than at early PDs (10-25PDs), 
although high proliferative DPSCs at late PDs (45-60PDs) failed to promote further 
inductions in catalase expression or activities with H2O2 treatments, compared to 
their early PDs (10-25PDs) counterparts.  The absence of SOD2 and GSTZ1 
antioxidant upregulation with increasing H2O2 exposure may suggest that the 
adaptive mechanisms of protection against oxidative stress are defective following 
extended expansion in culture.  Previous studies have reported either a delayed 
antioxidant induction in fibroblasts until premature senescence is fully reached 
(Chen et al., 2004), or the severely impaired induction of antioxidant defence genes 
in senescent fibroblast populations (Kim et al., 2003), following oxidative stress 
exposure.  Similar findings have also been reported in MSCs from various sources, 
with more aged cells exhibiting significantly lower SOD, catalase and GPX 
expression, leading to reduced antioxidant status and increased oxidative stress-
induced bimolecular damage and senescence overall (Stolzing and Scutt, 2006; 
Geißle et al., 2012; Ko et al., 2012; Jeong and Cho, 2015; Yu et al., 2018; Chen et 
al., 2019).  Thus, it appears that high proliferative DPSCs at late PDs (45-60PDs) 
possess certain impairments in their antioxidant defence capabilities due to persistent 
oxidative stress, culminating in their increased susceptibility to oxidative stress-
induced bimolecular damage and senescence, in line with the findings presented in 
Chapters 2 and 3. 
The results described in the present Chapter support the hypothesis that 
inherent differences exist in the enzymic antioxidant defence mechanisms and 
overall antioxidant status of high and low proliferative DPSCs, in line with similar 
correlations identified with other fibroblast and MSC populations, explaining the 
contrasting susceptibilities to oxidative stress-induced biomolecular damage and 
senescence between these DPSC sub-populations, as previously established 
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(Chapters 2 and 3).  Specifically, the differential expression and activity profiles for 
SOD2 and GSTZ1 appear to be the main enzymic antioxidant mediators of the 
superior antioxidant profiles in high proliferative DPSCs at early PDs (10-25PDs).  
As SOD2 and GSTZ1 are predominantly localised within the mitochondria of cells, 
this implies that their antioxidant and anti-senescence properties principally protect 
high proliferative DPSCs from oxidative damage and senescence within 
mitochondria, proposed to be the major source of endogenous ROS production in 
senescent cell populations.  In contrast, low proliferative DPSCs at early PDs (2-
10PDs), fail to induce SOD2 or GSTZ1 upregulation upon oxidative stress exposure, 
being reliant on cytosolic and extracellular antioxidant defense mechanisms, such as 
SOD1, SOD3, catalase, GPXs, GSR and GSS.  However, as these antioxidants are 
expressed at low/negligible levels in low proliferative DPSCs overall irrespective of 
H2O2 exposure, this suggests that low proliferative DPSCs are already exposed to 
excessive levels of oxidative stress which overcome normal antioxidant defences, 
resulting in defective antioxidant responses and enhanced oxidative stress-induced 
bimolecular damage and senescence.  However, as identified with other fibroblast 
and MSC populations, the superior abilities of high proliferative DPSCs at early PDs 
(10-25PDs) to mount effective SOD2 and GSTZ1 defenses against oxidative stress 
exposure also become impaired at late PDs (45-60PDs) with progression through 
their proliferative lifespans towards senescence and despite significant inductions in 
catalase expression/activities, this leads to increased susceptibilities to oxidative 
stress-induced biomolecular damage and senescence, as previously described 
(Chapters 2 and 3).  Therefore, overall, the results within this Chapter further 
highlight the complexity of cellular antioxidant systems, with MSCs derived from 
different stem cell niche and/or tissue sources exhibiting contrasting antioxidant 
responses and abilities to alleviate ROS accumulation and oxidative stress overall. 
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Chapter 5 
 
General Discussion 
 
5.1 Overview 
This PhD aimed to investigate the potential explanations for the contrasting 
differences in telomere length and proliferative potential between high and low 
proliferative dental pulp stem cells (DPSCs), focusing on whether differential 
oxidative stress responses and enzymic antioxidant profiles exist between DPSC 
sub-populations.  The basis for undertaking this study was that despite significant 
heterogeneity in the ex vivo expansion capabilities of individual DPSCs being 
recognized for a number of years (Gronthos et al., 2000, 2002; Huang et al., 2009a), 
only recently had studies begun to address the impact of such variations in 
proliferative capabilities prior to replicative (telomere-dependent) senescence, on the 
multipotency of different DPSC sub-populations (Alraies et al., 2017).  Although 
high proliferative DPSCs achieved >80 population doublings (PDs), low 
proliferating DPSCs only completed <40PDs before senescence, correlating with 
DPSCs with high proliferative capacities possessing longer telomeres (>18kb) and 
the absence of CD271 expression, compared to less proliferative populations (5-
13kb).  Low proliferative DPSC senescence was also associated with early loss of 
stem cell marker characteristics and impaired osteogenic and chondrogenic 
differentiation, in favour of adipogenesis.  In contrast, high proliferative DPSCs 
retained multipotent differentiation capabilities, only demonstrating impaired 
differentiation following prolonged in vitro expansion (>60PDs, Alraies et al., 
2017).  However, since most studies report no or negligible human telomerase 
catalytic subunit (hTERT) expression in DPSCs (Egbuniwe et al., 2011; Mehrazarin 
et al., 2011a; Murakami et al., 2013; Alraies et al., 2017), such conclusions imply 
that other intrinsic mechanisms may be responsible for the maintenance of telomere 
lengths, proliferative capabilities and multipotency in highly proliferative DPSC 
sub-populations.  Therefore, as oxidative stress is a prominent and well-established 
mediator of telomere-independent senescence (also known as premature senescence 
or stress-induced premature senescence, SIPS), in various cell types, including 
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somatic cells and MSCs (Liu et al., 2011; Shyh-Chang et al., 2013; Li et al., 2017); 
this PhD examined whether differential susceptibilities and responses to oxidative 
stress further contributed to these contrasting differences in proliferative and 
multipotency between high and low proliferative DPSCs. 
 In order to provide evidence for the enhanced ability of high proliferative 
DPSCs to resist oxidative stress, there was a need to confirm the differences between 
high and low proliferative DPSC sub-populations in their respective susceptibilities 
to oxidative stress induced via 50-200µM hydrogen peroxide (H2O2) treatments.  
While all DPSC sub-populations exhibited accelerated susceptibilities to oxidative 
stress-induced senescence in a H2O2 dose-dependent manner (especially at 100µM 
and 200µM concentrations), high proliferative DPSCs exhibited the highest 
resistance to H2O2-induced senescence, being capable of achieving 50-76PDs versus 
untreated controls (>80PDs).  In contrast, low proliferative DPSCs exhibited 
accelerated earlier inductions of oxidative stress-induced senescence with H2O2 
treatments (4-32PDs) and even in untreated controls (11-34PDs). 
Such differences in relative susceptibilities to oxidative stress (H2O2-
induced) senescence were accompanied by contrasting levels of detectable 
senescence-related markers (Ben-Porath and Weinberg, 2004; Campisi and d'Adda 
di Fagagna, 2007; Victorelli and Passos, 2017), with high proliferative DPSCs 
possessing reduced SA-β-galactosidase (SA-β-Gal) positivity and tumour 
suppressor marker (p53 and p16INK4a) expression, at PDs where low proliferative 
DPSCs demonstrated overall increases in the detection of these and other 
senescence-associated markers, such as p21waf1, particularly with increasing H2O2 
concentrations.  As both p53 and p16INK4a are both regarded as the principal 
mediators of senescence in MSCs (Shibata et al., 2007; Muthna et al., 2010; 
Mehrazarin et al., 2011; Feng et al., 2014) and as p21waf1 also has a role in 
maintaining stem cell renewal due to its positive effects on cell cycle progression 
(Kippin et al., 2005; Ju et al., 2007), this may explain the presence of early p21waf1 
expression in all DPSC sub-populations analysed.  Nonetheless, the contrasting p53 
and p16INK4a expression between high and low proliferative DPSCs further confirms 
the earlier onset of oxidative stress-induced senescence with low proliferative DPSC 
sub-populations, versus high proliferative DPSCs at equivalent PDs. 
 The principle reason previously identified to be responsible for the 
contrasting proliferative responses and susceptibilities to telomere-dependent 
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senescence in DPSC sub-populations, were the respective average telomere lengths 
between these populations (>18kb versus 5-13kb for high and low proliferative 
DPSCs respectively, Alraies et al., 2017) with such superior telomere dynamic 
characteristics in high proliferative DPSCs sub-populations permitting extended 
PDS in culture, whilst protecting these DPSC from the onset of replicative 
senescence.  However, in line with oxidative stress-induced senescence can occur 
irrespective to telomere length and without telomere shortening (Fumagalli et al., 
2012; Bielak-Zmijewska et al., 2014, 2018), all DPSCs analysed generally retained 
their average telomere length profiles during extended culture, both in the absence 
and presence of oxidative stress. 
 In agreement with the majority of previous studies (Egbuniwe et al., 2011; 
Mehrazarin et al., 2011a; Murakami et al., 2013; Alraies et al., 2017), no or 
negligible hTERT expression was identified in the high and low proliferative DPSC 
sub-populations assessed herein.  While hTERT expression is often an indication of 
the cell pluri-/multi-potency, down-regulation result in progressive telomere 
shortening and cellular senescence (Zimmermann et al., 2003, Flores and Blasco, 
2010).  Such findings imply that hTERT expression and activity appears not to be 
responsible for the maintenance of telomere lengths in high proliferative DPSCs or 
the variations in proliferative capabilities. 
The expression of various mesenchymal (CD29, CD73, CD90 and CD105), 
hematopoietic (CD45), embryonic (Oct4, Nanog, SSEA4, CD146 and CD166) and 
neural crest stem cell markers (CD271 and Slug), were further assessed in high and 
low proliferative DPSC sub-populations (Huang et al., 2009; Waddington et al., 
2009; Kawashima, 2012; Harrington et al., 2014; Alraies et al., 2017), to determine 
the impact of oxidative stress-induced senescence on the overall stem cell 
characteristics of high and low proliferative DPSCs.  However, although all sub-
populations were confirmed as being DPSCs, based on positive MSC marker (CD73, 
CD90, CD105) and absence of haematopoietic marker (CD45) expression, the 
expression of these and other stem cell markers were largely unaffected by 
increasing H2O2 treatment or culture expansion overall.  However, certain markers, 
such as CD73, CD105, Oct4, SSEA4, CD271 and Slug, did decline with prolonged 
culture expansion in the absence or presence of H2O2 treatment, in line with previous 
findings (Takahashi and Yamanaka, 2006; Boroujeni et al., 2012; Tsai et al., 2012; 
Forristal et al., 2013; Alraies et al., 2017; Mas-Bargues et al., 2017).  However, 
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intriguingly, despite BMI-1 expression also being proposed to be sensitive to 
oxidative stress and senescence, due to its role in repressing p16INK4a expression and 
maintaining cellular hyper-proliferation (Itahana et al., 2003; Park et al., 2004; Mas-
Bargues et al., 2017), no obvious differences in BMI-1 expression were identified 
between the high and low proliferative DPSCs assessed herein, despite the apparent 
variations identified in their overall susceptibilities to oxidative stress-induced 
senescence.  Nonetheless, the loss of these MSC markers by high or low proliferative 
DPSC sub-populations with prolonged culture expansion and/or H2O2 treatment, 
may impact on their retention of stem cell characteristics and altered differentiation 
capabilities (Rallapalli et al., 2009; Sivasankar and Ranganathan, 2015; Moraes et 
al., 2016; Alraies et al., 2017).  Additionally, the display of such significant 
variations in stem cell marker expression between DPSC sub-populations further 
highlights the diverse heterogeneity which exists, with each sub-population having 
contrasting phenotypic properties and/or biological activities based on their origins 
or stem cell niches within the dental pulp (Gronthos et al., 2000, 2002; Huang et al., 
2009; Sloan and Waddington, 2009; Ducret et al., 2016; Ledesma-Martínez et al., 
2016). 
 Having established that significant variations in the susceptibilities of DPSCs 
to oxidative stress-induced (telomere-independent) senescence, the study sought to 
investigate whether contrasting susceptibilities to oxidative stress-related 
biomolecular damage also existed between high and low DPSC sub-populations.  
Oxidative stress-induced senescence is well-established to be accompanied by an 
accumulation of oxidative DNA, protein and lipid modification and damage 
(Beckman and Ames, 1998; Chaudhari et al., 2014), resulting in the formation of 
oxidative markers, such as 8-hydroxy-deoxy-guanosine (8-OHdG), protein carbonyl 
content, malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE; Chen et al., 1995; 
Halliwell, 1999; Levine and Stadtman, 2001; Spiteller, 2001; Tahara et al., 2001; 
Cooke et al., 2003; Dalle-Donne et al., 2003; Evans et al., 2004; David et al., 2007). 
 In line with the contrasting susceptibilities of high and low proliferative 
DPSCs to oxidative stress-induced senescence, similar differences were also shown 
in the relative susceptibilities of such DPSC sub-populations to oxidative stress-
induced DNA, protein and lipid damage.  Indeed, low proliferative DPSC 
susceptibility to H2O2-induced senescence was accompanied by increased oxidative 
stress-induced bimolecular damage at early PDs (2-10PDs), with elevated DNA (8-
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OHdG), protein (carbonyl content) and lipid (peroxidation) detection, irrespective of 
H2O2 treatments.  In contrast, high proliferative DPSCs exhibited limited oxidative 
biomolecular damage at early PDs (2-10PDs), only equivalent to low proliferative 
DPSCs at much later PDs (45-60PDs). 
Oxidative DNA damage and impaired DNA repair capabilities are 
established to accompany cellular senescence (Chen et al., 1995, 2003; Duan et al., 
2005; Hazane et al., 2006; Hazane-Puch et al., 2010).  Therefore, considering the 
increased susceptibilities of low proliferative DPSC sub-populations to oxidative 
stress-induced senescence, it is conceivable that these increases in oxidative DNA 
damage contribute to the early-onset of p53, p21waf1 and p16INK4a induction and 
senescence in these DPSCs (Ben-Porath and Weinberg, 2004; Campisi and d'Adda 
di Fagagna, 2007; Victorelli and Passos, 2017).  Furthermore, the early existence of 
elevated oxidative protein and lipid detection in low proliferative DPSC sub-
populations reflects their enhanced susceptibility to oxidative stress-induced 
modification/damage and the accumulation of their oxidized products (Halliwell, 
1999; Sitte et al., 2000; Spiteller, 2001; Kohen and Nyska, 2002; Chondrogianni and 
Gonos, 2004; Grune et al, 2005; Torres and Perez, 2008), compared to the high 
proliferative DPSCs. 
 As enhanced oxidative stress-induced bimolecular damage and senescence 
are a consequence of excessive reactive oxygen species (ROS) production and 
exposure, at the expense of cellular antioxidant defence mechanisms, the evidence 
supporting distinct variations in the susceptibilities of high and low proliferative 
DPSCs to oxidative stress-induced senescence and biomolecular damage, led to the 
hypothesis that such differences were related to differential enzymic antioxidant 
expression and activity profiles between these DPSC sub-populations.  Indeed, 
enzymic antioxidant status is critical in maintaining the intracellular redox balance 
and cell survival, with strong correlations existing between superior cellular enzymic 
antioxidant capacities and resistance to oxidative stress and senescence, with such 
findings established in fibroblasts (Serra et al, 2000, 2003; Lorenz et al, 2001; 
Blander et al, 2003; Richter and von Zglinicki, 2007; Hammad et al., 2018) and 
mesenchymal stem cells (MSCs) from various sources (He et al., 2004; Valle-Prieto 
and Conget, 2010; Ko et al., 2012; Jeong and Cho, 2015; Yu et al., 2018; Chen et 
al., 2019). 
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In line with their resistance to oxidative stress-induced senescence and 
biomolecular damage, significant increases in superoxide dismutase (SOD2) and 
glutathione S-transferase ζ (GSTZ1) expression, in addition to significantly 
increased total SOD activities, were identified in high proliferative DPSCs at early 
PDs (10-25PDs).  Such findings suggest that the differential expression and activity 
profiles for SOD2 and GSTZ1 are the main enzymic antioxidant mediators of the 
superior antioxidant profiles in high proliferative DPSCs at early PDs (10-25PDs).  
Mitochondrial-specific SOD2 is acknowledged as the primary antioxidant enzyme 
that protects cells from excessive ROS within the mitochondria and premature 
senescence, including MSCs (He et al., 2004; Kienhöfer et al., 2009; Pervaiz et al., 
2009; Valle-Prieto and Conget, 2010; Fukai and Ushio-Fukai, 2011; Pietilä et al., 
2012; Yang et al., 2013; Gan et al., 2015; Sart et al., 2015; Sun et al., 2015; Sheshadri 
and Kumar, 2016).  High SOD2 expression/activity levels have also been implicated 
as having essential roles in regulating ESC self-renewal and pluripotency, in addition 
to supporting superior MSC differentiation capabilities, via the regulation of ROS 
homeostasis (Chen et al., 2008; Pietilä et al., 2012; Gan et al., 2015; Sheshadri et al., 
2015; Sheshadri and Kumar, 2016; Bertolo et al., 2017).  Therefore, in addition to 
alleviating oxidative stress and promoting greater cell expansion in high proliferative 
DPSCs, their high induction of SOD2 expression and activities could also contribute 
to the maintenance of stem cell characteristics and multipotent differentiation 
capabilities in these DPSC sub-populations (Alraies et al., 2017).  Furthermore, 
increased GSTZ1 expression, especially mitochondrial GSTZ1, has been strongly 
associated with decreased human ageing and prolonged longevity, partly due to 
restrictions in cellular telomere shortening (Starr et al., 2008; Di Cianni et al., 2013; 
Zhong et al., 2018).  Furthermore, GSTZ1-/- mice have also been shown to possess 
alterations in mitochondrial ultrastructure, size and activity, confirming the 
important protective effects that GSTZ1 play in mitochondria (Lim et al., 2004; 
Board and Anders, 2011).  Therefore, as mitochondria are regarded as a principle 
source of endogenous ROS production during cellular senescence (Passos and von 
Zglinicki, 2006; Passos et al., 2007; Geißle et al., 2012; Correia-Melo et al., 2016; 
Bertolo et al., 2017), these findings also imply that SOD2 and GSTZ1 
expression/activity profiles in high proliferative DPSCs, mediate antioxidant and 
anti-senescence protection in these sub-populations against mitochondrial ROS 
production and subsequent cellular damage/senescence. 
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 In contrast to high proliferative DPSCs, the findings obtained suggest that 
low proliferative DPSCs at early PDs (2-10PDs), fail to induce SOD2 or GSTZ1 
upregulation upon oxidative stress exposure, being reliant on cytosolic and 
extracellular antioxidant defense mechanisms, such as cytosolic SOD1, extracellular 
SOD3, catalase, glutathione peroxidases (GPXs), glutathione reductase (GSR) and 
glutathione synthetase (GSS).  Indeed, similar contrasts between SOD1/SOD2 and 
catalase expression/activity profiles have previously been identified in high and low 
proliferative bone marrow-derived, MSCs (Bertolo et al., 2017).  However, as these 
antioxidants are expressed at low/negligible levels in low proliferative DPSCs 
overall irrespective of H2O2 exposure, this suggests that low proliferative DPSCs are 
already exposed to excessive levels of oxidative stress which overcome normal 
antioxidant defences, resulting in defective antioxidant responses and enhanced 
oxidative stress-induced bimolecular damage and senescence.  Indeed, despite being 
a well-established and potent H2O2 detoxifying antioxidant, evidence suggests that 
catalase is particularly susceptible to down-regulated expression and/or enzymic 
inactivation following chronic ROS exposure, as reduced catalase activities have 
been reported in a number of tissues associated with excessive oxidative stress and 
disease (Góth and Eaton, 2000; Shi et al., 2007; Sadi et al., 2008; Waddington et al., 
2011).  Such findings suggest that low proliferative DPSCs at early PDs (2-10PDs) 
are exposed to chronic levels of oxidative stress, leading to an impaired ability to 
maintain catalase activities and degrade H2O2, resulting in enhanced oxidative stress-
induced bimolecular damage and senescence. 
 However, despite the superior abilities of high proliferative DPSCs at early 
PDs (10-25PDs) to elevate SOD2 and GSTZ1 expression, as with other fibroblast 
and MSC populations, such antioxidant responses become impaired at late PDs (45-
60PDs) with progression through their proliferative lifespans towards senescence.  
The absence of SOD2 and GSTZ1 antioxidant upregulation with increasing H2O2 
exposure may suggest that the adaptive mechanisms of protection against oxidative 
stress are defective following extended expansion in culture.  Previous studies have 
reported either a delayed antioxidant induction in fibroblasts until premature 
senescence is fully reached (Chen et al., 2004), or the severely impaired induction of 
antioxidant defence genes in senescent fibroblast populations (Kim et al., 2003), 
following oxidative stress exposure.  Similar findings have also been reported in 
MSCs from various sources, with more aged cells exhibiting significantly lower 
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SOD, catalase and GPX expression, leading to reduced antioxidant status and 
increased oxidative stress-induced bimolecular damage and senescence overall 
(Stolzing and Scutt, 2006; Geißle et al., 2012; Ko et al., 2012; Jeong and Cho, 2015; 
Yu et al., 2018; Chen et al., 2019).  As high SOD2 expression/activity levels have 
also been implicated as having essential roles in regulating ESC self-
renewal/pluripotency and supporting MSC differentiation capabilities (Chen et al., 
2008; Pietilä et al., 2012; Gan et al., 2015; Sheshadri et al., 2015; Sheshadri and 
Kumar, 2016; Bertolo et al., 2017), the loss of SOD2 expression and activities could 
account for the loss of multipotency in high proliferative DPSCs following extended 
culture expansion (Alraies et al., 2017).  Thus, it appears that high proliferative 
DPSCs at late PDs (45-60PDs) possess certain impairments in their antioxidant 
defence capabilities due to persistent oxidative stress, culminating in their increased 
susceptibility to oxidative stress-induced bimolecular damage/senescence and 
potential loss of stemness and multipotency properties. 
Overall, the findings presented in this Thesis provide further support for the 
hypothesis that inherent differences exist in the enzymic antioxidant defence 
mechanisms and overall antioxidant status of high and low proliferative DPSCs, in 
line with similar correlations identified with other fibroblast and MSC populations.  
Such conclusions help explain the contrasting susceptibilities to oxidative stress-
induced biomolecular damage and senescence between these DPSC sub-populations.  
The data also highlights the complexity of cellular antioxidant systems, with MSCs 
derived from different stem cell niche and/or tissue sources exhibiting contrasting 
antioxidant responses and abilities to alleviate ROS accumulation and oxidative 
stress overall.  It has been proposed that high proliferative/multipotent DPSCs are 
minority sub-populations within dental pulp tissues (Sloan and Waddington, 2009; 
Alraies et al., 2107).  Therefore, in order to exploit these desirable DPSCs for 
regenerative purposes, it is imperative that strategies are developed which permit the 
optimisation of population selection through the selectively screening and isolation 
of superior quality DPSCs from dental pulp tissues for in vitro expansion, 
assessment, bioprocessing and prudent cell banking.  Such initiatives will aid the 
translational development of more effective DPSC-based therapies for clinical 
evaluation and application (Hilkens et al., 2016; Ferrúa et al., 2017; Rodas-Junco et 
al., 2017; Deans et al., 2018).  Indeed, there are an ever-increasing number of cellular 
characteristics, such as telomere lengths and the relative expression of cell surface 
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markers (BMI-1, SSEA-4, CD271, STRO-1, c-Kit), being purported to characterise 
the presence of high proliferative/multipotent DPSC sub-populations (Mehrazarin et 
al., 2011; Kawanabe et al., 2012; Pisciotta et al., 2015; Yasui et al., 2016; Alraies et 
al., 2017).  Consequently, the identification of significantly elevated SOD2 and 
GSTZ1 expression levels in high proliferative, multipotent DPSC sub-populations 
will allow the optimization of population selection by selectively screening and 
isolating better quality DPSCs from intact dental pulp tissues for in vitro expansion 
and assessment, aiding the translational development of more effective DPSC-based 
therapies for clinical evaluation and application. 
 
5.2 Future Work 
This PhD study can serve as a base for future studies that can further our knowledge 
on the mechanisms underlying the contrasting regenerative capabilities of high and 
low proliferative DPSCs.  This Thesis showed that SOD2 and GSTZ1 expression 
and activities ae significantly elevated in high proliferative, multipotent DPSC sub-
populations.  Therefore, it would be strongly advised to examine this further through 
the stable knockdown of SOD2 and GSTZ1 gene expression in high proliferative 
DPSCs, using short hairpin RNA or CRISPR-CAS9 technology (Dowdy, 2017) and 
subsequently investigate the impact of such gene expression knockdowns on their 
susceptibilities to oxidative stress-induced biomolecular damage and senescence, 
stemness and multipotency characteristics. 
As SOD2 and GSTZ1 are particularly localised within the mitochondria of 
cells (Lim et al., 2004; Board and Anders, 2011; Fukai and Ushio-Fukai, 2011; 
Pietilä et al., 2012; Di Cianni et al., 2013; Yang et al., 2013; Gan et al., 2015; Sart et 
al., 2015; Sun et al., 2015; Sheshadri and Kumar, 2016; Zhong et al., 2018), their 
protection against mitochondrial oxidative stress may contribute to the maintenance 
of proliferative and differentiation capabilities in high proliferative/multipotent 
DPSCs.  Therefore, an alternative approach would be to examine whether low 
proliferative/unipotent DPSCs can be manipulated and ‘rescued’ from the negative 
effects of oxidative stress and senescence, via their over-expression of SOD2 and 
GSTZ1 through their transfection of non-viral plasmid or viral vectors carrying the 
SOD2 or GSTZ1 genes (Zhang and Godbey, 2006).  Alternatively, exogenous small 
molecules may be applied to culture medium to induce similar effects, by 
specifically preventing mitochondrial oxidative stress or cellular senescence, leading 
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to improved proliferative and differentiation responses.  Potential small molecules 
to examine for efficacy, include mitochondrial-targeting antioxidants (such as 
MitoQ and SkQ), suggested to provide higher protection against oxidative damage 
within mitochondria due to their ability to cross the mitochondrial membrane, hence 
eliminating ROS within their source (Oyewole and Birch-Machin, 2015; Feniouk 
and Skulachev, 2017).  Alternatively, established cellular senescence inhibitors 
(such as the ROCK inhibitor, Y27632), may be evaluated to increase the proliferative 
and differentiation capabilities of low proliferative DPSCs (Uzawa et al., 2016; Park 
et al., 2018).  Indeed, a recent study revealed that ROCK inhibitor, Y27632, caused 
ROS reduction and induced functional recovery of mitochondria in senescent 
fibroblasts, ultimately resulting in amelioration of senescence (Kang et al., 2017).  
Furthermore, a new class of synthetic and natural, bioactive compounds increasingly 
being evaluated as anti-senescence compounds are the senolytics which act by 
eliminating senescent cells or reversing the senescence-associated secretory 
phenotype (SASP, Mária and Ingrid, 2017; Gurău et al., 2018).  Following 2D 
confirmation of such effects, further work could subsequently investigate the 
antioxidant or anti-senescence protective roles of such small molecules in 3D 
biomaterial environments and whether such methods enhance DPSC behaviour and 
therapy development in such settings (Zhou et al., 2016). 
Another key consideration relating to the findings, is whether the contrasting 
proliferative, differentiation and enzymic antioxidant properties between high and 
low proliferative DPSC sub-populations reflect their isolation from different 
mesodermal or neuro-ectodermal origins (Pisciotta et al., 2015; Alraies et al., 2017) 
or stem cell niches within the dental pulp (Sloan and Waddington, 2009).   Although 
the nature and origins of these DPSCs within dental pulpal tissues have yet to be 
elucidated, a better insight into their cell surface marker profiles by Flow Cytometry 
and/or genotypic profiles by Microarray technology, may shed new light on the 
developmental origins and stem cell niche sources of these contrasting DPSC sub-
populations within dental pulp tissues (Gronthos et al., 2000, 2002; Sloan and 
Waddington, 2009; Alraies et al., 2017). 
In summary, this Thesis has established and provided a greater insight into 
the oxidative defence mechanisms underlying the contrasting proliferative and 
differentiation capabilities of high and low proliferative DPSC sub-populations.  
Thus, the Thesis has enhanced our understanding of DPSC biology and its inter-
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relationship with cellular ageing, in addition to ultimately providing additional 
cellular characteristic to utilise in the successfully screening, identification and 
isolation of superior quality high proliferative/multipotent DPSCs from dental pulp 
tissues.  Furthermore, the Thesis has suggested certain small molecule approaches 
to overcome the reduced proliferative and unipotent capabilities of low proliferative 
DPSCs, potentially enabling us to increase their expansion and differentiation 
capacities beyond current levels.  Such initiatives, therefore, may permit us to exploit 
DPSC sub-populations even more, for improved in vitro and in vivo assessment and 
more successful stem cell therapy development for eventual clinical use in 
regenerative medicine. 
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